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Abbreviations 
 
α/β T cel    T cel expressing a TCR composed of Vα- and Vβ-chains 
aa   amino acid 
Ab   antibody 
ABPA   alergic bronchopulmonary aspergilosis 
AdV   adenovirus 
APC   antigen presenting cel 
ARTE   antigen-reactive T cel enrichment 
BAL    bronchoalveolar lavage 
CCR    CC chemokine receptor 
CD   cluster of diferentiation (only with numbers) 
CD    Crohn´s Disease 
CD40L   CD40 ligand 
CF   cystic fibrosis 
CFSE   carboxyfluorescein succinimidyl ester 
CLR    C-type lectin receptor 
CMV   cytomegalovirus 
CRTAM  cytotoxic and regulatory T cel molecule 
CRTh2  chemoatractant receptor-homologous molecule expressed on Th2 cels 
CT   computed tomography 
CTL   cytotoxic T cel 
CV   coeficient of variation 
CXCR    CXC chemokine receptor 
DC    dendritic cel 
DNA    deoxyribonucleic acid 
EDTA   ethylenediamine tetraacetic acid 
ELISA   enzyme linked immunosorbent assay 
ELISPOT  enzyme-linked immunospot 
FACS   fluorescence-activated cel sorting 
FITC   fluorescein isothiocyanate 
Foxp3   forkhead box protein P3 
FSC   forward scater 
γδ T cel   T cel expressing a TCR composed of Vγ- and Vδ-chains 
GAD    glutamic acid decarboxylase 
GALT    gut associated lymphoid tissue 
GM-CSF   granulocyte-macrophage CSF 
h    human 
HIV    human immunodeficiency virus 
HLA    human histocompatibility leukocyte antigen 
HSCT    hematopoietic stem cel transplantation 
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IA    invasive aspergilosis 
IFI   invasive fungal infections 
IFN   interferon (e.g. IFN-γ) 
Ig   immunoglobulin 
IL   interleukin (e.g. IL-2) 
KLH    keyhole limpet hemocyanin 
MACS    magnetic cel separation 
MHC    major histocompatibility complex 
MOG    myelin oligodendrocyte glycoprotein 
MP65   C. albicans mannoprotein 65 
PBMC    peripheral blood mononuclear cels 
PCR    polymerase chain reaction 
PE    phycoerythrin 
PerCP    peridinin chlorophyl protein 
PMA    phorbol myristate acetate 
r   recombinant 
ROC   receiver-operating characteristic 
rpm   revolutions per minute 
PAMP    pathogen associated molecular patern 
PBS    phosphate-bufered saline 
pp    peptide pool 
PRR    patern recognition receptor 
pTreg    peripheral regulatory T cel 
SD   standard deviation 
SEB    Staphylococcal enterotoxin B 
SEM   standard eror of the mean 
SSC   side scater 
T-bet    Th1-specific T-box 1 transcription factor 
Tcon   conventional T cel 
TCR    T cel receptor 
TGF-β   transforming growth factor β 
Th cel    T helper cel 
TLR   tol-like receptor 
Tmem   conventional memory T cel 
TNF-α  tumor necrosis factor α 
Treg   regulatory T cel 
Tresp   responder T cel 
TSDR    Treg specific demethylated region 
tTreg   thymic regulatory T cel 
WBC    white blood cel 
WT-1    Wilms tumor antigen 
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1 Introduction 
 
1.1 T cels 
 
T cels are the central organizers of adaptive immune responses against various pathogens and 
are essential in the mediation of tolerance to auto-antigens or usualy harmless environmental 
antigens, such as commensals, alergens  or food.  They  diferentiate in the thymus from 
incoming  bone-marow  derived lymphocyte  progenitor cels into  naive  T cels, expressing 
T cel receptors (TCRs)  with a single specificity that enable the recognition  of antigenic 
epitopes. The majority of T cels (90-95%) express TCRs composed of a heterodimer of α/β 
immunoglobulin chains that are generated from variable, diversity, joining and constant gene 
fragments through somatic  gene arangement (Davis and  Bjorkman,  1988).  This  process 
alows the generation of a highly diverse TCR repertoire that enables the immune system to 
respond to a  multitude  of  diferent antigens.  The theoretical  number  of  diferent α/β  TCRs 
that can  be  generated  has  been estimated to  be  >1015 in  mice and  >1018 in  humans (Davis, 
1990; Davis and  Bjorkman,  1988).  However  direct assessment  of  TCR clonotypes  has 
revealed a repertoire diversity of about 106 in mice (Casrouge et al., 2000) and 108 in humans 
(Arstila et al., 1999; Robins et al., 2009). 
 
The α/β  TCR recognizes  peptides  presented  on  major  histocompatibility complex (MHC) 
molecules. During T cel development, each T cel has to pass through a process of positive 
and  negative selection that ensures survival  of those  T cels, that express a  TCR able to 
recognize self-MHC, but with a low afinity for self-peptides. Thus, each T cel in the naive 
repertoire that survived these selection  processes should  be capable to recognize self-MHC 
with a foreign peptide, but avoid self-peptide recognition (Hogquist et al., 2005; Jenkins et al., 
2010). In general, two major subsets of α/β T cels can be distinguished. T cels expressing 
the co-receptor CD8 (cytotoxic cels, CTL) recognize MHC class I (MHC I) molecules, which 
are expressed  on almost al cel types and  present  peptides from endogenous  proteins, e.g. 
from intracelular  pathogens  but also self-peptides.  This  mechanism alows the immune 
system to look inside the cels and clear virus infected or tumor cels. Recognition of peptide-
MHC I  by  CD8+  T cels induces  usualy apoptosis  of the  presenting cel  by release  of 
cytotoxic molecules like perforins and granzymes or via cel surface molecules (Harty et al., 
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2000; Trapani and Smyth, 2002; Van Parijs and Abbas, 1996). In contrast, T cels expressing 
the co-receptor  CD4 (T helper cels,  Th) recognize  MHC class I (MHC I)  molecules. 
MHC I is expressed on professional antigen-presenting cels (APCs), such as dendritic cels 
(DCs),  B cels  or  macrophages that  present  peptides from exogenous  proteins, e.g. from 
extracelular  pathogens,  but also  normaly  harmless antigens like alergens, food, etc. 
Activated CD4+ T cels conduct a variety of diferent functions: they provide help to B cels 
to  produce antibodies, support  priming and  maintain responses  of  CD8+  T cels, control 
recruitment and  migration  of innate immune cels and also regulate/ suppress immune 
responses to control autoimmunity and to dampen overwhelming immune reactions (Swain et 
al., 2012; Zhu et al., 2010). 
 
 
1.1.1 Functional heterogeneity of CD4+ T cels 
 
Upon antigen encounter in the secondary lymphoid organs, those naive T cels that express a 
TCR specific for the antigen undergo clonal expansion and diferentiate into efector cels that 
orchestrate specific immune responses. The diferentiation into efector cels is accompanied 
by the acquisition  of  distinct efector functions that enable an adequate and  protective 
immune reaction  depending e.g.  on the  nature  of the  pathogen and/  or the site  of exposure. 
Folowing clearance of the antigen, the expanded pool of efector T cels contracts, leaving a 
smaller population of persistent memory cels, which maintain the acquired efector functions 
and provide protection upon re-exposure to the antigen (Jenkins et al., 2001). 
The  kind  of efector response is  mainly  determined  by the cytokine  milieu  during the first 
antigen encounter, although other factors like the afinity to the TCR might play a role (Zhu 
and  Paul,  2010).  Polarizing cytokines  produced  by  APCs induce the expression  of  master 
transcription factors,  which in turn  determine the cytokine  producing capacity  of the  T cel 
(Murphy and Reiner, 2002). In particular CD4+ T cels are heterogeneous and conduct a wide 
range of diferent efector functions, which alow their further classification into several Th 
cel subsets. In addition to their cytokine-producing capacities,  Th cel subsets can  be 
classified according to the expression  of several  homing receptors that are induced  during 
polarization and  mediate selective recruitment  of the  T cels to the site  of antigen  uptake 
(Bromley et al., 2008; Butcher and Picker, 1996; Salusto et al., 2004). 
Th1 cels diferentiate in presence of IL-12 and IFN-γ, express the transcription factor T-bet 
(Rogge et al.,  1997; Szabo et al.,  2000) and the chemokine receptors  CXCR3 and  CCR5 
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(Salusto et al.,  1998).  They are characterized  by  production  of the  pro-inflammatory 
cytokines IFN-γ and  TNF-α,  which activate  macrophages and  other immune cels. In 
addition, Th1 cels produce IL-2, a key cytokine for T cel proliferation and homeostasis. In 
contrast,  Th2  diferentiation  occurs in  presence  of IL-4 and requires the transcription factor 
GATA-3 (Zheng and  Flavel,  1997).  Th2 cels express the  homing receptors  CCR3,  CCR4 
and CRTh2 and the cytokines IL-4, IL-5, IL-13, IL-25 and are important in providing help for 
antibody class switching and recruitment of eosinophils. Th17 cels express the transcription 
factor Ror-γt (Ivanov et al., 2006) and have been shown to diferentiate in presence of IL-6, 
IL-23, IL-1β and/  or  TGF-β, although the requirements seem to  difer  between  mouse and 
human Th17 cels and the role of TGF-β in human Th17 cel diferentiation is stil a mater of 
debate (Acosta-Rodriguez et al.,  2007a; Cosmi et al.,  2008; Das et al.,  2009; Manel et al., 
2008; Santarlasci et al.,  2009; Volpe et al.,  2008; Yang et al.,  2008). In addition, the 
diferentiation requirements may vary depending on the nature of the pathogen (Zielinski et 
al., 2012). Th17 cels are further characterized by the expression of the chemokine receptors 
CCR6 and CCR4 (Acosta-Rodriguez et al., 2007b; Annunziato et al., 2007) and production of 
the cytokines IL-17, IL-21 and IL-22 (Liang et al.,  2006). IL-17 induces recruitment and 
activation of neutrophils and triggers the secretion of pro-inflammatory cytokines by a variety 
of diferent immune cels (Harington et al., 2005). In contrast, IL-22 has been shown to act 
mainly on epithelial cels and triggers the expression of anti-microbial peptides (Ouyang and 
Valdez, 2008; Wolk et al., 2004). More recently, Th22 cels have been introduced as another 
potential  Th subset that is characterized  by secretion  of IL-22,  but  neither IL-17  nor IFN-γ. 
Th22 cels express in addition to  CCR6 and  CCR4 the chemokine receptor  CCR10,  which 
facilitates  migration into the skin and  may therefore  play an important role in skin immune 
homeostasis and pathology (Duhen et al., 2009; Trifari et al., 2009). 
Another subset of CD4+ T cels are regulatory T cels (Treg). They are important suppressors 
of immune reactions and are crucial for the  maintenance  of  peripheral tolerance  by their 
ability to suppress autoimmunity, immunopathology and tissue destruction (Sakaguchi et al., 
2010). Critical for the suppressive capacity of Treg, is the transcription factor Foxp3, which 
controls the expression of genes essential for Treg homeostasis and function (Fontenot et al., 
2003; Hori et al., 2003). Furthermore, Treg are characterized by their constitutive expression 
of  CD25, the IL-2 receptor α-chain.  Foxp3+  Treg  have  been shown to arise in the thymus 
during  CD4+  T cel  development,  maybe from those  precursors  with an afinity for self-
peptide-MHC at the  upper end  of the  positive selection range (thymic regulatory  T cels, 
tTreg) (Jenkins et al.,  2010; Josefowicz and  Rudensky,  2009).  However, they can also  be 
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induced in the  periphery from  naive  CD4+  T cels (peripheral  Treg,  pTreg), folowing 
encounter  with specific antigens (Bluestone and  Abbas,  2003).  The factors that  determine 
Treg diferentiation in the thymus as wel as in the periphery are not completely understood, 
but several evidences suggest, that the afinity and strength  of  TCR  binding and antigen 
presentation might play an important role (Apostolou and von Boehmer, 2004; Bensinger et 
al., 2001; Gotschalk et al., 2010; Graca et al., 2005; Kretschmer et al., 2005). 
 
Previous research  has established a connection  between the  patern  of the  Th cel response 
and the  nature  of the  pathogen  or antigen encountered.  For example  Th1 cels  have  been 
shown to  mediate immune responses against intracelular  viral and  bacterial antigens. In 
contrast, Th2 cels mediate host defense against extracelular parasites like helminths, but are 
also involved in  promotion  of alergy to  normaly  harmless environmental antigens, e.g. 
polen,  house  dust mite  or food.  Th17 cels  have  been implicated to  play a  major role in 
immune responses at mucosal surfaces and are believed to be critical in host defense against 
bacteria and fungi.  However,  pathogenic  Th17 responses are also strongly linked to several 
autoimmune  diseases and tissue  destruction (Zhu and  Paul,  2008; Zhu and  Paul,  2010). 
Finaly, several evidences from mouse models suggest, that Treg and in particular pTreg play 
an important role in  maintaining tolerance against commensals  or inhaled antigens 
encountered at  mucosal sites (Bilate and  Lafaile,  2012; Curoto  de  Lafaile et al.,  2008; 
Curoto de Lafaile and Lafaile, 2009; Josefowicz et al., 2012). 
Although the classification  of  Th cel subsets in  general, and establishments  of the relation 
between pathogens and the class of Th cel response are useful for a beter understanding and 
dissection of memory T cel responses, they might oversimplify the complex heterogeneity of 
T cel responses against a certain antigen. Especialy for complex pathogens it is likely that 
immune responses are  mediated  by several  Th cel subsets that al together contribute to 
protective immunity. In addition, there is a lack of knowledge about the antigen specificity of 
pathogen-reactive Th cels, in particular of regulatory T cels, as wel as their frequency and 
phenotype  within the  human  T cel repertoire,  or their relation to the conventional  T cel 
response specific for the same antigen. Therefore more detailed analyses of antigen-specific 
T cel responses  need to  be  obtained that  provide comprehensive information about antigen 
specific naive, memory as wel as Treg within the human T cel repertoire. This wil help to 
understand the  mechanisms  of  protective immunity versus  disease  progression  or immune 
pathology. 
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1.2 Antigen-specific T cels 
 
T cels are the central  organizers  of adaptive immune responses.  Within the total  T cel 
repertoire, however, only the very smal number of cels with specific T cel receptors enables 
the specific defense against a certain antigen. Information about the frequency, phenotype and 
function  of those antigen-specific  T cels is essential to  gain information about the immune 
status of an individual and to understand the mechanisms of protective immunity in healthy 
donors versus  disease  progression in  diferent  patient  groups  or the  development  of 
immunopathology, e.g. autoimmunity or alergy. 
The  major chalenge for the analysis  of  T cels specific for a certain antigen is their low 
frequency  within the  vast  pool  of  T cels  with irelevant specificities. In  highly  boosted 
immune responses, such as acute infections,  persistent  viruses  or immediately after 
vaccination, transient frequencies  of several  percent can  be  detected  within the total  T cel 
compartment. However, in absence of acute infections, the frequencies of specific T cels are 
usualy only in the range of 0.01-1%. This also applies to the memory T cel pool, where the 
specific T cels have already undergone clonal expansion. For rare cels, such as auto-antigen- 
or alergen-specific  T cels, the frequencies are even lower (1 cel  per  104-105) and finaly 
within the  naive repertoire,  T cels specific for a single  peptide-MHC can  be found  with 
frequencies of only 1 cel per 105-107 naive T cels (Alanio et al., 2010; Geiger et al., 2009; 
Jenkins et al., 2010; Jenkins and Moon, 2012; Kwok et al., 2012). 
These low frequencies  of antigen-specific  T cels  make it  obvious that  methods for their 
analysis need to be highly specific, to detect only those cels that are specific for the antigen, 
and furthermore  need to enable the  processing  of large cel  numbers to colect suficient 
numbers  of target cels for statisticaly relevant analyses.  Due to these  high technical 
requirements, antigen-specific  T cels could for long time  be  measured  only indirectly 
folowing in vitro expansion.  However, in vitro expansion  of antigen-specific  T cels can 
induce an  unpredictable  bias to the cels in terms  of  phenotypical and functional 
modifications, outgrowth of certain T cel clones or proliferation due to bystander activation. 
This makes it impossible to draw conclusions from in vitro expanded T cels on their ex vivo 
properties and to determine the actual frequency of cels that are specific for a certain antigen. 
Therefore, the direct ex vivo detection and characterization of specific T cels has become an 
ultimate goal for an unbiased knowledge about antigen-specific T cel responses. 
In the recent years, several flow-cytometric methods for the ex vivo identification of antigen-
specific  T cels  have  been  developed (Schefold and  Kern,  2000; Thiel et al.,  2004).  These 
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methods enable either the direct identification of the specific T cels via binding of the TCR 
to its MHC-peptide ligand (Altman et al.,  1996),  or their identification folowing activation 
with the specific antigen and measurement of functional parameters, e.g. cytokine production 
or the expression  of activation  markers (Schefold and  Kern,  2000; Thiel et al.,  2004).  The 
combination  of these technologies  with  magnetic enrichment approaches alows the  pre-
enrichment of the antigen-specific T cels from large cel numbers, which drasticaly increases 
sensitivity and enables the analysis  of rare antigen-specific  T cels even in the  naive 
repertoire. So far, the magnetic enrichment of cytokine producing T cels (Brosterhus et al., 
1999), as wel as  MHC  multimer labeled cels (Day et al.,  2003; Moon et al.,  2007)  has 
successfuly  been  used for the analysis  of rare antigen-specific  T cels  undetectable  via 
conventional  methods.  However, especialy for complex  pathogens, containing  hundreds  or 
thousands  of  diferent target epitopes, several limitations stil restrict a comprehensive and 
unbiased insight into the heterogeneous T cel response. Thus, a method for the direct ex vivo 
analysis of CD4+ T cels specific for an unrestricted pool of T cel epitopes from any antigen 
of interest at  high resolution is stil  missing.  Such a  method should  be sensitive enough to 
enable the analysis  of the total antigen-specific  CD4+ compartment, i.e.  memory,  naive, as 
wel as regulatory T cels, whose target antigens remain so far largely elusive. 
The  development  of a  method that fulfils these requirements  was  part  of this  dissertation 
(Bacher et al.,  2013;  manuscript  3; Bacher et al.,  2013;  manuscript  2).  The  diferent 
approaches for the detection of antigen-specific T cels and their limitations are reviewed in 
detail in chapter 3.1 of this thesis (Bacher and Schefold, 2013; manuscript 1). 
 
 
1.3 Human fungal diseases 
 
Ubiquitous fungi are among the most common microbes encountered by humans (Wüthrich et 
al., 2012). It is estimated that everybody routinely inhales several hundreds or thousands of 
fungal spores per day (Latge, 1999; Park and Mehrad, 2009). In addition, several fungi, like 
Candida species, are commensals  on skin epithelia and the  gut  mucosal surfaces  of 
mammalian  hosts (Iliev et al.,  2012).  Depending  on the immune status  of an individual, 
environmental fungi can cause a  wide range  of  human  diseases: in immunocompetent 
individuals fungal  diseases range from superficial  mycosis to alergic  hypersensitivity and 
non-invasive colonization.  However, in immunocompromised  patients fungi can even cause 
life-threatening invasive infections with often fatal outcome (Brakhage, 2005). 
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Most fungus-related alergic  diseases including asthma, sinusitis and alveolitis  occur 
folowing repeated exposure and consequently sensitization to fungal antigens  but  without 
fungal colonization or invasion. In contrast, the most severe alergic pulmonary complication, 
alergic  bronchopulmonary aspergilosis (ABPA), is characterized  by recurent  pulmonary 
infiltrates and  mycelial  growth in the lung (Latge,  1999).  ABPA is  mainly caused  by 
Aspergilus fumigatus and occasionaly also other Aspergilus species (Moss, 2005). It afects 
approximately  1-2%  of  patients  with  persistent asthma and  5-15%  of  patients  with cystic 
fibrosis (Moss,  2002; Stevens et al.,  2003).  Due to compromised  mucociliary clearance in 
these  patients, A. fumigatus spores can colonize the  bronchial airways and  germinate into 
mycelia.  Although lungs  of  ABPA  patients are colonized  with A. fumigatus  mycelia,  no 
invasive  growth  of the fungus into tissues and  blood  vessels is  observed.  The  disease is 
characterized  by a strong  Th2 response against fungal antigens, leading to symptoms  of 
severe asthma that  may  proceed to airway  destruction,  bronchiectasis and lung fibrosis 
(Knutsen et al.,  2012; Knutsen and  Slavin,  2011; Latge,  1999).  An  ongoing  problem is the 
diagnosis  of  ABPA, since the  diagnostic criteria like asthma,  peripheral  blood eosinophilia, 
increased total and fungus specific IgE levels, skin reactivity to A. fumigatus antigens, 
expectoration of mucus plugs and pulmonary infiltrates are rarely present in al patients and 
are furthermore not specific for the disease or overlapping with signs and symptoms of cystic 
fibrosis (Knutsen and  Slavin,  2011; Latge,  1999).  The failure to  detect  ABPA  may lead to 
permanent lung damage and thus significant morbidity and mortality of the patients (Knutsen 
and Slavin, 2011). 
Invasive fungal infections (IFI) are the most devastating disease caused by ubiquitous fungi. 
They  occur  primary in immunocompromised  patients,  where  deficits in the  host  defense 
render them susceptible. Upon arival in the lungs, fungal spores can germinate into hyphal 
forms that invade the lung  parenchyma and  blood  vessels and  may further  disseminate to 
diferent organs. Due to increasing numbers of immunocompromised patients, the incidence 
of IFIs is rising and  despite  pharmacotherapeutic improvements, the  mortality rate  of these 
infections is stil  unacceptably  high (Brown et al.,  2012).  The  most common cohorts  of 
patients at risk for IFIs include leukemic  patients,  hematopoietic stem cel  or solid  organ 
transplant recipients (De  Pauw et al.,  2008; Kontoyiannis et al.,  2010; Low and  Rotstein, 
2011). Within these groups, the incidence and ethiopathology of IFIs difers depending on the 
underlying conditions  of  disease and treatment (Low and  Rotstein,  2011).  Among 
hematopoietic stem cel transplant (HSCT) recipients, a recent multicenter study covering 250 
cases  of IFIs from  2004 to  2007 reported, that invasive aspergilosis (59.2%)  was the  most 
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frequent, folowed by invasive candidiasis (24.8%), Mucorales infections (7.2%), and IFI due 
to other molds (6.8%) (Neofytos et al., 2009). Although Candida spp. has for long time been 
considered as being the predominant fungal pathogen in immunosuppressed patients, there is 
apparently a change in the epidemiology  of IFIs  with rising  prevalence  of invasive 
aspergilosis (IA) as  wel as  mucormycosis and  other  mold infections (Low and  Rotstein, 
2011; Neofytos et al.,  2009).  The trend towards  more invasive  mold infections is serious, 
because the mortality rate difers depending on the infecting fungal pathogen, with numbers 
ranging from  35.5% for IA to  64.3% for  Mucorales infections and  80% for  other  mold 
infections (Neofytos et al., 2009). 
A  major factor in increasing the survival  of infected  patients is the early initiation  of the 
appropriate antifungal therapy, which is mainly hampered by a timely and reliable diagnosis 
(Chamilos et al.,  2008; Cornely et al.,  2011; De  Pauw et al.,  2008; Greene et al.,  2007; 
Mengoli et al.,  2009; Ostrosky-Zeichner et al.,  2005).  The  diagnosis  of IFI is chalenging, 
because the clinical manifestations are often not specific for fungal infections and the curent 
diagnostic tools (e.g.  blood cultures,  detection  of Aspergilus spp. cel  wal antigen 
galactomannan, detection of fungal β-1,3-D-glucan, or amplification of fungal DNA by PCR) 
have  been shown to  be  highly  variable regarding sensitivity and specificity (Mengoli et al., 
2009). In addition, the results are often available too late to be clinicaly useful. 
Given the changing epidemiology of IFI, a further chalenge for the diagnosis, is the species-
specific discrimination, as rare species are becoming more common and require diferent anti-
fungal treatment (Auberger et al., 2012; Bitar et al., 2009). Usualy, only in proven IFI cases, 
the distinct identification of the invading fungal pathogen is possible. To diagnose a proven 
IFI, it requires the  direct  microscopic  or cultural  detection  of the fungus in a sample taken 
from the infected site (De Pauw et al., 2008). Such invasive surgical procedures can rarely be 
applied to the majority of criticaly il patients and rather represent a last therapeutic option, 
than a feasible  diagnostic tool.  Additionaly, the  histological examination  of these samples 
may not be specific enough to clearly distinguish similar filamentous fungal species (Low and 
Rotstein,  2011; Ostrosky-Zeichner,  2012).  The further classification  of IFI  diagnosis into 
probable and possible cases relies on a high value of suspicion, and requires a combination of 
the  presence  of a  host factor (e.g.  neutropenia), characteristic findings  on lung computed 
tomography (CT) scans and  microbiological findings (De  Pauw et al.,  2008; Low and 
Rotstein,  2011).  Thus there is an  urgent  need for  new  diagnostic  methods for the early 
detection  of IFI  with  high sensitivity and specificity that alow  distinct  discrimination 
between diferent fungal pathogens to enable an early and targeted antifungal therapy. 
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1.4 Immune responses against fungal pathogens 
 
Of the estimated  105 fungal species,  only few  hundreds cause  diseases in  humans 
(LeibundGut-Landmann et al.,  2012).  Two  of the  most commonly encountered fungal 
pathogens are Aspergilus fumigatus and Candida  albicans. A. fumigatus is an  ubiquitous 
mold, acquired  primary  by inhaling airborne spores,  whereas C.  albicans is a  dimorphic 
commensal, that  occurs as a  yeast and  hyphal  morphotype and forms  normal  part  of the 
human microbiota. Although al humans are routinely in contact with both fungi, the majority 
of  people  do  not  develop any signs  or symptoms  of  disease.  This is atributed to eficient 
innate and adaptive immune responses that are activated upon recognition of fungal particles 
and prevent fungal colonization and invasive diseases (Brakhage et al., 2010; Romani, 2011; 
Wüthrich et al., 2012). 
The surface of resting A. fumigatus spores is covered by a hydrophobin layer, which masks 
fungal structures and avoids their immune recognition (Aimanianda et al.,  2009).  However, 
resting conidia rapidly become swolen within few hours upon arival in the lungs as a first 
step  of  germination (Osherov and  May,  2001; Park and  Mehrad,  2009).  This  maturation 
process is associated with a profound rearangement of the conidial surface leading to loss of 
the  hydrophobin layer and exposure  of several structures that are recognized  by tol-like 
receptors (TLRs) and C-type lectin receptors (CLRs) (Brown, 2011; Hasenberg et al., 2011). 
Similar alterations of the cel wal structure apply for C. albicans during transition from yeast 
to  hyphal form, alowing  distinct recognition  of  both  morphotypes  by  patern recognition 
receptors (PRRs) (Hernandez-Santos and  Gafen,  2012).  Upon fungal recognition, activated 
lung-resident alveolar  macrophages and  neutrophils  provide first line  protection against 
inhaled fungal spores by phagocytosis and kiling of fungal particles as wel as secretion of 
antimicrobial compounds and  pro-inflammatory cytokines (Behnsen et al.,  2007; Hasenberg 
et al., 2011). The elimination of inhaled fungal spores is highly eficient with ~ 90% of fungal 
spores being cleared within 24-48 hours after inoculation (Murdock et al., 2011; Philippe et 
al.,  2003).  Neutrophils  have  been shown to  be essential in this early anti-conidial  defense 
(Mircescu et al.,  2009), as  wel as in  kiling  of  hyphae  or capturing  of fungal structures 
through the formation of extracelular traps (Bruns et al., 2010). Also in C. albicans infection, 
cytokines released by damaged epithelial cels recruit neutrophils that directly kil C. albicans 
cels through  phagocytosis and  degranulation (Naglik et al.,  2011). In line  with their 
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important role in anti-fungal immune defense, neutropenia in immune-suppressed patients is 
considered as a main risk factor for developing invasive fungal diseases. 
 
Although early immune  defense against A. fumigatus and C. albicans is  mediated  by innate 
immune cels, several evidences suggest, that adaptive immunity, and in  particular  CD4+ 
T cels  may also contribute to the immune  defense against  both fungi.  For example,  non-
neutropenic patients with advanced AIDS, who lack CD4+ T cels, are highly susceptible to 
invasive fungal infections (van  de  Veerdonk and  Netea,  2010).  Furthermore, a considerable 
number  of invasive fungal infections in  HSCT  patients  occur at a time  point,  when 
neutropenia has already resolved, but patients stil sufer from T cel deficiency (Lehrnbecher 
et al.,  2013).  Dendritic cels and  monocytes  have  been shown to take  up fungal spores and 
hyphae and  prime specific  CD4+  T cel responses in vitro and in vivo (Bozza et al.,  2002; 
Hohl et al., 2009; Rivera et al., 2006; Rivera et al., 2005; Serbina et al., 2009). In adoptive 
transfer  models  of immune-supressed  or  T cel  deficient  mice, transfer  of  CD4+ T cels 
prolonged survival after A. fumigatus or C. albicans infection (Cenci et al., 2000; Farah et al., 
2002).  Similarly, transfered  dendritic cels  pulsed  with A. fumigatus conidia  or C. albicans 
yeasts generated protective anti-fungal immunity by activation of IFN-γ producing Th1 cels 
(Bozza et al., 2003; d'Ostiani et al., 2000). 
In  general,  Th1 responses  mediated  by IFN-γ are thought to confer  protective immunity to 
several  pathogenic fungi (Romani,  2011; Wüthrich et al.,  2012),  most likely  by enhancing 
recruitment  of  phagocytes and fungal  kiling.  Also in  humans, a  predominant IFN-γ 
production  of A. fumigatus stimulated  CD4+  T cels  has  been  observed in  patients that 
survived invasive aspergilosis (Hebart et al., 2002) and adoptive transfer of IFN-γ producing 
T cel clones corelated  with a  decrease  of  galactomannan levels in invasive aspergilosis 
patients (Peruccio et al.,  2005). In contrast, several studies suggest, that  Th2 cytokines are 
detrimental in anti-fungal immune responses  by counter-regulation  of  protective  Th1 
responses and  promotion  of alergic immune reactions in  murine  models and  patients  with 
invasive fungal disease and ABPA (Cenci et al., 1999; Haraguchi et al., 2010; Hernandez et 
al., 2005; Kreindler et al., 2010). The Th17 subset has also been implicated to play a major 
role in  mucosal immunity against fungi. IL-17 and IL-22  produced  by  Th17 cels are 
important inducers  of  neutrophil recruitment and anti-microbial  peptide expression from 
epithelial cels (Hernandez-Santos and  Gafen,  2012).  Thus,  Th17 cels are in  general 
believed to  have a  protective role in fungal infections.  This is supported  by several studies 
with IL-17 receptor  deficient  mice that  demonstrated an increased susceptibility to 
disseminated and oropharyngeal candidiasis (Conti et al., 2009; Huang et al., 2004). Also in 
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human patients an impaired IL-17 response directly corelates with increased susceptibility to 
Candida infections (Eyerich et al., 2008; Ma et al., 2008; Milner et al., 2008). However, the 
role of Th17 cels in host defense against A. fumigatus is less clear. Although IL-17 and IL-22 
have been shown to enhance A. fumigatus clearance in mice (Gessner et al., 2012; Werner et 
al.,  2009),  other studies even implicate that  Th17 cels  may  have adverse efects  on anti-
fungal immunity  by  driving  pathologic inflammatory responses and impairing antifungal 
immune resistance in mouse models of pulmonary aspergilosis (Romani et al., 2008; Zelante 
et al., 2009; Zelante et al., 2007). Thus, the curent data regarding the potential role of Th17 
cels in immune responses against fungi are ambiguous. 
 
Since CD4+ T cels seem to play a role in anti-fungal immune responses, a potential strategy 
to  protect from fungal infections could  be the  development  of an anti-fungal  vaccine that 
induces a specific and  protective  memory repertoire  of fungus-specific  CD4+  T cels. In 
A. fumigatus infection models, vaccination with crude fungal lysate has been shown to protect 
mice from invasive aspergilosis (Cenci et al., 2000; Ito and Lyons, 2002; Liu et al., 2011). 
However, immunocompromised  patients,  who  have  usual low  T and  B cel counts, are at 
particular risk for developing serious invasive fungal infections, questioning the practicability 
of a vaccine protection in these patients. Alternatively, the restoration of specific anti-fungal 
immunity in immunocompromised  patients  via adoptive transfer  of fungus-specific  CD4+ 
T cels seems to be a promising strategy (Beck et al., 2006; Gaundar et al., 2012; Peruccio et 
al.,  2005; Tramsen et al.,  2009; Tramsen et al.,  2013).  However, there is  only fragmentary 
knowledge about the frequency,  phenotype and function, as wel as the  precise antigen-
specificity of fungus specific CD4+ T cels in humans, which would be a prerequisite for such 
immuno-therapeutic approaches.  Although the  presence  of A. fumigatus and C. albicans 
specific T cels has been demonstrated in humans (Acosta-Rodriguez et al., 2007b; Chai et al., 
2010; Chaudhary et al., 2010; Hebart et al., 2002; Liu et al., 2009; Zhou et al., 2008), most of 
these analyses employed long-lasting in vitro culture and/or  population-based  methods (3H-
thymidine incorporation,  ELISA)  or  ELIspot to analyze fungus-specific  T cel responses. 
These  methods sufer from  prolonged in vitro  manipulation,  making it  dificult to  draw 
conclusions  on the ex vivo  phenotype  of the specific  T cels,  or are restricted to certain 
cytokine  producing subsets,  which  may represent  only a fraction  of al reactive  T cels. In 
particular  direct ex vivo analyses  describing the total repertoire  of  human fungus-specific 
T cels  without  prolonged in vitro  manipulation are so far  missing. In addition,  due to the 
complexity of fungal pathogens, comprehensive information about the antigens recognized by 
human CD4+ T cels is almost completely lacking. 
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1.5 Aim of the study 
 
Fungi represent a chalenge for the immune system since they can occur as usualy harmless 
commensals  or  daily encountered environmental antigens,  but can also cause  detrimental 
diseases as opportunistic pathogens or alergens. Antigen-specific CD4+ T cels play a major 
role in balancing immune responses to harmless antigens and orchestrate protective immune 
responses against  pathogens.  However, their role in anti-fungal immunity is  only  poorly 
understood. In addition, the contribution of specific Treg in anti-fungal immune responses, for 
example for the prevention of adverse reactions, is completely unknown. The main roadblock 
to gain information about fungus-specific T cels is the lack of appropriate methods for their 
identification.  Such  methods should alow the  direct ex vivo identification and 
characterization of rare fungus-specific T cels from human peripheral blood or tissues with 
high sensitivity and specificity  by  using an  unrestricted  pool  of antigens, since  no immune-
dominant fungal  T cel targets are  known. Information about fungus-specific  T cels  wil 
provide  basic  knowledge  on  human anti-fungal immune responses and wil alow to  define 
pathogen-specific defense mechanisms, as wel as diferences in anti-fungal T cel responses 
in relevant patient cohorts. Therefore, the aim of this study was to identify and characterize 
the human fungus-specific CD4+ T cels in healthy donors and various patient groups, with a 
focus  on Aspergilus fumigatus and Candida  albicans as two  major  opportunistic fungal 
pathogens in humans. 
 
The folowing objectives were addressed in course of this study: 
 
1. Direct ex vivo  detection  of rare fungus-reactive  CD4+ T cels including  Treg in  human 
peripheral blood. 
2. In depth phenotypical and functional characterization of the CD4+ T cel response against 
A. fumigatus and C. albicans. 
3. Comparison of T cel phenotype and function between healthy donors and patient groups 
with fungus-related pathologies. 
4. Analysis of single antigen specificities of A. fumigatus-reactive T cels and identification 
of potentialy immunogenic in vivo targets. 
 
The detailed knowledge about human fungus-reactive T cels is essential to define corelates 
of  protection against fungal  diseases and  disease  progression and  wil  help  develop  pre-
emptive or therapeutic intervention against fungus-related pathologies. 
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2 Overview of manuscripts 
 
Manuscript I 
 
“Flow-cytometric analysis of rare antigen-specific T cels.” 
 
Bacher P and Schefold A. 
 
Review article published in 
Cytometry A. 2013 Aug; 83(8):692-701. 
 
Summary: 
Detection of antigen-specific T cels is chalenging due to the low frequencies of the specific 
T cels.  Especialy the  direct ex vivo identification and characterization  of these cels is 
essential to gain unbiased knowledge about antigen-specific T cel responses. In this review 
article, the curent flow-cytometric technologies for analyses of antigen-specific CD4+ T cels 
were summarized,  with a focus  on enrichment  methods that  provide suficiently  high 
sensitivity for the ex vivo characterization  of  very rare antigen-specific  T cels even in the 
naive or regulatory T cel repertoire. 
 
 
Author contribution: 
Petra Bacher wrote this review article together with Alexander Schefold. 
 
_______________________ 
Prof. Dr. Axel A. Brakhage 
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Manuscript II 
 
“Antigen-Reactive T cel Enrichment for Direct, High-resolution Analysis of the Human 
Naive and Memory Th Cel Repertoire.” 
 
Bacher P, Schink C, Teutschbein J, Kniemeyer O, Assenmacher M, Brakhage AA, 
Schefold A. 
 
Manuscript published in 
The Journal of Immunology, Vol. 190, pp. 3967-3976, 2013. 
 
Summary: 
CD4+ T cels play a central role in the immune defense against pathogens or tumors but also 
in immunopathology, such as autoimmunity  or alergy.  Due to technical limitations, 
comprehensive information about the frequency and  phenotype  of antigen-specific  CD4+ 
T cels against  many  disease-relevant antigens is  missing.  This  paper  describes the 
development  of a  highly sensitive  detection system for rare antigen-reactive  CD4+ T cels 
directly from  human  peripheral  blood.  Based  on a  pre-enrichment strategy  of  CD154 
expressing T cels, antigen-reactive Th cels can be visualized and characterized in detail by 
using multi-parameter flow-cytometry. This system alows for the first time the direct ex vivo 
access and in  depth characterization  of specific  Th cels at  high resolution  within the  naive 
and  memory  CD4+  T cel repertoire,  but  without any restriction to  pre-selected epitopes  or 
MHC aleles. 
 
Author contribution: 
Petra  Bacher  performed al experiments  described in this  manuscript, except  of some 
experiments in  Figure  5B that  were  performed  by  Christian Schink.  Furthermore she  was 
significantly involved in writing the manuscript. 
 
_______________________ 
Prof. Dr. Axel A. Brakhage 
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Manuscript III 
 
“Antigen-specific Expansion of Human Regulatory T Cels as a Major Tolerance 
Mechanism against Mucosal Fungi.” 
 
Bacher P, Kniemeyer O, Schönbrunn A, Sawitzki B, Assenmacher M, Rietschel E, 
Steinbach A, Cornely OA, Brakhage AA, Thiel A, Schefold A. 
 
Manuscript published in 
Mucosal Immunology, advanced online publication, 2013. 
 
Summary: 
Our immune system is  daily chalenged  by a  variety  of fungal  organisms.  This requires a 
highly  balanced immune  defense,  which  provides  protection  without causing  detrimental 
damage to the  host,  due to  overeacting immune reactions. In  mouse  models, regulatory 
T cels (Treg) have been described to maintain tolerance at mucosal sites. However, the direct 
identification of antigen-specific human Treg against ubiquitous environmental antigens has 
so far  been  missing.  Here  we identified that specific  Treg against the  opportunistic fungal 
pathogens Aspergilus fumigatus and Candida albicans are strongly expanded in  human 
peripheral  blood.  The  data reveal further a  unique capacity  of the airborne fungus 
A. fumigatus to selectively trigger  Treg responses,  while  maintaining a large  part  of the 
conventional  T cel repertoire in a  naive state.  This  Treg  dominance is abrogated in cystic 
fibrosis  patients  with Aspergilus alergies, indicating an important contribution  of the 
pathogen-specific Treg to Tcon ratio in the prevention of alergic immune reactions. 
 
Author contribution: 
Petra  Bacher  performed al experiments  described in this  manuscript, except  of the  TSDR 
analyses that were performed by the group of Birgit Sawitzki (Berlin-Brandenburg Center for 
Regenerative  Therapies,  Charité  –  University  Medicine  Berlin).  Furthermore she  was 
significantly involved in writing the manuscript. 
 
_______________________ 
Prof. Dr. Axel A. Brakhage 
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Manuscript IV 
 
“The Human Th17 Cel Pool against Airborne Fungal Pathogens is Regulated 
by Cross-reactivity to Fungal Gut Microbiota.” 
 
Bacher P, Kniemeyer O, Hamprecht A, Assenmacher M, Cornely OA, Syrbe U, Maul J, 
Brakhage AA, Schefold A. 
 
Manuscript in preparation. 
 
Summary: 
The gut microbiota is known to have a major impact on local, but also on systemic immune 
homeostasis as  wel as immuno-pathology.  One  possible  mechanism  of  how  gut  microbiota 
may influence gut-distal immune responses is via T cel cross-reactivity as a consequence of 
the extraordinary large amount of foreign microbial antigens. This manuscript shows, that the 
common  human  gut commensal Candida albicans triggers the expansion  of a  T cel 
population, which is cross-reactive to antigens of the airborne fungus Aspergilus fumigatus. 
This  T cel cross-reactivity  not  only leads to a  quantitative  modulation  of the A. fumigatus-
specific  T cel response,  but importantly, also a  qualitative  modulation  by the specific 
induction of Th17 cels in the otherwise Th1 biased A. fumigatus immune response. As Th17 
responses in the lung are associated with a variety of lung disorders, these data might give an 
explanation  of  how the  microbiota can influence the  development  of systemic  diseases, 
through selective expansion of certain Th cel subsets with cross-reactivity for microbiota and 
gut-distal antigens. 
 
Author contribution: 
Petra  Bacher  performed al experiments  described in this  manuscript.  Furthermore she  was 
significantly involved in writing the manuscript. 
 
_______________________ 
Prof. Dr. Axel A. Brakhage 
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Manuscript V 
 
“Rapid Diagnosis of Invasive Mold Infection by Measuring Fungus-Reactive CD4+ 
T Cels in Peripheral Blood.” 
 
Bacher P*, Steinbach A*, Kniemeyer O, Hamprecht A, Assenmacher A, Vehreschild MJGT, 
Vehreschild JJ, Brakhage AA, Cornely OA*, Schefold A*. 
 
* These authors contributed equaly to this work. 
 
Manuscript in preparation. 
 
Summary: 
Invasive fungal infections (IFI) are life-threatening in immunocompromised patients leading 
to  unacceptably  high  mortality rates.  This is largely atributed to the lack  of a timely and 
reliable  diagnosis for IFI.  This  manuscript shows that the  quantification  of fungus-specific 
CD4+ T cels by flow-cytometry in peripheral blood of immune-suppressed patients, alows a 
highly sensitive and specific  discrimination  between fungus infected and  non-infected 
individuals.  Fungus infected  patients selectively show increased frequencies  of fungus-
specific T cels, compared to healthy controls or patients at risk, but without fungal infections. 
By analyzing the response against  diferent fungal  pathogens,  discrimination  between the 
invading fungal species  was  possible.  Therefore, the  detection  of IFI  by flow-cytometric 
measurement  of fungus-specific  T cel frequencies  might enable the early and targeted anti-
fungal treatment  of infected  patients and thus  might strongly improve the  non-satisfying 
situation of IFI diagnosis. 
 
Author contribution: 
In this equal contribution paper, Petra Bacher performed al experiments and was significantly 
involved in writing the manuscript. The clinical evaluation and classification of patients were 
performed by Angela Steinbach. 
 
_______________________ 
Prof. Dr. Axel A. Brakhage 
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Manuscript VI 
 
“Identification of Immunogenic Antigens from Aspergilus fumigatus by Direct Multi-
Parameter Characterization of Specific Conventional and Regulatory CD4+ T Cels.” 
 
Bacher P, Kniemeyer O, Teutschbein J, Thoen M, Vödisch M, Wartenberg D, Scharf DH, 
Koester-Eiserfunke N, Schüte M, Dübel S, Assenmacher M, Brakhage AA, Schefold A. 
       
Manuscript submited. 
 
Summary: 
Although a smal  population  of Aspergilus fumigatus-specific  CD4+  T cels can  be 
consistently  detected in al  healthy  donors, it is curently  unknown against  which  proteins 
these  T cels react and  which specificities are  protective.  Here, the antigen-specific  CD4+ 
T cel responses  of  healthy  donors against  various A. fumigatus  morphotypes, subcelular 
fractions and selected single proteins were analyzed. The data indicate that a large part of the 
A. fumigatus immune response is  directed against  membrane  proteins  of the  metabolicaly 
active  developmental stages  of the fungus.  Further analyses  of single A. fumigatus  proteins 
alowed to  define a set  of immunogenic  proteins,  but  display a  broad and  variable  T cel 
response against  various A. fumigatus  proteins, independent  of the subcelular localization, 
i.e. cel wal, membrane, cytosol or secretome. These data suggest that the complexity of the 
fungal proteome is reflected by the heterogeneity of the human T cel response and chalenges 
the existence of one or few immune-dominant A. fumigatus proteins. 
 
Author contribution: 
Petra  Bacher  performed al experiments, except  of the  production  of recombinant  proteins, 
and was significantly involved in writing the manuscript. The recombinant CRF2 protein was 
generated  by  Mark  Schüte (Department  of  Biotechnology,  Technical  University  of 
Braunschweig).  Al A. fumigatus lysates were generated and al other recombinant proteins 
were identified and purified by colaborators from the Department of Molecular and Applied 
Microbiology, Hans-Knöl-Institute and Friedrich-Schiler-University Jena. 
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Prof. Dr. Axel A. Brakhage 
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3 Manuscripts 
 
3.1 Manuscript I 
 
 
“Flow-cytometric analysis of rare antigen-specific T cels“ 
 
Bacher P and Scheffold A. 
 
Review article published in 
 
 Cytometry A. Aug; 83(8):692-701, 2013 
 
 
Copyright 2013. International Society for Advancement of Cytometry. Permission to reprint the article 
was given by the publisher John Whiley & Sons Inc. on April 22, 2014.
  
Flow-Cytometric Analysis of Rare
Antigen-Specific T Cels
Petra Bacher,1Alexander Schefold2*
The cytometric enumeration and characterization of antigen-specific lymphocytes, as
introduced about 15 years ago, has contributed significantly to our understanding of
adaptive immune responses in health and disease. Despite the development of several
technologies, alowing to directly or indirectly analyze many aspects of lymphocyte
specificity and function, several unresolved issues remain, due to the low frequency of
certain antigen-specific lymphocyte subsets and the complexity of T cel antigen recog-
nition. This is especialy true for CD41conventional as wel as regulatory T cels, which
bring major contributions to immune protection and pathology. Here we review the
current technologies for the analysis of antigen specific T cels within the physiologic T
cel repertoire and with a special focus on recent technologies addressing the analysis of
rare antigen-specific T cel populations including naive and regulatory T cels.VC 2013
International Society for Advancement of Cytometry
Key terms
antigen-specific T cels; rare cels; flow-cytometry; CD154; CD137; MHC multimer; tet-
ramer; cytokine secretion assay; MACS
ANTIGEN-specific T cels play a central role in mediating specific immune responses
as wel as in the formation of immunological memory. Information about their fre-
quencies, phenotypes, and functional capacities is essential to estimate the specific
immune status of an individual, to understand the mechanisms of protective immu-
nity or immunopathology and to predict immune protection or diagnose immune-
related diseases. As a result of the high diversity of the T cel repertoire, alowing to
respond to a myriad of diferent antigens, the frequency of T cels specific for a single
peptide-MHC ligand is very low, in particular within the naive repertoire (range 0.2–
60 cels/106naive T cels)(1–19). But even within the memory repertoire, in the
absence of acute infections, specific T cel frequencies in peripheral blood are typi-
caly wel below 1%. Therefore, the analysis of antigen-specific T cels concerns the
detection of rare events, demanding highly specific labeling methods which also
alow processing of large cel samples to enable detection of suficient numbers of the
few antigen-specific T cels within the vast majority of nontarget cels.
Due to their low frequencies, antigen-specific T cels have been measured for
decades only on the basis of antigen-specific proliferation, for example, via3H-thy-
midine incorporation. However, in such assays the phenotypic and functional prop-
erties of the reactive cels may be massively altered. Furthermore it is almost
impossible to determine the actual frequency and phenotype of reactive cels in the
starting cel sample and to exclude bystander proliferation. Therefore in this review,
we focus on technologies alowing the direct quantification and characterization of
antigen-specific T cels with only minimal in vitro manipulation. Flow cytometry has
become the method of choice, since it combines the possibility to simultaneously
measure a multitude of parameters for a single cel with the possibility to acquire
high event numbers (106). Therefore the development of several flow-cytometric
methods for the identification of antigen-specific T cels has largely contributed to
our current understanding of antigen-specific T cel responses by permiting a
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detailed phenotypical and functional characterization of each
single detected cel. The possibility to measure 20 or more
parameters from a single cel using polychromatic cytometry
enables to gain maximal information from one measurement,
which is essential for smal sample sizes or rare subsets. For
rare cel analysis the detection limit of flow-cytometric assays
can further be decreased by combination with suitable pre-
enrichment strategies, such as magnetic cel separation, which
alow rapid processing of large cel numbers (>>107). In this
way, a suficient number of target cels can be colected for
subsequent flow-cytometric characterization. Such technolo-
gies, alow the direct ex vivo detection and characterization of
specific T cels for an unbiased knowledge about antigen-
specific T cel responses. Here we review the current technolo-
gies for direct ex vivo flow-cytometric detection of antigen-
specific T cels, including strategies to identify antigen-specific
regulatory T cels and to access even extremely rare antigen-
specific T cel populations, such as within the naive repertoire.
We focus on technologies analyzing T cels within the physio-
logic repertoire, which are broadly applicable to human T
cels. Technologies based on adoptive transfer of traceable
numbers of antigen-specific T cels in mice are reviewed else-
where (20).
FLOWCYTOMETRICMETHODS FOR THEEXVIVO
DETECTION OFANTIGEN–SPECIFICTCELLS
Detection methods can be classified into two categories,
which together alow to access T cel specificity and function.
Labeling of the specific TCR using recombinant MHC-peptide
multimers identifies specific T cels directly according to their
specific antigen receptor without restriction to certain func-
tional parameters. This alows unbiased access to the total
pool of T cels with a distinct specificity and within a certain
afinity range (see below).
The second category employs certain functional parame-
ters as a read-out for T cels, which react to specific antigen
chalenge. Al relevant functions of T cels, such as cytokine
release, expression of costimulatory molecules, cytotoxicity
and proliferation are accessible via single-cel flow-cytometric
assays and for most technologies also, selection markers on
the cel surface are available alowing additional isolation of
the specific cels.
Direct Labeling of Specific TCRs—MHC-Multimers
MHC-multimers have emerged as an important tool for
the identification and characterization of antigen-specific T
cels, by direct binding of the T cel receptor to its fluores-
cently labeled MHC-peptide ligand. Initial problems due to
the low binding afinity of the T cel receptor to MHC-peptide
monomers (21) have been overcome by the multimerization
of peptide-MHC complexes to increase the relative binding
avidity (22). Class I MHC-peptide multimers have widely
been used to quantify and characterize antigen-specific CD81
T cel responses. The construction of class I multimers has
initialy been more dificult due to diferences of the MHC
class I structure and TCR afinity, but in the recent years a
variety of MHC I multimers for the specific recognition of
CD41 T cels have successfuly been generated. In addition
CD1 tetramers for detection of lipid reactive T cels including
NKT cels have been developed (23–25).
The major limitation of the tetramer technology is that
the antigenic epitope has to be characterized in detail, that is,
a defined peptide restricted to a particular MHC haplotype.
Peptide-exchange technologies alow rapid engineering of
numerous diferent MHC-peptide reagents (26,27). Based on
this, rapid epitope mapping techniques have been developed,
which were successfuly used to identify large numbers of new
T cel epitopes (28–31). Furthermore, the use of combinatorial
color coded tetramers enabled the simultaneous use of several
tetramers to detect a greater number of diferent antigen-
specificities (32,33). A distinct combination of fluorophores is
used for each T cel specificity, alowing withnfluorophores a
theoretical detection of 2n2 1 specificities. So far, this
method has been shown to enable the detection of up to 63
diferent T cel specificities by the use of six diferent fluoro-
phores (33).
Methods Analyzing T Cel Antigen-Reactivity
The MHC-multimer technology does per se not provide
information on the functionality of the detected cels. But in
particular, T helper cels can be subdivided in numerous sub-
types solely defined by their specific set of efector functions,
which are mostly acquired during first antigen encounter and
form part of the immunological memory. Thus, information
about the functional capacities of antigen-specific T cels and
their classification into functionaly diferent subsets is impor-
tant to determine the quality of an immune response.
The detection of antigen-specific T cels by functional
parameters requires the prior in vitro stimulation with the
specific antigen. For stimulation, single peptides, proteins or
whole antigen lysates can be used, as wel as peptide pools,
covering the whole sequence of a protein and al possible T
cel epitopes. The possibility to use whole proteins and lysates
is especialy of interest to analyze T cel responses against com-
plex antigens (e.g., whole pathogens or alergens), containing
hundreds or thousands of diferent T cel epitopes. An advant-
age of activation dependent methods to enumerate antigen-
specific T cels is that they are independent of MHC aleles or
exact definition of the antigenic epitopes. However, the assays
depend on the presence of a suficient number of functional
antigen presenting cels and per definition exclude anergic T
cels from the analysis.
Cytokine detection alows identification of functional T cel
subsets. The first reports about direct ex vivo enumeration
of the frequencies of antigen-specific T cels by flow-
cytometry utilized antigen-induced cytokine production (34–
36). Cytokine expression is mostly confined to TCR activated
T cels and it is transient, typicaly measured within 4–12 h,
although within this time window diferent cytokines might
have diferent kinetics. Cytokines can be detected either intra-
celularly when cels are simultaneously incubated with secre-
tion inhibitors like Brefeldin A or Monensin (37,38) or on the
cel surface by retention of the secreted cytokine on the surface
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of the secreting cels via a capture matrix (34,39). The later
method has the advantage that surface retained cytokines ena-
ble the detection of live cytokine secreting cels as wel as the
enrichment via magnetic cel sorting. However, almost al
cytokines are restricted to certain T cel subsets and in particu-
lar naive T cels produce only few cytokines upon stimulation.
Therefore the enumeration of antigen-specific T cel frequen-
cies solely based on cytokine production may be incomplete
and has to be handled with care. On the other hand, the
enrichment of highly specialized subsets can have significant
advantages, for example, purified virus-specific IFN-csecret-
ing T cels are idealy suited for adoptive T cel therapy of viral
infections (40–43).
Activation markers identify the total pool of reactive T cels.
An alternative approach for the direct visualization of
antigen-specific T cels by flow cytometry is the detection of
activation markers, which are upregulated on the T cel sur-
face upon antigen-specific triggering. Expression of some of
these markers is independent of other efector functions like
cytokine secretion or cytotoxicity, which may be restricted to
the diferentiation state of the T cels (e.g., naive, central
memory, efector memory) or certain T cel subsets (e.g., Th1,
Th2, Th17, etc.). Therefore activation markers permit the
comprehensive characterization of the total pool of specific T
cels against a given antigen, irrespective of functional speciali-
zation, MHC alele or exact definition of the antigenic epi-
tope, as outlined above. A prerequisite for high specificity is
that the marker expression should solely depend on T cel
receptor triggering and expression should also be transient. A
number of potential activation markers have been proposed,
including CD69, CD25, CD71, HLA-DR, CD134 (OX40),
CRTAM, CD137 (4-1BB), CD154 (CD40L) (44–55). However,
a limitation for many of these markers is their sensitivity to
bystander activation (CD69, CD25), their constitutive or
exclusive expression on specialized T cel subset (CD69,
CD25, CRTAM), or their late upregulation folowing in vitro
stimulation (HLA-DR, CD134, CD71), which afects their
usability for accurate enumeration of antigen-specific T cels
occurring at low frequencies (<<1%).
One widely used activation marker for CD41and CD81
T cels is CD69, which is one of the earliest markers (3–15 h;
(44)) expressed on activated T cels, as wel as B cels or NK
cels (56–59). However, as CD69 background expression is
also found in variable amount on nonstimulated T cels (49),
and CD69 upregulation is not solely dependent on T cel
receptor triggering (60,61), analysis of CD69 expression alone
may strongly overestimate the frequencies of antigen-specific
T cels. In contrast, in combination with other early activation
markers (e.g., CD154 and CD137, see below) or cytokine
expression, the analysis of CD69 coexpression as a second
parameter is a useful tool to increase the sensitivity and opti-
cal discrimination of rare cels in flow-cytometry data.
For CD41 T cels, CD154 (CD40L), a member of the
TNF superfamily, has been shown to be a reliable functional
marker for the detection of antigen-activated T cels (45–47).
As the central mediator of T cel help CD154 is expressed by
virtualy al functional activated CD41T cels irrespective of
their diferentiation status, as wel as by a subset of CD81T
cels. Another technicaly important feature of CD154 is its
extremely low ex vivo background expression, which alows a
highly specific detection of antigen-induced CD154 expres-
sion (62). This is most probably due to its rapid internaliza-
tion and degradation folowing interaction with its receptor
CD40 expressed on antigen-presenting cels. CD154 expres-
sion can readily be assessed either intracelularly by adding
secretion inhibitors like Brefeldin A or Monensin to the cul-
ture or on the surface by blocking the interaction with its
ligand through addition of an anti-CD40 mAB. As CD154
upregulation occurs fast (4–12 h) folowing antigen encoun-
ter, its detection can easily be combined with staining for
cytokines and phenotypic markers.
Another wel described marker with suficiently high
specificity is CD137 (4-1BB), a member of the TNFR super-
family, which has been shown to be expressed on antigen-
activated CD41and CD81T cels as wel ascd1T cels, fol-
lowing 16–24 h of stimulation (51–53). Recently, CD137 has
also been shown to be expressed on antigen-activated
CD41Foxp1regulatory T cels (Treg, see below) (63). Since
both, CD154 and CD137 are expressed on the surface of the
antigen-specific T cels, enrichment and analysis of living cels
is possible alowing further functional characterization or
clinical-scale enrichment of antigen-specific T cels for adop-
tive therapies.
ACCESSINGRAREANTIGEN–SPECIFICTCELLS
Despite its high sensitivity, standard flow-cytometry is
limited by the number of events, which can be acquired
(typicaly 106cels) as wel as the staining background,
which is typicaly between 0.01 and 0.1%. This usualy
restricts the analysis of un-manipulated samples to popula-
tions occurring at frequencies>0.01–0.1%. Therefore, the
technologies described above have mainly be used for the
detection of pathogen specific memory T cels, although the
frequency of pathogen-specific T cels can vary widely,
depending on the nature of the pathogen, the status of the
immune response and the persistence or clearance of the
pathogen. In absence of an acute infection, frequencies of
antigen-specific memory cels are typicaly in the range of
one cel within 100 to 105. However, many functionaly
important T cel populations occur at much lower frequen-
cies and cannot be accessed without additional measures.
This applies in general for the naive compartment, as wel
as the CD41T cel repertoire and in particular for the smal
population of regulatory T cels. Furthermore T cels specific
for nonpathogen derived antigens, that is, auto-antigens,
tumor antigens, environmental antigens (alergens, toxins,
food) or neo-antigens are typicaly below 0.01% (Fig. 1).
Methods to enumerate such rare populations must therefore
alow to process large cel numbers, to colect suficient tar-
get events for statistical relevant analyses and at the same
time prevent accumulation of background events.
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In Vitro Expansion of Antigen-Specific T Cels to
Facilitate Detection
One solution to the rare cel problem is to increase the
number of antigen-specific T cels by in vitro expansion meth-
ods. Numerous approaches have been published using cultiva-
tion of un-separated PBMC with the particular antigen for 1–
2 weeks alowing the specific T cels to grow preferentialy.
However, the expansion of a single T cel is afected by a num-
ber of hardly predictable parameters such as its functional sta-
tus (e.g., naive, memory, anergic), the presence of other
reactive cels (bystander activation), or the relation between
the number of cel divisions and cel death. Therefore, it is dif-
ficult to extrapolate from the frequencies obtained after pro-
longed in vitro culture to the frequencies of cels in the
original samples, even if the proliferative history of the cels
has been visualized, for example, by use of cel proliferation
dyes. Similarly, the phenotype and function of the expanded
cels may significantly be altered by the culture conditions.
The group of Salusto recently described the use of libra-
ries of polyclonal expanded CD41T cels, to determine the
frequencies of antigen-specific T cels within the human naive
and memory repertoire (64). Each library consists of several
hundred single cultures, each seeded with 2,000 T cels cels/
wel, so that at the most one specific T cel/wel could be
expected. The cels are polyclonaly expanded while maintain-
ing the TCR diversity and restimulated with one or several
antigens in the presence of autologous monocytes. The origi-
nal frequency of antigen-specific T cels can then be calculated
based on the number of proliferating cultures and the number
of input cels. Using this approach, the authors could detect
frequencies of antigen-specific naive CD41T cels for protec-
tive antigen fromBacilus anthracisbetween 10 and 26 per 106
naive CD41T cels and for KLH between 10 and 70 cels per
106naive CD41T cels. An advantage of this method is that it
enables the enumeration of antigen-specific T cels specific for
naturaly processed antigens. By presorting of diferent T cel
subpopulations for set-up of the libraries, antigen specific T
cel frequencies from various T cel compartments can be
determined and compared. Once generated, the libraries can
be used for screening of several antigens and for further func-
tional analyses such as TCR afinity determination. However,
the technique requires maintaining several hundreds of indi-
vidual cultures for several weeks. Furthermore, a bias through
selective outgrowth or loss of certain T cel clones cannot be
excluded, especialy for mixed starting populations, for exam-
ple, diferent memory subsets, due to diferential expansion
and survival potential. Finaly, the detection limit is deter-
mined by the number of individual cel cultures per library
and the number of input cels per culture. For a frequency of
one cel within 105only 10 positive wels are detected within
500 cultures (i.e., 2,000 cels/culture, 106cels in total). This
basicaly restricts the analysis to a frequency window from 1
cel within 2,000 (al cultures positive) to maximaly one cel
within 105(10 cultures positive). For example the authors fail
to detect the rare specific T cels against neo-antigens within
the memory T cel compartment, which have been previously
described (65) and can be readily detected by other
approaches (62,66).
Antigen-Specific Pre-Enrichment
Magnetic enrichment to colect few target cels from large
cel samples. An alternative approach to increase the num-
ber of rare antigen-specific T cel frequencies for proper cyto-
metric analysis utilizes quantitative pre-enrichment of target
cels via magnetic cel separation, which alows rapid process-
ing of large cel samples (106–109) (67–70). In this way, al
labeled antigen-specific T cels (e.g., peptide-MHC tetramer,
activation marker, surface captured cytokines) from a large
sample are retained on the column and can subsequently be
conveniently analyzed by flow-cytometry or used for further
functional studies or expansion. A prerequisite for the mag-
netic enrichment of antigen-specific T cels is a high specificity
of the sorting marker to reliable identify the few antigen-
specific T cels within the vast number of irrelevant cels. As
the eluted fraction stil contains significant frequencies of
nontarget cels, additional exclusion criteria, such as staining
of non-T cel lineage cels, doublets and dead cels are required
to increase sensitivity and specificity. In combination with
multi-parameter flow cytometry, this technology alows the
direct ex vivo detection and in depth characterization of few
antigen specific T cels from large sample sizes. The magnetic
enrichment of antigen-specific cels leads to a dramatic
increase of sensitivity, which is mainly limited by the number
of available input cels, and gives important new insights into
previously undetectable parts of the T cel repertoire, includ-
ing even the naive compartment. The general characteristics
of diferent enrichment methods for the detection of antigen-
specific T cels are summarized in Table 1.
Enrichment of cytokine secreting cels. The enrichment of
rare cytokine producing T cels, enabled by the cytokine secre-
tion assay was the first report utilizing magnetic enrichment
for the analysis of rare antigen-specific T cels undetectable via
conventional flow-cytometry (34).
This has been extended to several other rare cytokine
producing T cel subpopulations. For example, tetanus-
Figure 1.Frequencies of antigen-specific CD41and CD81T cels
within human peripheral T cel repertoire determined directly by
ex vivo enrichment methods. Dashed lines indicated the detec-
tion limit range of standard flow cytometric counting and mag-
netic enrichment methods, respectively.
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specific IFN-c1and IL-41CD41T cels orC. albicans-specific
IL-171CD41T cels were isolated with frequencies of approx-
imately one cel within 104–105PBMC (34,71) and auto-
reactive IFN-c1and IL-41CD41T cels in pemphigus vulga-
ris patients could be detected with frequencies of 3–40 cels
per 105PBMC and less than 10 cels per 105PBMC in healthy
individuals (72). In addition, rare alergen-specific IL-4, IFN-
c, and IL-10 producers have been isolated from alergic
patients and healthy individuals with frequencies of 1–10 cels
within 104CD41 T cels (73). The direct visualization of
alergen-specific cytokine secreting cels revealed a higher fre-
quency of IL-10 producing cels in healthy individuals,
whereas in alergic patients IL-4 producers were dominant
indicating that the balance between IL-10 and IL-4 producing
cels might be decisive in the development of alergy (73).
Enrichment of rare IFN-cproducing cels has also been
instrumental for clinical adoptive immunotherapy, for exam-
ple, clinical-scale isolation of rare virus-specific T cels (40–
43).
However, as outlined above cytokine secretion is hetero-
geneous and restricted to certain T cel subsets, which often
represent only a smal fraction of the total antigen-specific T
cels. Although the cytokine secretion assay alows simultane-
ous detection of more than one cytokine, it is limited to maxi-
maly two or three, since the labeling of an individual cel with
diferent catch matrices for the respective cytokines reduces
the labeling intensity, which precludes their proper identifica-
tion as wel as magnetic enrichment.
Tetramer enrichment. MHC tetramers were also used to
detect and isolate rare antigen-experienced CD41and CD81
memory T cels of humans and mice (26,74–82). The sensitiv-
ity of the tetramer-based enrichment technology was further
extended to the identification and first direct enumeration of
the extremely rare antigen-specific CD41and CD81T cels
within the naive T cel repertoire. In the murine system, naive
CD81 T cels specific for epitopes of ovalbumin or various
viruses could be detected with varying frequencies from 15 to
1,500 cels per mouse (7–14,18). The peptide-MHC class I
tetramer based enrichment revealed frequencies of naive
CD41T cels specific for epitopes within ovalbumin,Salmo-
nela typhimurium, Listeria monocytogenes,I-E alpha chain or
the interphotoreceptor retinoid binding protein (IRBP) from
20–260 cels per mouse (1–6). Given an average number of 2.5
3107naive CD81 and 3.53107naive CD41 T cels per
mouse (83), the identified frequencies of T cels for an indi-
vidual peptide-MHC ligand range from 0.6 to 60 cels per 106
naive CD81T cels and 0.6–7.4 cels per 106naive CD41T
cels. Also in humans, antigen-specific naive T cels were
enumerated by tetramer-based enrichment with surprisingly
Table 1.Enrichment methods for the detection of rare antigen-specific T cels
METHOD ADVANTAGES DISADVANTAGES
DETECTABLE T CELL
POPULATIONS
Direct detection
MHC-multimer Activation independent
High specificity
Knowledge/availability of MHC
and epitope required
Restricted to single epitope specificities
Does not reveal functional status of the cels
Detection of low-afinity cels dificult
Naive, memory,
Treg
Activation
dependent
No MHC/epitope restriction
Reveal functional status
Dependent on T cel activation
Cytokine
secretion
assay
Selective isolation of distinct
cytokine producing subsets
Restricted to few selected cytokine producers
Laborious
Risk of contaminating cels through cross-feeding
Memory
CD154 (6 h) Detection of the whole
antigen-specific
CD41T cel response
Fast kinetics
Compatible with cytokine
analysis
Mainly restricted to CD41T cels Naive, memory
CD137 (16 h) Detection of the whole
antigen-specific CD41, CD81
T cel response
Not compatible with cytokine analysis
No diferentiation between Treg
and conventional CD41T cels
(due to 16 h stimulation)
Naive, memory
CD154/CD137
(6 h)
Detection of the whole
antigen-specific CD41
conventional and regulatory
T cel response
No CD81T cels Naive, memory, Treg
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similar frequencies: CD41 T cels specific for a peptide of
influenza hemagglutinin and three diferent epitopes ofBacil-
lus anthracisranged between 0.2 and 10 cels per 106naive
CD41T cels (2,16), which is in the same range as estimated
by the library method (64). Within the CD81T cel repertoire
antigen-specific naive T cels for epitopes of diferent viruses
and the auto-antigen NY-ESO1 were analyzed, with frequen-
cies of 0.5–30 per 106naive CD81T cels (15,17,19).
An interesting finding of these studies was that the fre-
quencies of naive precursor T cels for diferent antigens can
vary widely, but showed limited inter-individual variation.
This is especialy surprising in humans, as HLA haplotypes are
highly diverse. Furthermore, the size of the naive T cel
population specific for a given antigen could be linked to
immune dominance (13,84), as it was shown that naive pre-
cursor frequencies correlate with the size of the memory T cel
response (4,10,13,16,19,84).
Only recently a completely diferent mechanism for shap-
ing the human memory repertoire has been highlighted by
Davis and coworkers (66). They used highly sensitive HLA
class I tetramer enrichment to show that the peripheral blood
of human individuals which have not been infected with a cer-
tain virus before contain significant frequencies of bona fide
memory T cels specific for the very same virus, suggesting
that cross-reactivity during life contributes significantly to
shaping of the immune repertoire. Also our own data, using
Figure 2.Detection of antigen-specific conventional CD41 T cels and regulatory T cels folowing combined magnetic enrichment of
CD1541and CD1371cels. PBMC of a healthy human volunteer were stimulated for 6 h withA. fumigatuslysate. CD1541and CD1371
CD41T cels were isolated by magnetic enrichment and counterstained for CD25 and CD127 expression. For an optimal detection of CD41
CD1541and CD1371events, cel aggregates (scater area versus scater height), dead cels and nontarget cels (CD81CD141, CD201,
dump) were excluded and cels were gated on CD41lymphocytes. Numbers in brackets indicated cel count within 2.53105analyzed
PBMC before enrichment and folowing enrichment from 13107PBMC. FSC, forward scater; SSC side scater; LD, live/dead; PE, phycoer-
ythrin; APC, alophycocyanin. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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ex vivo enrichment of CD154 expressing cels folowing auto-
antigen stimulation suggest, that a significant proportion of
the self-reactive CD41T cel pool in healthy individuals has a
memory phenotype, which may result from cross-reactivity to
other antigens ((62) and see below).
Tetramer based enrichment has also been used to analyze
rare alergen-specific T cels as potential correlates for disease
status or eficacy of immunotherapy. Because of their low fre-
quencies, previous analyses of alergen specific T cels using
MHC-multimers were mainly performed after in vitro expan-
sion, which can alter the phenotype and functional capacities
of the cels, as already discussed above. Direct ex vivo tetramer
enrichment of alergen-specific CD41T cels has recently been
used to analyze specific T cels against epitopes from cat, pea-
nut, alder, and birch alergens (85–87). Alergen-specific T
cels were barely detected in peripheral blood of nonatopic
individuals with frequencies of about one to five cels within
106CD41T cels. In contrast, average–frequencies in alergic
patients ranged from 7–500 cels within 106CD41T cels. The
diferences in the frequencies of alergen-tetramer positive
cels might reflect, that alergen specific T cels are present at
lower frequencies in nonalergic subjects. Alternatively, a lower
avidity of alergen-reactive T cels in healthy individuals has
been suggested (88), and tetramers may be limited in their
ability to detect low-afinity T cels (89). Although target pro-
teins and T cel epitopes are defined for many alergic diseases,
the tetramer technology restricts the analysis to a few pre-
selected epitopes and MHC haplotypes and might therefore
underestimate the frequencies of alergen specific T cels in
healthy donors. In fact, our own preliminary results, analyzing
the total alergen-reactive T cel pool using CD154 enrichment
after stimulation with whole proteins or alergen extracts (see
below), indicate no diference in specific T cel numbers
between healthy and alergic subjects but a modulation of
memory T cel subsets, as wel as a strong shift towards a Th2
phenotype (Bacher et al., unpublished).
Rare antigen-specific CD41 T cel analysis using CD154
enrichment. The advantages of CD154 as a marker for the
total pool of antigen-reactive T cels were discussed above. We
recently demonstrated that CD154 enrichment can also be uti-
lized to strongly increase the sensitivity of detection for rare
cels (1025–1026largely depending on the number of input
cels) (62). Using this approach, a broad functional heteroge-
neity of virus-, bacteria- or fungus-specific CD41T cels was
visualized, demonstrating that many functional relevant cyto-
kines occur only in very low frequencies within the total anti-
gen specific T cel pool, undetectable without pre-enrichment
methods (1–10% of CD1541 cels, which corresponds to
0.0001–0.1% within the CD41T cel repertoire). Despite this
heterogeneity, these “cytokine micro-paterns” were character-
istic for a specific pathogen, indicating a pathogen-specific
immune modulation, which cannot be classified according to
the simplified Th1, Th2, Th17 lineage diferentiation scheme.
The increased sensitivity through the magnetic enrichment
was further used to directly analyze the ful repertoire of
KLH-, HIV- or several auto-antigen-specific CD41T cels in
the peripheral blood of healthy donors. The frequencies of
these cels were in the range of 1 cel within 104to 106, which
is similar to the results obtained using the “T cel library
approach” (64). However, we could furthermore demonstrate
that about on third of the identified neo- or auto-antigen-
specific CD1541T cels in healthy donors had a memory phe-
notype, suggesting that these cels are the result of priming by
cross-reactivity, which extends the findings by Mark Davis
group for virus-specific T cels using tetramer enrichment
(66).
ANTIGEN–SPECIFICREGULATORYTCELLS
A further chalenge is the detection and enumeration of
antigen-specific CD41Foxp31 regulatory T cels (Treg).
Despite their importance for the regulation of immune
responses and the maintenance of tolerance, exact informa-
tion of antigen-specificity and the frequency of antigen-
specific Treg is lacking. Fragmentary knowledge of specific tar-
get antigens or even antigenic peptides limits the applicability
of MHC class I multimers. In addition, less is known about
the afinity of Treg cels to their peptide-MHC ligands, which
might difer from conventional T cels and may be below the
detection threshold of MHC class I multimers. Treg also lack
most of the efector functions typicaly used for the analysis of
conventional T cels, such as cytokine production or in vitro
proliferation. Finaly, sensitive analysis tools are particularly
relevant for antigen-specific Treg, since they usualy represent
a subset of only 5–10% within the circulating human CD41T
cel compartment but have similar TCR diversity, which
means that antigen-specific Treg are extremely rare. Therefore,
enrichment strategies are essential for their reliable detection
in nonmanipulated biological samples.
TETRAMERDETECTION OFTREGCELLS
MHC class I tetramers have been successfuly used to
analyze antigen-specific Treg cels in studies of autoimmunity,
alergy, transplantation or pathogen-specific immune
responses. A recent study in mice addressed the question of
thymic selection impact on Foxp31and Foxp3–self-peptide
specific CD41T cels, using tetramer enrichment (90). Self-
peptide specific CD41T cels were not deleted in mice that
ubiquitously expressed the antigen, but both Foxp3–and
Foxp31 subsets were reduced compared to wildtype mice.
However, the remaining T cels were enriched for Foxp31
cels, indicating a higher resistance of Foxp31T cels to nega-
tive selection. Another important finding of this study was
that Treg cels specific for foreign antigens could be detected
in the CD41T cel repertoire of mice, that were never exposed
to the antigen before (90,91). The frequencies of Foxp31cels
specific for epitopes of I-Ea-chain,Lymphocytic choriomenin-
gitis virus, Listeria monocytogenesor ovalbumin ranged from
7.5 to 12% of the respective specificities in the naive T cel
repertoire (90).
In humans MHC class I tetramers were used to identify
antigen-specific Treg cels for birch, alder, and timothy grass
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alergens, as wel as epitopes fromStreptococcus pneumonia,
Varicela zoster, Mycobacterium tuberculosis,Hepatitis C Virus,
Influenza, HIV or the islet specific antigens GAD and IGRP
(87,92–99). However, due to their low frequencies, in most of
these studies antigen-specific Treg cels were previously
expanded for several days, by stimulation of bulk cultures with
the respective antigenic epitopes. Under these conditions, difer-
entiation between Treg and conventional T cels is dificult, since
Treg specific markers such as CD25 and Foxp3 or lack of CD127
expresion are also acquired by non Treg cels upon activation
(100). This further underlines the importance to analyze and
enumerate antigen-specific Treg cels directly ex vivo.
Recent studies using MHC I tetramers have demon-
strated directly ex vivo the existence of human regulatory T
cels specific for foreign antigens. Foxp31 Treg cels specific
for a peptide of the major birch polen alergen Bet v1 were
detected in human tonsils with frequencies of approximately
one cel within 1,000 CD41 T cels, which corresponded to
about 30% of the total tetramer positive population (93).
However, in peripheral blood no specific Treg cels could be
detected. Similarly, tetramer positiveStreptococcus pneumonia
specific Foxp31 Tregs could be detected in human tonsils,
with frequencies ranging from 0.53 to 1.96% among the total
tonsilar Treg cel population, whereas among peripheral
blood Treg cels no tetramer positive cels were found (96).
The diferent Treg frequencies in tonsilsversusperipheral
blood argue for a selective accumulation of foreign antigen-
specific Treg cels at the site of antigen encounter. Also after
cutaneousVaricela zosterorMycobacterium tuberculosischal-
lenge, human antigen-specific Tregs were identified by specific
tetramers at the site of antigen-chalenge in the skin (97).
However, when tetramer enrichment was used, antigen-
specific Tregs against Hepatitis C virus, Influenza and alder
alergen could directly be detected in human peripheral blood
with frequencies of 5–15% of the total tetramer positive
population (87,95), which is surprisingly similar to the 7.5–
12% Treg cels within the foreign peptide-specific naive T cel
repertoire detected in mouse (90). These data in fact suggest
that Treg are part of the natural repertoire against foreign
antigens and that specific Treg coexpand together with con-
ventional T cels during an immune response most likely to
control or prevent excessive immune reactions.
Treg Specific Activation Markers
Although the typical markers of TCR-activated conven-
tional T cels are lacking on Treg cels, several Treg specific
activation-markers have been introduced that alow the isola-
tion of activated Treg cels after in vitro stimulation, including
CD121a/b, latency-associated peptide (LAP) and GARP
(LRRC32) (101–103). But so far none of these markers has
been evaluated for an antigen-specific analysis of Treg cels.
However, only recently the activation markers CD154 and
CD137 have been reported to be upregulated on Treg cels fol-
lowing short term in vitro antigen stimulation (63,104).
Sch€onbrunn et al. show that the kinetics of activation marker
expression difer between Treg and conventional T cels, that
is after 6 h stimulation only Tregs express CD137 whereas
conventional T cels require>12 h of stimulation (63). In this
study, also the relation between CD154 and CD137 expression
was analyzed. CD137 is expressed by al activated Tregs,
whereas CD154 expression is restricted to a subset of Treg cels
which actualy seem to represent a population with instable
Foxp3 expression as shown by methylation analysis of the
Foxp3 promotor region. Thus the combined analysis of
CD137 and CD154 folowing short-term (6 h) stimulation
might be optimal to detect in paralel conventional T cels and
Tregs reacting against the same antigen and alows even to dis-
criminate between subsets with stable (CD1371CD154–)or
unstable (CD1371 CD1541) Foxp3 expresion. Sch€onbrunn
et al. used the technology to directly sort highly suppresive alo-
reactive Tregs out of PBMC stimulated with alogenic APCs.
Since both markers can be accessed on the cel surface
they can also be used in combination with a magnetic pre-
enrichment of the activation marker positive cels (62). This
approach thus enables the detection of rare antigen-specific
cels with high sensitivity, but without limitations of TCR
afinities or restriction to certain epitopes and could therefore
be extended to any antigen of interest. Our own preliminary
results using a combined CD137/CD154 enrichment indeed
show that antigen-specific Treg can be detected with high sen-
sitivity (Fig. 2) and we are currently using this approach to
characterize antigen-specific Treg cels from human peripheral
blood directed against environmental antigens, as wel as
auto-antigens.
CONCLUSION
Recent developments which significantly increase the sensi-
tivity for cytometric detection of antigen-specific T cels and
also enable the detection of antigen-specific Tregs, now alowing
to analyze the ful CD81 as wel as CD41 T cel repertoire
against most pathogens, environmental antigens, and tumor- or
auto-antigens, even in the unexposed host. In particular, the
posibility to simultaneously analyze T cel responses in the
naive, efector as wel as regulatory T cel compartment wil help
to define their role within the immune network and to deduce
their lineage relationship. Understanding of the ful antigen-
specific repertoire wil significantly improve diagnostic and
prognostic as wel as therapeutic intervention strategies.
Although the various technologies yield comparable
results in terms of cel frequencies they highlight diferent
aspects of T cel specificity and function and therefore integra-
tive approaches are mandatory. The main limitation seems to
be the availability of suficient sample material, especialy
from patients, which alows to colect a suitable number of
target cels. The smal number of target cels also makes high
demands on downstream analysis tools and therefore multi-
parameter analysis tools such as polychromatic flow-
cytometry wil be essential to extract maximal information
from the few available cels.
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Antigen-Reactive T Cel Enrichment for Direct,
High-Resolution Analysis of the Human Naive and Memory
Th Cel Repertoire
Petra Bacher,* Christian Schink,* Janka Teutschbein,†Olaf Kniemeyer,†,‡
Mario Assenmacher,* Axel A. Brakhage,†and Alexander Schefoldx
Ag-speciﬁc CD4+T cels orchestrating adaptive immune responses are crucial for the development of protective immunity, but
also mediate immunopathologies. To date, technical limitations often prevented their direct analysis. In this study, we report
a sensitive ﬂow cytometric assay based on magnetic pre-enrichment of CD154+T cels to visualize rare Ag-reactive naive and
memory Th cels directly from human peripheral blood. The detection limit of∼1cel within105–106permitted the direct
enumeration and characterization of auto-, tumor-, or neo-Ag–reactive T cels within the naive and even memory CD4+T cel
repertoire of healthy donors. Furthermore, the analysis of high target cel numbers after pre-enrichment of rare Ag-speciﬁc
T cels from large blood samples dramaticaly improved the identiﬁcation of smal subpopulations. As exempliﬁed in this work, the
dissection of the Ag-speciﬁc memory responses into smal cytokine-producing subsets revealed great heterogeneity between
pathogens, but also pathogen-related microsignatures reﬁning Th cel subset classiﬁcation. The possibility to directly analyze
CD4+T cels reactive against basicaly any Ag of interest at high resolution within the naive and memory repertoire wil open up
new avenues to investigate CD4+T cel–mediated immune reactions and their use for clinical diagnostics. The Journal of
Immunology, 2013, 190: 3967–3976.
Thelper cels play a central role in the induction of immuneresponses against pathogens as wel as in the developmentof immune-mediated diseases such as autoimmunity or al-
lergy. T cels recognizing protective or disease-relevant Ags are
usualy rare, especialy in the naive repertoire, but information
about their frequency, phenotype, and functional capabilities has
important diagnostic and/or prognostic value. Frequencies of Ag-
speciﬁc T cels within the human naive repertoire have been es-
timated to range between 1 cel in 104–107(1–3). In the memory
repertoire, the frequencies strongly vary depending on the status
of the immune reaction and are usualy in the range between 1025
and 5%. Recent eforts to deﬁne corelates of immune protection,
for example, after vaccination, have revealed that multiparameter
classiﬁcations are crucial, for example, for the identiﬁcation of
multifunctional CD8+T cels (4–6). This imposes the need to
analyze sufﬁcient target events to be able to identify smal subsets
with high statistical signiﬁcance.
Several ﬂow cytometric methods for the direct detection of rare
Ag-speciﬁc T cels have been described in the recent years, in-
cluding peptide-MHC multimers, cytokine secretion, and expres-
sion of activation markers (7, 8). However, these technologies are
limited by the number of cels per sample that can be acquired in
reasonable time (105–106) as wel as by the natural and/or tech-
nological background of the assay, which is typicaly between
0.01 and 0.1%. T cels occuring at lower frequency have tradi-
tionaly been analyzed via indirect methods, such as long-lasting
in vitro cultivation and/or population-based methods ([3H]thymidine
incorporation, CFSE dilution, ELISA) or ELISPOT (9–14). These
techniques provide only limited information about the relation-
ship between frequency, phenotype, and function of the reactive
cels.
Recent studies have shown that magnetic enrichment can be
used to colect rare peptide MHC-multimer–labeled cels from
large sample sizes, alowing direct cytometric detection of murine
and human Ag-speciﬁc CD4+and CD8+T cels even in the naive
repertoire (1, 15–22). However, the MHC-multimer technology is
limited to the previous knowledge of MHC aleles and antigenic
epitopes. Due to the very high diversity of MHC molecules and
especialy for complex pathogens, containing hundreds or thou-
sands of diferent target epitopes, choosing the right peptide-
MHC combinations to study Ag-speciﬁc T cel responses is quite
chalenging (23). Furthermore, the restriction to few antigenic
epitopes gives only limited and preselected insight into the het-
erogeneous T cel populations speciﬁc for a certain Ag. In addi-
tion, the generation of functional peptide-MHC class I multimers
for the detection of Ag-speciﬁc CD4+T cels, especialy for low-
afﬁnity autoreactive cels, is stil difﬁcult.
A more recent approach used libraries of polyclonal expanded
naive or memory CD4+T cels to determine the frequencies of Ag-
speciﬁc T cels against naturaly processed Ags (2). This method
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does not require knowledge of peptide-MHC combinations and
alows detection of the total pool of Ag-speciﬁc T cels even for
complex organisms in the memory as wel as the naive CD4+
T cel compartment. However, a disadvantage of this technique is
that it requires several weeks of in vitro cultivation and does not
alow directly enumeration and characterization of the Ag-speciﬁc
T cels, which implies the risk of potential phenotypic or func-
tional changes introduced by in vitro manipulation.
To overcome the curent limitations, we developed a method
based on magnetic enrichment of Ag-reactive CD154+(CD40L)–
expressing T cels to access directly ex vivo the human Ag-
speciﬁc naive and memory CD4+T cel repertoire. CD154, which
is speciﬁcaly expressed by al Ag-activated CD4+T cels shortly
after TCR stimulation, is a reliable functional marker for Ag-
speciﬁc CD4+T cels irespective of MHC alele or exact deﬁni-
tion of the antigenic epitope (24–26). We developed an optimized
magnetic Ag-reactive T cel enrichment protocol (ARTE) of
CD154+T cels, which alows reproducible and highly sensitive
capture of rare Ag-speciﬁc CD4+T cels prior to their pheno-
typical and functional in-depth characterization by multiparameter
ﬂow cytometry. The high sensitivity of our method provides direct
access to the human naive T cel repertoire and, to our knowledge,
enabled the ﬁrst characterization of human CD4+T cels speciﬁc
for an unrestricted pool of T cel epitopes from various auto- and
tumor-associated Ags, directly ex vivo from peripheral blood of
healthy donors. By performing functional in-depth characterizations,
we dissected the Ag-reactive CD4+T cel memory responses against
various pathogens into smal cytokine subsets and identiﬁed a high
functional heterogeneity with additional pathogen-related paterns
not necessarily associated with the dominant Th1, Th2, or Th17
classiﬁcation.
Our technology wil be broadly applicable and strongly improve
the analysis of autoimmunity and alergies, as wel as tumor im-
munology and infection research, and wil greatly reﬁne CD4+
T cel monitoring during vaccinations and other immunotherapies.
Materials and Methods
Blood donors and isolation of PBMCs
Bufy coats or leukaphereses products from healthy donors were obtained
from the university hospital in Dortmund and Cologne. This study was
performed according to established ethical guidelines, and al blood donors
gave informed consent. PBMCs were separated by use of Ficol–Hypaque
(GE-Healthcare, Bio-Science) density gradient centrifugation.
Preparation ofAspergilus fumigatuslysate
TheA. fumigatusstrain ATCC 46645 (LGC Standards) was used for
preparation of protein extract from mycelium. Conidia were inoculated at
a concentration of 23106spores/ml in YPD medium and shaken for 20 h
at 37˚C with 200 rpm (27). Mycelium was recovered by ﬁltration, washed
with water, and stored at270˚C. Frozen mycelium was resuspended in
saline (0.9% [w/v] NaCl) and disrupted in a microdismembrator (Sartorius)
at 200 rpm for 10 min using glass beads. The extract was resuspended in
13PBS bufer (2 mM MgCl2) and centrifuged for 20 min at 20,0003g.Supernatant was stored in aliquots at220˚C until use.
Stimulation, isolation, and characterization of Ag-speciﬁc
T cels
Stimulations were performed in RPMI 1640 medium (Miltenyi Biotec),
supplemented with 5% (v/v) AB serum (Lonza) and 2 mML-glutamine
(PAA Laboratories). For enrichment of recal Ag-speciﬁc T cels, 13107
PBMCs were stimulated for 7 h with the folowing Ags:A. fumigatus-
lysate (40mg/ml),Candida albicans-lysate (20mg/ml; Greer Laborato-
ries), CMV-lysate (10mg/ml; Siemens), tetanus-toxoid (10mg/ml; Statens
Serum Institute), or peptide pools of CMV pp65, adenovirus (AdV) Hexon
(0.6 nmol/ml; both Miltenyi Biotec) in the presence of 1mg/ml CD40 and
1mg/ml CD28 functional grade pure Ab (both Miltenyi Biotec). For en-
richment of auto-/tumor-/neo-Ag–speciﬁc T cels, 13108PBMCs were
stimulated with keyhole limpet hemocyanin (KLH; 200mg/ml; Immuco-
thel Biosyn) or peptide pools ofC. albicansMP65, myelin oligodendro-
cyte glycoprotein (MOG), glutamic acid decarboxylase (GAD), NY-ESO,
Wilms tumor Ag (WT-1; 0.6 nmol/ml; al Miltenyi Biotec), and HIV Gag
(1mg/ml; JPT Peptide Technologies). If separation of Ag-speciﬁc T cels
was combined with intracelular staining, 1mg/ml brefeldin A (Sigma-
Aldrich) was added for the last 2 h ofstimulation. After stimulation,
cels were separated using the CD154 MicroBead Kit (Miltenyi Biotec). In
brief, cels were indirectly magneticaly labeled with CD154-biotin and
antibiotin Microbeads and enriched by two sequential MS MACS columns
(Miltenyi Biotec). If separation of Ag-speciﬁc T cels was combined with
an intracelular staining, surface staining was performed on the ﬁrst col-
umn, folowed by ﬁxation, permeabilization (Inside stain kit; Miltenyi
Biotec), and intracelular cytokine staining on the second column.
HLA-DR–blocking experiments and ﬁxation of APCs
A total of 13107PBMCs from CMV-seropositive donors was stimulated
in presence or absence of a HLA-DR–speciﬁc mAb (100mg/ml clone
AC122; Miltenyi Biotec). CD154+T cels were isolated, as described
above, and the number of CD154+cels after enrichment or the frequencies
of CD154+cels after stimulation (1mg/ml staphylococcal enterotoxin B,
Sigma–Aldrich; anti-CD3/CD28 beads, Miltenyi Biotec) were analyzed by
ﬂow cytometry.
For Ag-processing experiments, T cels and APCs were separated from
PBMCs via untouched isolation with the pan T cel isolation kit (Miltenyi
Biotec) and depletion of CD3+T cels with anti-CD3 Microbeads (Miltenyi
Biotec). Both fractions reached a purity.99%. CD3-depleted APCs were
either loaded overnight with diferent Ags or left unloaded, and were
subsequently ﬁxed in 0.18% (v/v) paraformaldehyde in PBS/EDTA bufer
for 5 min. A total of 13107cels was stimulated in an APC:T cel ratio of
1:1, and CD154-expressing cels were separated and analyzed by ﬂow
cytometry. The number of enriched CD154+cels was normalized to the
control using nonﬁxed APCs plus Ags for stimulation.
Ab staining and ﬂow cytometry analysis
PBMCs were stimulated and Ag-speciﬁc CD4+T cels were isolated, as
described above. Depending on the experiment, enriched cels were stained
in diferent combinations of the folowing mAbs (clone names in paran-
theses), according to manufacturer’s protocols: CD14-PerCP, CD14-VioGreen
(TU¨K4), CD20-PerCP, CD20-VioGreen (LT20), CD3-PerCP (BW264/56),
antibiotin-PE, antibiotin-VioBlue (Bio3-18E7), CD4-Vioblue, CD4-FITC,
CD4-alophycocyanin, CD4-alophycocyanin-Vio770 (VIT4), CD27-FITC,
CD27-alophycocyanin (M-T271), CD28-PE (15E8), CD95-PE (DX2),
CD45RA-FITC, CD45RA-VioBlue (T6D11), CD45RO-alophycocyanin,
and CD45RO-FITC (UCHL1) (al Miltenyi Biotec); CD11a-alophycocyanin
(HI111), CCR7-AlexaFluor488 (MOPC-173), and CD45RA-PerCP.Cy5.5
(HI100) (al BioLegend); CD45RO-PE.Cy7 (UCHL-1; Becton Dickinson
Biosciences); and CCR7-PE (150503; R&D Systems).
After ﬁxation and permeabilization (Inside stain kit; Miltenyi Biotec),
CD154 expression was stained with CD154-VioBlue, CD154-alophycocyanin,
CD154-PE, and CD154-FITC (5C8; Miltenyi Biotec) alone, or in com-
bination with diferent cytokines, as folows: TNF-aFITC (cA2), IFN-g
alophycocyanin, IFN-gFITC, IFN-gPE (45-15), IL-2 PE (N7.48A), IL-4
PE (7A3-3), IL-5 alophycocyanin (JES1-39D10), IL-10 alophycocyanin
(B-T10), IL-13 PE (JES10-5A2.2), IL-17 FITC (CZ8-23G1) (al Miltenyi
Biotec); IL-22 PE (142928; R&D Systems); IL-22 PerCP.Cy5.5 (22URTI;
eBioscience); and IFN-gPerCP.Cy5.5 (4S.B3; BioLegend).
Data were acquired on a MACSQuant analyzer, and MACSQuantify
software (Miltenyi Biotec) was used for analysis.
Expansion and restimulation of Ag-speciﬁc T cel lines
Stimulation of PBMCs and isolation of CD154+cels were performed, as
described above. Isolated CD154+cels were cultured with mitomycin C
(Sigma–Aldrich)–treated autologous feeder cels in a ratio of 1:100 at
a density of 2.53106cels/cm2in 48-wel plates in X-Vivo15 (Lonza),
supplemented with 5% (v/v) AB serum (Lonza), 100 U/ml penicilin, 100
mg/ml streptomycin (Invitrogen), and 200 IU/ml IL-2 (Proleukin; Novartis).
Cels were expanded for 14 d, culture medium was replenished, and cels
were split, when needed.
For restimulation, autologous PBMCs were CD3 depleted with a purity
.99% using anti-CD3 Microbeads (Miltenyi Biotec) and were cryo-
preserved until restimulation of expanded T cel lines. For restimulation,
53105expanded T cels were combined with thawed autologous CD3-
depleted PBMCs in a ratio of 1:1 and stimulated with diferent Ags, in
presence of 1mg/ml CD28 functional grade pure Ab for 2 h plus addi-
tionaly 4 h with 1mg/ml brefeldin A (Sigma–Aldrich). After ﬁxation and
permeabilization, cels were stained intracelular for CD154 and cytokine
expression.
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For expansion of T cel lines from the naive or memory repertoire,
CD4+T cels were isolated by negative selection using the naive CD4+
T cel isolation kit or the memory CD4+T cel isolation kit (both Miltenyi
Biotec), respectively. In brief, PBMCs from leukapheresis product were
labeled with a mixture of biotin-conjugated Abs and antibiotin Microbeads
for depletion of unwanted cel types. Sorted T cel subsets always reached
a purity of.99%, as analyzed by ﬂow cytometry. A total of 23107
isolated naive or memory CD4+T cels was stimulated with autologous
CD3-depleted PBMCs as APCs in a ratio of 1:1 and the diferent Ags.
Enrichment, cultivation, and restimulation of reactive CD154+cels from
both CD4+T cel subsets were performed, as described above.
Generation of Ag-speciﬁc T cel clones
Ag-speciﬁc T cel clones were generated by single-cel sorting fromA.
fumigatusor AdV-stimulated and magneticaly pre-enriched CD154+CD4+
T cels using a FACS Aria II cel sorter (Becton Dickinson Biosciences).
Single cels were sorted into 96-wel round-botom plates with 13105/
wel iradiated (20 Gy) autologous feeder cels in 200ml TexMACS
medium (Miltenyi Biotec), supplemented with 15% AB serum, 2mM2-
ME (Life Technologies), 2 mM glutamine, 300 IU/ml IL-2 (Proleukin),
100 IU/ml penicilin, 100mg/ml streptomycin, and expanded polyclonal
with 30 ng/ml anti-CD3 (OKT3; Miltenyi Biotec). After 7 d, 100ml me-
dium was replaced and 13105iradiated feeder cels were added. An
additional 7 d later, cels were split into 96-wel ﬂat-botom plates and
further expanded. Restimulation was performed 4 wk after the single-cel
sort by stimulating 53105expanded T cels/wel with 53105autologous
CD3-depleted PBMCs with or without Ag for 6 h. A total of 1mg/ml
brefeldin A was added for the last 4 h. Speciﬁcity of the expanded T cel
clones was analyzed by intracelular cytokine staining.
Statistics
Statistical tests were performed with Prism software (GraphPad Software)
using paired Studentttest. For comparison of CD154+cel recovery with
or without column staining (Supplemental Fig. 1A), unpaired Studentttest
was used. Pearson’s corelation coefﬁcient was used to calculate corela-
tions. Thepvalues,0.05 were considered statisticaly signiﬁcant.
Results
CD154+enrichment alows quantitative capture and highly
sensitive enumeration and characterization of Ag-speciﬁc
CD4+T cels
CD154 is speciﬁcaly expressed by al Ag-activated CD4+T cels,
irrespective of deﬁned peptide-MHC combinations and without
any bias toward a certain cytokine-producing subset (24, 25).
CD154-expressing CD4+T cels can readily be detected folowing
7-h stimulation of PBMCs with various viral (CMV, AdV), bac-
terial (tetanus toxoid), or fungal (A. fumigatus,C. albicans) recal
Ags (Fig. 1A). However, it is also evident that, for certain Ags
and/or donors, the frequencies of Ag-speciﬁc CD4+T cels are
often,0.1%, which is in general the limit of detection for stan-
dard ﬂow cytometry. In particular, at frequencies,0.1%, the
resulting low total number of positive cels per sample (e.g.,
,100–1000 cels for sample sizes of 105–106CD4+T cels)
restricts the further dissection into specialized subpopulations.
This limits the applicability of this method for many clinicaly and
scientiﬁcaly relevant situations.
To enable the analysis of Ag-reactive T cels from larger sam-
ple sizes (.106cels), as required for rare cel detection, we mag-
neticaly pre-enriched the Ag-speciﬁc CD154+Tcelsbefore
analysis. In this way, Ag-speciﬁc T cels from 106–109PBMC
could be rapidly selected and subsequently analyzed within short
time. As shown in Fig. 1B, in total PBMCs stimulated withA.
fumigatuslysate,∼70 CD154+CD4+T cels could be detected
within 23105acquired events. In contrast, when 13107PBMCs
were stimulated and the CD154+cels were enriched before the
analysis,.2000 CD154+T cels could be detected by acquiring
the entire positive fraction with only∼53104total events.
FIGURE 1. CD154+ enrichment increases the
sensitivity of detection of Ag-speciﬁc CD4+Tcels.
(A) Frequencies of CD154+cels among CD4+(bold)
or total lymphocytes (italics) of one representative
donor after stimulation of PBMCs with the indicated
Ags. (B) Magnetic enrichment of CD154+Tcels
combined with intracelular cytokine staining. PBMCs
were stimulated withA. fumigatuslysate or left
unstimulated. CD154 expression was assessed among
CD4+T cels without enrichment (left plots) and after
CD154+enrichment (right plots). Numbers in brack-
ets indicate the number of CD154+cels after ac-
quiring 23105PBMCs (left plots) or obtained from
13107PBMCs after enrichment (right plots). (Cand
D) Comparison of the CD154+enrichment assay with
standard ﬂow counting using 13106starting PBMCs
(n= 20; 4 independent experiments were performed).
(C)CD154+cel numbers of nonstimulated orA.
fumigatus–stimulated samples. To optimize the de-
tection and quantiﬁcation of CD154+events among
CD3+CD4+T cels, cel aggregates (scater area ver-
sus scater height) and non-T cel lineages (CD14+,
CD20+, dump) were excluded. (D) Signal-to-noise
ratio was calculated based on CD154+cel numbers in
A. fumigatus–stimulated and nonstimulated PBMCs.
Signiﬁcance was determined using paired Studentt
test. (EandF) Detection limit of the CD154+en-
richment assay (n= 5; 2 independent experiments
were performed). (E) The total number of enriched
CD154+cels from diferent starting cel numbers of
A. fumigatus–stimulated or nonstimulated PBMCs is
shown. (F) Signal-to-noise ratio was calculated based
on CD154+cel numbers inA. fumigatus–stimulated
and nonstimulated PBMCs. Signiﬁcance was deter-
mined using paired Studentttest.
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By performing al staining and washing steps directly on the
magnetic columns, the protocol was optimized to result in minimal
cel loss during processing (Supplemental Fig. 1A), a minimal
intra-assay variability, and a linear correlation between isolated
target cels and the input cel number (106–108PBMCs) (Sup-
plemental Fig. 1B). This shows that the enrichment technology
alows reproducible and quantitative assessment of rare CD154+
T cels from large cel populations and enables to calculate back
the frequency of Ag-speciﬁc CD4+T cels based on the number of
enriched CD154+cels.
We further compared the background levels by acquiring the
CD154+cels of 106PBMCs with and without pre-enrichment.
Using an optimized staining and analysis strategy (see Fig. 1
legend), the background without enrichment ranged between 50
and 200 CD154+cels per 106counted PBMCs (Fig. 1C), that is,
0.02–0.07% among CD4+T cels, given an average frequency of
30% CD4+T cels in human PBMCs. In contrast, using the pre-
enrichment strategy, the background was reduced by a factor of
10, whereas the number of CD154+target cels was only half
reduced. Despite a strong donor-to-donor variation, this resulted in
a considerably improved signal-to-noise ratio of∼5–50 fold with
enrichment versus 2- to 10-fold without enrichment (Fig. 1D).
Interestingly, at higher input cel numbers (up to 108), the number
of isolated target cels increased linearly, whereas the proportion
of background cels declined, resulting in an even superior signal-
to-noise ratio at higher cel numbers (Fig. 1E, 1F).
These data show that magnetic pre-enrichment of CD154+
T cels alows rapid, quantitative, and reproducible analysis of
rare Ag-speciﬁc T cels from large sample sizes and results in
a strongly improved signal-to-noise ratio. The detection limit
ranges between 1025and 1026for 107–108starting cels, but
basicaly the sensitivity of the assay depends on the number of
input cels.
CD154+enrichment speciﬁcaly identiﬁes Ag-reactive T cels
CD154 induction was dependent on MHC-peptide recognition, be-
cause an added HLA-DR–blocking Ab strongly inhibited CD154
upregulation on CD4+T cels, but had no efect on CD4+T cels
activated by staphylococcal enterotoxin B or anti-CD3/CD28
(Supplemental Fig. 2A) nor on activated CD8+T cels (not depic-
ted). Furthermore, the CD4+T cel responses against the Ag
lysates but not against the pp65 peptide pool were prevented when
APCs were ﬁxed with formaldehyde before incubation with the
Ags (Supplemental Fig. 2B), indicating that CD154 induction
for native Ags is MHC class I and Ag processing dependent.
To further verify the speciﬁcity, the diferent recal Ag-activated
CD154+T cels were magneticaly isolated, expanded for 14 d,
and subsequently restimulated with autologous APCs and the in-
dicated Ags. The expanded T cels showed high reactivity toward
the inducing Ag (30–60%), as demonstrated by the upregulation
of CD154 and expression of cytokines (Fig. 2A), whereas reac-
tivity against irelevant Ags was at background level.
In addition, T cel clones were generated via single-cel FACS
sorting of CD154+cels and expansion with anti-CD3 and IL-2.
The cloning efﬁciency of the sorted CD154+cels was∼50% in
each case (data not shown). Upon restimulation, 89% (107 of 120
clones) and 92% (110 of 120 clones) of initialyA. fumigatusand
AdV-stimulated clones, respectively, produced cytokines in an Ag-
speciﬁc manner (Fig. 2B).
These data conﬁrm the high speciﬁcity of the CD154+enrich-
ment assay and demonstrate that speciﬁc T cel lines or clones can
rapidly be generated for al tested Ags.
CD154+enrichment reveals pathogen-related functional
heterogeneity of Ag-speciﬁc CD4+T cel responses
After applying ARTE for diferent recal Ags, the frequencies of
Ag-speciﬁc T cels were calculated from the total number of
FIGURE 2. Speciﬁcity of expanded CD154+T cels. (A) PBMCs were stimulated with the indicated recal Ags. CD154+cels were isolated and sub-
sequently expanded for 14 d with IL-2 and autologous feeder cels. Expanded cel lines were restimulated in presence of autologous APCs with and without
Ags, as indicated, and reactive CD4+T cels were determined by CD154 and TNF-aexpression. Representative dot plot examples of one donor of ﬁve with
percentage of reactive cels among CD4+lymphocytes are shown. (B) T cel clones were generated from single CD154+CD4+cels sorted by FACS fromA.
fumigatuslysate or AdV peptide pool-stimulated PBMCs. Cytokine expression was analyzed by intracelular staining upon Ag-speciﬁc restimulation.
Dashed lines indicate the cutof value of.5% cytokine producers. A total of 89.2% (107 of 120 clones) and 91.7% (110 of 120 clones) of the clones was
speciﬁc forA. fumigatusand AdV, respectively.
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CD154+cels obtained after enrichment relative to the total
number of CD4+cels applied on the column. The frequency
range for the diferent recal Ags was between 1 cel within 104–
102CD4+T cels, depending on the pathogen and the immune
status of the donor (Fig. 3B, ﬁrst diagram). The quality of an
immune response is not only afected by the frequency or ab-
solute number of the Ag-speciﬁc T cels, but also by their
functional capacity, such as cytokine production. Dissection of
pathogen-speciﬁc T cel responses into diferent functional T cel
subsets therefore gives important insights into the induction of
diferent functional capacities in vivo. A highlight of our method
is that it alows the simultaneous assessment of the functional
capacity of Ag-reactive T cels by multiparameter ﬂow cyto-
metric analysis, without long-term in vitro cultivation, thus di-
rectly reﬂecting the in vivo situation of the Ag-reactive T cels.
Therefore, we used the CD154+preselection to analyze the cy-
tokine proﬁles of Ag-speciﬁc T cels reactive against the various
recal Ags at high resolution.
A
B
FIGURE 3. Characterization of smal cytokine-producing subsets within the total Ag-speciﬁc T cel pool. (AandB) Flow cytometric ex vivo analysis of
cytokine-expressing subsets within Ag-speciﬁc CD4+T cel responses. A total of 13107PBMCs was stimulated with the indicated Ags, and Ag-speciﬁc
T cels were analyzed for cytokine expression using the CD154+enrichment assay. Cels were gated on CD4+lymphocytes, and percentages of cytokine-
expressing cels among CD154+T cels are shown. (A) Representative dot plot examples and (B) statistical analysis from several donors with indicated
mean values (n= 5; two independent experiments were performed). Frequencies of Ag-speciﬁc T cels (ﬁrst diagram) were calculated from the total number
of CD154+cels obtained after enrichment normalized to the total number of CD4+cels applied on the column.
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The power of our method is ilustrated in Fig. 3, as folows:
cytokines, which are not restricted to a certain T cel lineage, for
example, IL-2 or TNF-a, occured at high frequencies (up to 85%)
in the Th cel responses against al analyzed Ags. However, most
other cytokines, including the lineage-deﬁning cytokines IFN-g,
IL-4, IL-17, and IL-22, which are important parameters for the
classiﬁcation of Th cel responses into Th1, Th2, Th17, or Th22
subsets, showed much higher variability and represented often
only 1–10% of the total Ag-speciﬁc T cel pool, that is, 0.0001–
0.1% for the Ags analyzed in this work (Fig. 3). As depicted in
Fig. 3A, the magnetic preselection alows the colection of a number
of Ag-reactive T cels, high enough to enable the precise identiﬁ-
cation of smal cytokine-producing subsets, down to 1–10% within
the Ag-reactive CD4+T cel pool (Supplemental Fig. 3) (28).
Th cel responses against certain pathogens are often classiﬁed
according to a certain dominant cytokine expression. For example,
viral Ags have been shown to induce Th1 responses, extracelular
pathogens, Th2 responses, and fungi Th17 responses. However,
besides these dominant signatures, our reﬁned analysis revealed
a much higher heterogeneity in the functional cytokine repertoire of
Ag-speciﬁc T cels. Consistent with previous data (29), the re-
sponse againstC. albicanswas of a clear Th17 phenotype, with
high levels of IL-17 and IL-22 producers (10–30%), but we also
detected smal populations of Th1 (IFN-g)- and Th2 (IL-4, IL-5,
IL-13)-type cels that mainly did not coproduce IL-17 or IL-22
(data not shown). In contrast, in the T cel response against an-
other fungal pathogen,A. fumigatus, the Th1 cytokine IFN-gwas
dominant (10–30%), but also distinct populations of non-Th1
cytokines, such as IL-10 (4–6%), IL-17, and IL-22 (1–5%), as
wel as Th2 cytokines (IL-4 and IL-13, 1–5%), were present in
most donors.
In contrast, the response against the vaccine Ag tetanus was less
dominated by a single signature with intermediate levels of Th1
cels (IFN-g, 10–40%) and quite variable frequencies of Th2 cels
(IL-4, 2–30%; IL-5, 1–6%; IL-13, 1–20%). In some donors, we
also observed a smal population of IL-17 producers, but almost
no IL-22 producers. However, even within the highly Th1-
polarized antiviral immune responses against CMV and AdV, we
found smal diferences with regard to non-Th1 cytokines. For
example, we detected clear populations of IL-4 and IL-10 pro-
ducers against CMV, whereas AdV-speciﬁc T cels also contained
a smal population of IL-17 and IL-22 producers that were com-
pletely absent in the response to CMV. Interestingly, despite this
heterogeneity in the cytokine paterns against diferent pathogens,
the distribution on the diferent T cel subsets was quite similar for
diferent donors (Fig. 3B), indicating indeed the existence of
pathogen-related cytokine signatures. Because most of the cyto-
kines are restricted to small subpopulations, we use the term
microsignatures to diferentiate them from the classiﬁcation
according to the dominant Th cel signatures.
Taken together, to our knowledge, our method enables for the
ﬁrst time to directly visualize the total ex vivo functional reper-
toire of complex pathogen-speciﬁc T cel responses on a single-
cel level at high resolution. The reﬁned subpopulation analysis
reveals that, in addition to the major cytokine-producing subsets,
the detection of rare cytokine-producing T cels alows to identify
an unexpected broad complexity within the pathogen-speciﬁc
CD4+T cel responses.
ARTE unmasks the naive T cel repertoire, and enables the
direct visualization of autoreactive T cels even from healthy
donors
Until now, the cytometric analysis of Ag-reactive T cels using
cytokines or activation markers as a readout was mainly restricted
to the analysis of the memory T cel pool because the frequency
of naive T cels was below the level of detection. The high sen-
sitivity of our method prompted us to extend our study to the
analysis of Ag-speciﬁc CD4+T cel responses in the naive T cel
repertoire. We therefore investigated the human T cel repertoire
reactive against auto- and neo-Ags, which have to date escaped
direct quantitative and qualitative characterization. We applied
ARTE to analyze the CD4+T cel responses of healthy donors
against peptide pools of six diferent auto (MOG, GAD)-, tumor-
associated (NY-ESO, WT-1), or neo-Ags (KLH, HIV Gag), and
MP65, a majorC. albicansAg, as a positive control. Without en-
richment, no CD154+T cels against the auto- and neo-Ags were
detectable within 53 105acquired PBMCs, whereas MP65-
reactive T cels could immediately be detected with a frequency
of∼1in104CD4+T cels (range 1023–1025) (Fig. 4A). However,
folowing the enrichment from 108stimulated PBMCs, reactive
T cels against al Ags were clearly detected in al donors tested,
with frequencies ranging from,1026to 1024(Fig. 4A, 4B). The
frequencies of T cels difered between the various Ags, but, for
a particular Ag, rather smal donor-to-donor variations were ob-
served. Surprisingly, we found similar frequencies (1025to 1024)
against the auto-Ags, MOG and GAD, and the neo-Ags, KLH and
HIV Gag. However, the frequencies against the tumor-associated
Ags NY-ESO and WT-1 were∼10-fold lower (1026–1025). Fur-
ther phenotypic analysis of the enriched CD154+cels revealed
that a large fraction, but not al of the T cels reactive against the
auto-, tumor-associated, or neo-Ags indeed have a naive pheno-
type (40–60%, CD45RO2CCR7+), whereasC. albicansMP65-
speciﬁc CD4+T cels were mainly memory cels (80–90%, Fig.
4C, 4D). These data demonstrate that the CD154+enrichment
assay can be used to monitor the human naive Ag-reactive T cel
repertoire. The data also indicate that even in healthy donors
a signiﬁcant fraction of the self-reactive repertoire has a clear
memory phenotype, which suggests a role for cross-reactivity
against external Ags for priming of autoreactive T cels even in
a healthy individual.
Generation of Ag-speciﬁc T cel lines folowing CD154+
enrichment from the naive CD4+T cel compartment
To conﬁrm the speciﬁcity of the CD4+T cels reactive against auto-,
tumor-associated, and neo-Ags within the naive, as wel as in
memory compartment, reactive cels were enriched from highly
puriﬁed naive and memory CD4+T cels (Supplemental Fig. 4A,
4B), expanded for 14 d, and tested for speciﬁcity by Ag restim-
ulation. As shown in Fig. 5, expanded T cels from the naive as
wel as from the memory population speciﬁcaly reacted against
the inducing Ag. Interestingly, for the auto-, tumor-associated, and
neo-Ags, but not for the recal Ag MP65, the frequency of speciﬁc
T cels within the expanded T cel lines was higher for T cel lines
generated from naive T cels versus memory-derived cel lines.
This may indicate lower afﬁnity or reduced proliferative potential
of self-reactive T cels within the memory pool. However, these
data clearly conﬁrm our ex vivo phenotypic observations and
demonstrate the applicability of ARTE for the direct ex vivo de-
tection, enumeration, and characterization of Ag-speciﬁc T cel
populations, undetectable by standard assays.
Discussion
The Ag-induced expression ofCD154 has been described as
a versatile tool for the direct ex vivo detection of CD4+T cels
speciﬁc for any pathogen or Ag of interest (24–26). We employed
its high speciﬁcity in combination with a magnetic enrichment
step of rare CD154+cels from large cel samples. In this way, the
sensitivity of detection is mainly restricted by the number of input
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cels, that is, for 107–108PBMCs we estimated a sensitivity of
1025–1026. This alowed us to directly access extremely rare
populations such as Ag-speciﬁc T cels within the naive CD4+
T cel repertoire as wel as to dissect the Ag-speciﬁc memory
repertoire at high resolution.
High resolution, that is, the characterization of minor sub-
populations with high statistical precision, requires the colection
of sufﬁcient target events, alowing a proper statistical analysis.
For example, to estimate a 10% subset of a population with a
coefﬁcient of variation,10%, at least 1000 CD154+T cels have
to be acquired (Supplemental Fig. 3) (28). The magnetic prese-
lection alowed the colection of a number of Ag-reactive T cels,
sufﬁcient for the identiﬁcation of smal cytokine-producing sub-
sets, down to 1–10% within the total reactive CD4+T cel pool.
The power of magnetic pre-enrichment has already been demon-
strated for various rare cel populations (30–32) and has been
employed for MHC-multimers to identify Ag-speciﬁc T cels even
in the naive repertoire (1, 18–20). However, the method we de-
scribe in this work has several advantages over the MHC-multimer
technology, which is restricted to a set of exactly deﬁned peptide-
MHC combinations. Therefore, the CD154+enrichment technol-
ogy ﬁls an apparent gap in the Ag-speciﬁc T cel analysis tool
box, now also providing ex vivo access to the functional CD4+
T cel pool with a sensitivity comparable to the MHC-multimer
enrichment approach, but without the need for in vitro expansion
or restriction to a certain Ag or MHC alele.
We used this method to dissect the CD4+T cel response against
various pathogens into smal but functionaly distinct subpopu-
lations. Many analyses restrict the characterization of pathogen-
speciﬁc T cels to rather abundant cytokines such as IL-2, TNF-a,
or IFN-g, due to the limited access to Ag-speciﬁc T cel numbers.
In this study, we show that many functionaly important cytokines,
such as IL-4, IL-5, IL-10, and IL-13, and for many pathogens,
also IL-17 and IL-22 are produced only by∼1–10% of the total
Ag-speciﬁc T cel pool and therefore may represent only 0.01–
0.001% of the total CD4+T cel compartment. These data dem-
FIGURE 4. Enumeration and characterization of CD4+T cels reactive against auto- or neo-Ags. (A) A total of 13108PBMCs was stimulated as
indicated, and CD154+expression among CD4+T cels was analyzed without enrichment (upper plots) and after performing the CD154+enrichment assay
(lower plots). Indicated are percentages of CD154+cels among CD4+and number of CD154+cels after acquiring 53105PBMCs (upper plots)or
obtained from 13108PBMCs after enrichment (lower plots). (B) Enumeration of rare Ag-speciﬁc CD4+T cels in several donors using the CD154+
enrichment assay. The total number of enriched CD154+T cels was determined using a single, live, nondump, CD3+CD4+gating strategy, and background
enriched from the nonstimulated control was subtracted. Depicted is the total number of CD154+cels obtained after enrichment normalized to the total
number of CD4+cels applied on the column (MP65,n= 21; GAD, NY-ESO,n= 19; MOG, WT-1,n= 16; KLH, HIV Gag,n= 6). (CandD) Enriched
CD154+cels were ex vivo analyzed for phenotypic surface markers CD45RO and CCR7. Cels are gated on CD4+CD154+lymphocytes. (C) Representative
dot plot examples from one donor with percentages of cels among CD154+cels and cel count (in brackets) and (D) statistical analysis for percentage of
CD45RO2CCR7+cels among the total number of CD154+cels (n= 6; two independent experiments were performed). Background enriched from the
nonstimulated control was subtracted.
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onstrate that the rather simpliﬁed classiﬁcation of an immune
response into Th1, Th2, or Th17 according to the few dominant
lineage-deﬁning cytokines can be reﬁned by identiﬁcation of the
underlying cytokine microsignatures. Indeed, our analysis of the
cytokine-producing subsets revealed an unexpected broad func-
tional heterogeneity of T cels reacting against the diferent
pathogens. Interestingly, the responses against a given pathogen
were remarkably similar between diferent donors, indicating in-
deed the existence of pathogen-related cytokine signatures that
can be identiﬁed only via high-resolution analysis.
One interesting ﬁnding was that the two fungal pathogensA.
fumigatusandC. albicanselicit completely diferent paterns of
Th cel responses. Although Th17 responses are often described as
prototypic for antifungal immunity, we show that onlyC. albi-
cans–reactive T cels produce mainly IL-17 and IL-22, whereas
the response againstA. fumigatuswas rather dominated by IFN-g–
producing Th1 cels and also contained a smal fraction of IL-10
producers. Interestingly, also a smal fraction ofA. fumigatus–
speciﬁc Th17/22 cels was consistently present throughout al
donors. The Th17 versus Th1 signatures might reﬂect the selective
capability ofC. albicansto elicit Th17 responses in vivo and
in vitro, as it has recently been described (29, 33), or diferent
infection routes of the two pathogens, that is, the lung forA.
fumigatusversus gut and skin epithelia forC. albicans. However,
it wil be interesting to further analyze the origin of theA. fumi-
gatus–reactive Th17 versus Th1 subset and to deﬁne which role
the two subsets possess in the various antifungal immune responses,
that is, alergies or invasive infections.
Also, in the antiviral CD4+T cel responses, which are clearly
dominated by a Th1 cytokine proﬁle, we found a second, het-
erogeneous response of non-Th1 cytokines, speciﬁcaly associated
with a certain virus. In particular, IL-10 and IL-4 were found at
low level against both viruses, but were more pronounced in re-
sponse to CMV, whereas IL-22 and at lower level also IL-17
producers, which were consistently present in the AdV-speciﬁc
immune response, were absent against CMV (,0.1%). This
indicates that, besides the major Th subset-inducing capacity of
certain classes of pathogens, for example, Th1 for viruses, dif-
ferent pathogens have additional capabilities to induce distinct
cytokine microsignatures not necessarily related to the dominant
signature. It wil be interesting to identify the critical factors re-
sponsible for the induction of these cytokine microsignatures that
al together constitute functional T cel immunity, such as the
nature of the pathogen-associated signals, Ag dose, the site of Ag
exposure, or the preparation of vaccine adjuvants, as wel as po-
tential cross-reactivity between species with diferent cytokine-
inducing capabilities. Indeed, the importance of multiparameter
characterization of the Ag-speciﬁc repertoire, for example, for
prediction of immune protection, has been highlighted before by
many studies (4–6). Thus, the possibility to directly visualize now
in detail the broad heterogeneity of Ag-speciﬁc CD4+T cel
responses at high resolution wil be an important tool to identify
the underlying principles of subset heterogeneity and their use for
diagnostic assays, for example, during immunotherapies.
Another important application of our technology was the
analysis of Ag-speciﬁc T cels in the naive T cel compartment,
which could to date not be directly assessed without restriction to
selected peptides. Knowledge about Ag speciﬁcity in the naive
repertoire may alow to predict the success of immunomodulation
strategies, such as vaccination and tolerization, or to assess the risk
for the development of immunopathologies. To our knowledge, the
high sensitivity of the CD154+enrichment assay alowed us for
the ﬁrst time to visualize the ful repertoire of CD4+T cels re-
active against various neo-, auto-, or tumor-associated Ags directly
from PBMCs of healthy donors. We observed frequencies of re-
active cels against these Ags in a range of,1026–1024, which is
quite similar to the frequencies of naive CD4+T cels speciﬁc for
other naturaly processed Ags determined by the T cel library
approach (2). However, recentstudies in humans, using MHC-
multimer enrichment, detected frequencies of Ag-speciﬁc naive
CD8+and CD4+T cels of 0.3–3.6 (1) and 0.2–10 (18) per milion
cels, respectively. The higher frequencies found in our study are
most probably due to the fact that we did not determine fre-
quencies of T cels speciﬁc for a single epitope. The peptide pools
used in this study consist of overlapping 15-mer peptides (11-aa
overlap), covering the complete protein sequence and al possible
T cel epitopes (34). Therefore, the total frequency of Ag-speciﬁc
T cels most likely reﬂects responses to multiple epitopes.
FIGURE 5. CD154+enrichment alows generation of Ag-speciﬁc T cel lines from the naive CD4+T cel repertoire. A total of 23107puriﬁed memory
(A) or naive (B) CD4+T cels was stimulated with CD3-depleted APCs and the indicated Ags. Enriched CD154+cels were expanded for 14 d with IL-2 and
autologous feeder cels. Expanded cel lines were restimulated in presence of autologous APCs with and without Ags, as indicated, and reactive CD4+
T cels were determined by CD154 and TNF-aexpression. Representative dot plot examples of one donor of three with percentage of reactive cels among
total CD4+are shown.
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Surprisingly, although a large number of the neo-, auto-, or tumor
Ag-speciﬁc T cels was indeed in the naive state, as expected for
healthy individuals, the reactive cels always contained a signiﬁcant
fraction of memory T cels. These are truly Ag-speciﬁc T cels
because enriched cels from both T cel compartments gave rise
to highly speciﬁc T cel lines folowing in vitro expansion. In
healthy donors, memory T cels against auto-Ags and in particular
against the neo-Ag KLH are most probably the result of cross-
reactivity to external Ags. Accordingly, we observed a tendency
that T cel lines against the neo- and auto-Ags were less efﬁciently
generated from memory versus naive derived T cels, whereas
pathogen-reactive T cel lines could efﬁciently be generated from
memory T cels. This may be explained by lower afﬁnity of T cels
reactive against the cross-reactive versus the original priming Ag.
Alternatively, this could be due to a reduced proliferative potential
that may indicate an anergic state of the autoreactive memory
T cels, although this would not apply for T cels reactive against
neo-Ags like KLH or HIV gag. However, the contribution of cross-
reactive memory T cels against neo- and auto-Ags to immune
protection or the development of autoimmunity requires further
investigation. Interestingly, the number of reactive cels against
a certain neo- or auto-Ag was relatively constant between diferent
donors, but difered between the various Ags, as described before
for CD8+T cels (1). Speciﬁcaly, T cels reactive against the
tumor-associated Ags NY-ESO and WT-1 were∼10-fold less
frequent, but contained similar proportions of naive and memory
T cels. Whether these diferences result from diferences in
thymic negative selection or peripheral depletion or simply result
from a lower number of available T cel epitopes remains to be
analyzed. However, in the murine model, it has been shown that
the size of a certain naive CD4+Tcelpopulationisstronglyaf-
fected by negative thymic selection with a stronger thymic deletion
of smaler naive T cel populations (35). Furthermore, a corelation
between naive precursor frequencies and the size and TCR diversity
of the memory responses to diferent peptides has been reported
(19, 35, 36). Because NY-ESO and WT-1 are used for antitumor
vaccination, it would be interesting to study whether the frequency
of precursors predicts the outcome of vaccination, as it has, for
example, recently been shown for anthrax vaccination (18).
In summary, the CD154+enrichment technology alows the vi-
sualization and quantiﬁcation of functional Ag-speciﬁc T cels at
unprecedented sensitivity, providing even access to the naive
CD4+T cel repertoire. Our results highlight the importance of
dissecting the total Ag-reactive T cel pool into smal, but func-
tionaly relevant subsets, giving a more precise picture of the
functional T cel repertoire. The method alows quantiﬁcation of
various parameters with potential diagnostic or prognostic rele-
vance within one single, short, and sensitive assay and can in
principle be extended to any pathogen or Ag of interest. Because
the absolute cel numbers available for a single analysis are low or
require sample sizes that are difﬁcult to obtain routinely from
patients, as many parameters as possible should be measured in
paralel. Therefore, recent developments, which have dramaticaly
increased the number of parameters for cytometric analysis, wil
optimaly synergize with the Ag-reactive T cel enrichment tech-
nology described in this work (37). The accurate and sensitive
assessment of Th cel immunity provides new, exciting possibili-
ties for basic and clinical research and represents a powerful di-
agnostic tool for infections, autoimmunity, and alergies.
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Figure S1. CD154+ enrichment assay alows accurate and reproducible quantification of rare 
antigen-specific  T cels. (A)  Performing intracelular staining  directly  on the  magnetic 
columns strongly increases cel recovery.  1x107  PBMCs  were stimulated  with A. fumigatus 
lysate and the recovery range  of  CD154+ cels folowing intracelular staining  performed 
either  directly  on the  magnetic column  or after elution from the column  was analyzed (n  = 
30).  Horizontal  bars indicate  mean  values and significance  was  determined  using  unpaired 
Student´s t-test. (B) Intra-assay variability of the recovered CD154+ cel numbers. Diferent 
PBMC starting cel numbers from two donors were stimulated in triplicates with A. fumigatus 
lysate and recovered  CD154+ cel  numbers  were analyzed after  performing the  CD154+ 
enrichment assay.  Pearson´s corelation coeficient  was  used to calculate corelations (p  < 
0.0001). 
Supplementary Figure 2 Bacher et al. 
BA
Figure  S2. Specific induction  of  CD154+ expression folowing antigen stimulation. (A) 
Inhibition  of the  CD154 induction  by  HLA-DR  blockade.  PBMCs  of  CMV  pp65-tetramer 
positive donors were stimulated with the indicated antigens in the presence or absence of anti-
HLA-DR and the  number  of  CD154+  T cels after enrichment (left)  or the frequencies  of 
CD154+ T cels without enrichment (right) were analyzed. Bars show mean percentages and 
SEM from  4  donors refering to samples  without anti-HLA-DR.  Two independent 
experiments  were  performed. (B)  CD154 induction is antigen-processing  dependent. 
Stimulation  of isolated  CD3+  T cels  was  performed  under the indicated conditions and the 
number  of  CD154+  T cels after enrichment  was analyzed.  Bars indicate  percentages  of 
CD154+ cel  numbers  under the  various conditions relative to the stimulation  with live 
APCs + antigen from 3 diferent donors. 
Supplementary Figure 3 Bacher et al. 
Figure S3. The precision of rare cel analysis is dependent on the number of acquired target 
cels. To describe the precision of flow cytometry data, the coeficient of variance (CV) can 
be calculated from the  variance and the standard  deviation (SD).  For rare cel analysis, the 
approximations SD = r and CV % = 100/r can be used, where r is the number of positive 
events (28). 
Using this approximation, the  CV  of a certain cytokine  producing subset is ilustrated, 
depending  on the  number  of acquired  CD154+ target cels.  For example, to  obtain a  CV  of 
10%, 100 CD154+ cels must be acquired. If the cytokine producing cels are a subpopulation 
of 10% among al CD154+ cels, 1000 CD154+ cels need to be acquired. 
Supplementary Figure 4 Bacher et al. 
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Figure S4. Phenotypic and functional characterization of isolated naive and memory CD4+ T 
cels. (A)  Phenotypic characteristics  of  non-sorted  CD4+  T cels and isolated  memory and 
naive CD4+ T cels subsets. (B) Cytokine expression by T cel subsets: Isolated memory and 
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CD154+ expression and cytokine  production.  Data are representative  of three independent 
experiments. 
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Antigen-specific expansion of human regulatory
T cels as a major tolerance mechanism against
mucosal fungi
P Bacher1, O Kniemeyer2,3, A Scho¨nbrunn4, B Sawitzki4, M Assenmacher5, E Rietschel6, A Steinbach7,
OA Cornely7,8, AA Brakhage2, A Thiel4and A Schefold1,9
Foxp3þregulatory Tcels (Treg) have a central role for keeping the balance between pro- and anti-inflammatory immune
responses against chronicaly encountered antigens at mucosal sites. However, their antigen specificity especialy in
humans is largely unknown. Here we used a sensitive enrichment technology for antigen-reactive T cels to directly
compare the conventional vs. regulatory CD4þ T-cel response directed against two ubiquitous mucosal fungi,
Aspergilus fumigatusandCandida albicans. In healthy humans, fungus-specific CD4þCD25þCD127 Foxp3þTreg are
strongly expanded in peripheral blood and possess phenotypic, epigenetic and functional features of thymus-derived
Treg. Intriguingly, forA. fumigatus,the strong Treg response contrasts with minimal conventional T-cel memory,
indicating selective Treg expansion as an efective mechanism to prevent inappropriate immune activation in healthy
individuals. By contrast, in subjects withA. fumigatusalergies, specific Th2 cels were strongly expanded despite the
presence of specific Treg. Taken together, we demonstrate a largely expanded Treg population specific for mucosal
fungi as part of the physiological human T-cel repertoire and identify a unique capacity ofA. fumigatusto selectively
generate Treg responses as a potentialy important mechanism for the prevention of alergic reactions.
INTRODUCTION
The mucosal immune system is constantly confronted with the
chalenge to combat a vast number of pathogens from the
environment without causing colateral tissue damage due to
uncontroled or inappropriate immune reactions. There is
substantial evidence from animal experiments that regulatory T
cels (Treg) have an important role in maintaining tolerance
against commensals or inhaled antigens encountered at mucosal
sites.1–6However, the antigen specificity of this protective Treg
population in particular in humans remained so far elusive due to
the high number of potential targets and a lack of specific and
sensitive technologies for the direct quantitative and qualitative
analysis of Treg with a defined antigen specificity.7
Fungi represent a prototypic example for mucosaly encoun-
tered environmental pathogens and/or commensal microbiota
whose importance has been underestimated for many years.8
Humans continuously inhale several thousands of airborne
fungal spores per day.9,10Other fungi such asCandida albicans
belong to the normal mucosal microflora of humans.11In
immunocompromised patients, fungi such asAspergilus fumigatus
andCandida albicanscan cause life-threatening invasive infec-
tions.12In addition, inhaled airborne fungi can cause alergic
hypersensitivity especialy in patients with respiratory disorders,
such as severe asthma or cystic fibrosis (CF). These patients
frequently sufer from severe Th2-driven alergic reactions and
alergic bronchopulmonary aspergilosis (ABPA).13
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Strikingly, despite daily contact with fungal antigens,
immunocompetent persons are highly resistant to severe
fungal infections as wel as hypersensitivity reactions.14This
implicates the existence of eficient protective immune
responses as wel as regulatory mechanisms that are able to
prevent inappropriate immune reactions.15It has been shown
that fungal components trigger eficient innate immune
reactions and eventualy also initiate adaptive immune
responses mainly mediated by CD4þT cels.16,17We recently
showed that fungus-reactive conventional memory CD4þ
T cels are indeed present in peripheral blood of al healthy
donors18(and unpublished data), which most likely reflects the
ubiquitous presence of fungal antigens in the environment.
However, the celular basis for anti-inflammatory or tolero-
genic mechanisms, which avoid immunopathology such as
chronic inflammation or alergies against fungi is less clear. We
therefore analyzed Treg as wel as conventional naive and
memory CD4þT cels (Tcon) specific for the two major fungal
pathogensA. fumigatusandC. albicansdirectly in blood of
human subjects. This comparison was possible by using a new
sensitive pre-enrichment technology for the direct detection of
rare antigen-specific Tcon and Treg, according to the converse
expression patern of the activation markers CD154 and
CD137.18,19Interestingly, we found that both fungi, but in
particularA. fumigatus,elicited a strong Treg response in adult
but not in cord blood. ForC. albicans, the specific Treg response
was accompanied by a paralel dominant memory Tcon
(Tmem) formation. However, forA. fumigatus, the balance
was strongly shifted toward Treg as the specific Tcon were
composed of only a minimaly expanded memory and a large
naive compartment. Thus, Treg numbers even exceeded those
of Tmem, resulting in a marked suppression of the anti-A.
fumigatusTcon response inin vitroassays. This presumably
protective Treg dominance was abrogated in CF patients with
Aspergilus-associated alergies due to a strong expansion of
Th2-type Tmem. These data provide direct evidence for the
preferential generation of an antigen-specific Treg response
against a chronicaly encountered mucosal pathogen and
suggest that subversion or bypassing of this mechanism
contribute to the development of alergies.
RESULTS
High frequencies of fungus-specific memory Treg in
peripheral blood of healthy donors
To beter define the contribution of T cels to the delicate
balance between pro- and anti-inflammatory immune
responses against chronicaly exposed fungi, we performed
a side-by-side comparison of human Tcon and Treg responses
againstA. fumigatusandC. albicans. Converse expression of
CD137 and CD154 folowing short-term stimulation with
fungal lysates enabled identification of activated forkhead box
protein P3 (Foxp3) expressing Treg together with Tcon.19
Stimulation withA. fumigatusandC. albicansantigens
induced overal low frequencies of CD154þor CD137þCD4þ
T cels (Figure 1aandb). Despite their low overal abundance,
this corresponds to surprisingly high frequencies within the
CD25þFoxp3þ population, which actualy represents only
5–10% of the total CD4þT cels, i.e., 1.3% (range 0.06–3.4%)
forA. fumigatusand 0.6% forC. albicans(range 0.02–2.6%)
(Figure 1c). In contrast, the frequencies of fungus-reactive
Tcon among total CD4þT cels were about 5- to 10-fold lower,
and here the frequencies ofC. albicans-reactive Tcon were
significantly higher (0.27%; range 0.11–0.55%) than those of
A. fumigatus-reactive Tcon (0.19%; range 0.06–0.37%).
For a more sensitive and detailed analysis, we used antigen-
reactive T-cel enrichment (ARTE)7,18to enable the quantifica-
tion and characterization of the few CD154þ and CD137þ
cels from larger cel samples (Z1 107PBMC) with high
sensitivity and specificity (Figure 1d). Approximately 90%
(range 60–93%) of the CD137þcels were positive for Foxp3
and CD25 and negative for CD127 (Figure 1dande). In
addition, the majority of the antigen-reactive CD137þ
CD154 Foxp3þ cels co-expressed the transcription factor
Helios (Figure 1f). FACS-sorted CD137þCD154 cels had a
highly demethylated Treg-specific demethylated region
(TSDR), at levels comparable to CD25þCD127dim-sorted
CD4þ T cels or Staphylococcal enterotoxin B (SEB)-
stimulated CD137þCD154 CD4þcels. In contrast, CD154þ
CD137 T cels had a methylated Foxp3 locus (Figure 1g) and
a phenotype matching that of Tcon (Foxp3CD25
CD127þ).
Analysis of CD45RO and CCR7 expressions on the fungus-
specific CD137þCD154 Treg revealed a memory phenotype
with a higher frequency of cels in the CCR7 efector memory
compartment (Figure 2aandb). Further analysis of cytokine
expression demonstrated that production of the cytokines IL-2,
IL-10, IL-17, TNF-aand IFN-gis restricted to the fungus-
specific CD154þTcon, but lacking in CD137þTreg (Figure 2c
andSupplementary Figure S1online).
In summary, these data confirm that the combined analysis
of CD137þ and CD154þ expression can identify fungus-
specific memory Treg as wel as Tcon in human peripheral
blood. The direct comparison between both fungi further
suggests thatA. fumigatushas a stronger potential to induce
and/or expand Treg, whereasC. albicansinduces a stronger
Tcon response.
Fungus-reactive CD137þ Treg can be expanded and
maintain strong antigen-specific suppressive potential
To proof specificity and function of the fungus-specific Treg,
we expanded magneticaly enriched CD137þ T cels in the
presence of IL-2 and rapamycin for up to 3 weeks. To determine
specific reactivity, CD137 expression was analyzed upon re-
chalenge with the specific or control antigens in the presence of
autologous APCs. As shown inFigure 3a, fungus-specific Treg
specificaly upregulated CD137þ expression after restimula-
tion with the specific fungal lysate but not in response to
irrelevant antigens. In contrast, polyclonaly expanded CD25þ
CD127dimTreg reacted strongly only upon stimulation with the
high control SEB. Interestingly, we also saw low reactivity
againstA. fumigatusin the polyclonal expanded Treg cel
lines (Figure 3a), which is consistent with the high frequency
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ofA. fumigatus-specific Treg in peripheral blood reported
here.
We further analyzed whether the expanded Treg exert
antigen-specific suppressive function in vitro. When
A. fumigatusantigen was added to the co-culture of alogeneic
CD4þT cels with autologous APCs, theA. fumigatus-specific
Treg suppressed alo-specific CD4þ T-cel proliferation
already at a 1:16 ratio, whereas polyclonal Treg exerted similar
Figure 1 Combined analysis of CD154 and CD137 expression identifies in paralel fungus-specific Tcon and Treg. (a,b) PBMCs were stimulated with
the indicated antigens and analyzed for CD154 and CD137 expression. For an optimized quantification of activation marker positive events among
CD3þCD4þT cels, cel aggregates (scater area vs. scater height), dead cels and non-target cels (CD14þ, CD20þ, CD8þ, dump) were excluded, and
cels were counterstained for the activation marker CD69. Summary of several donors is shown with horizontal lines indicating mean values.
(c) Frequencies of reactive CD137þcels among CD25þFoxp3þCD4þT cels in PBMC. Panelsa–cshow the summary from seven independent
experiments withn¼27 donors. Statistical significance was determined by two-tailed paired Student’st-test. (d) Expressions of CD154 and CD137
on CD4þT cels folowing short-term stimulation of PBMC withA. fumigatuslysate before enrichment and after combined CD154þ/CD137þenrichment.
Analysis of CD25, CD127 and Foxp3 expression among enriched CD154þCD137 CD4þ Tcon vs. CD137þCD154 CD4þ Treg was
performed. (e) Percentage of Foxp3 expression among enriched CD137þCD4þcels in several donors, folowing short-term stimulation with the fungal
lysates. Data from three independent experiments are shown (n¼12). (f) Representative dot plot examples for Helios expression in enriched
CD137þCD4þ cels. Percentages among CD137þCD4þ are indicated. Six independent experiments with several donors were performed.
(g) Polyclonal Treg and Tcon as wel asA. fumigatusor SEB stimulated CD137þCD154 or CD154þCD137 CD4þ T cels were purified by
FACS and analyzed for percentage of demethylation of the Foxp3 Treg-specific demethylated region (TSDR). Graph represents mean±s.e.m. from
five diferent donors. Two independent sorting experiments were performed.
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suppressive activity only at a 1:1 ratio (Figure 3band
Supplementary Figure 2). As known forin vitrosuppres-
sion assays, the suppressive activity of both populations was
dependent on stimulation with antigen. The fact that also the
weak suppressive activity of the polyclonal Treg populations is
antigen-dependent again shows that polyclonal Treg contain a
relatively high frequency ofA. fumigatus-specific Treg. In
contrast, both Treg populations exerted similar suppressive
activity after activation with CD3/CD28 beads. As a control,
expandedA. fumigatus-specific CD154þ Tcon did not show
comparable suppressive capacity folowing CD3/CD28
stimulation and only modestly inhibited when stimulated
withA. fumigatusantigens, probably due to the massive
expansion of the antigen-specific CD154 cels and competition
for nutrients or growth factors as reported before.20We also
analyzed suppression of CD154 and TNF-aexpressions
folowing short-term stimulation of antigen-specific T cels,
which is less sensitive to competitive efects due to the short
stimulation time. HereA. fumigatus-specific Treg as wel as
polyclonal Treg, but not CD154 Tcon, showed suppressive
activity (Supplementary Figure 3). Analysis of Foxp3 and
Helios expressions during 3 weeks of in vitroexpansion
revealed that, despite the high suppressive activity, the
A. fumigatus-specific Treg lost Foxp3 expression by about
50%, accompanied by a loss of the demethylated TSDR region
and Helios expression, in contrast to polyclonaly expanded
Treg (Figure 3candd). Comparable suppressive capacity
and loss of Foxp3 and Helios expressions were observed
for the expandedC. albicans-reactive Treg (Supplementary
Figure 4).
These data demonstrate the specificity as wel as the strong
antigen-specific suppressive capacity of the isolated fungus-
specific CD137þ Treg. However, the reduction in Foxp3
expression and the loss of Helios and TSDR demethylation
during long-termin vitroexpansion might indicate that at least
a subset of the specific Treg has limited stability, although we
cannot exclude selective outgrowth of contaminating Tcon as
an alternative explanation.
Minimal peripheral expansion ofA. fumigatus-specific
Tcon and preservation of the naive repertoire
Our data revealed so far a stronger potential ofA. fumigatusto
induce or expand antigen-specific Treg, whereas the potential
to induce antigen-specific Tcon was diminished compared with
C. albicans. To further explore potential diferences between
A. fumigatusandC. albicans-specific Tcon, we analyzed the
expression of the surface markers CD45RO and CCR7 on
CD154þcels to distinguish between naive and memory T cels.
As expected for peripheraly expanded T cels,C. albicans-
reactive Tcon mainly displayed a CD45ROþ memory
phenotype (Figure 4aandb) and were found preferentialy
within the CCR7þ central memory compartment. For
Figure 2 Fungus-specific CD137þTreg have a memory phenotype and do not produce efector cytokines. Flow cytometricex vivocharacterization of
magneticaly enriched CD154þ or CD137þ T cels from short-term stimulated PBMCs. (a,b) Phenotypic characterization of fungus stimulated
Treg or SEB as a high control. Enriched CD137þCD4þ T cels were gated on CD25þFoxp3þ and analyzed for the expression of CD45RO and
CCR7. (a) Representative dot plot examples and (b) statistical analysis for several donors (n¼8, two independent experiments were performed).
Statistical significance was determined by two-tailed paired Student’st-test. (c) Fungus-specific T cels were analyzed for cytokine expression.
Percentages of cytokine-expressing cels among activation marker positive CD4þ T cels are shown for several donors (n¼8, two independent
experiments were performed; for IL-2: one experiment with four diferent donors was performed).
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A. fumigatus-specific Tcon, the distribution between the two
memory subsets was variable between diferent donors. Most
interestingly, however, 20–70% of alA. fumigatus-reactive
Tcon displayed a naive CD45RO-CCR7þphenotype. Further
characterization indicated that these cels represent genuine
naive T cels as demonstrated by their expression of CD45RA,
CD27, a mixed phenotype for CD31,21and lack of CD95 and
CD11a expression. Furthermore, they did not secrete
efector cytokines like IFN-gor IL-17 (Supplementary
Figure 5). The specificity of the fungus-specific CD154þ
T cels within the naive and memory compartment was
confirmed by specific restimulation of expanded CD154þcels
from highly purified naive and memory CD4þ T cels
(Supplementary Figure 6). This shows that, despite chronic
Figure 3 Specificity and suppressive capacity of fungus-specific Treg. Fungal lysate-stimulated CD137þTreg or polyclonal CD25þCD127lowTreg
were magneticaly isolated and subsequently expanded with IL-2 and rapamycin. (a) Expanded Treg were restimulated after 3 weeks of
expansion in presence of autologous APCs with and without antigens as indicated and analyzed for re-expression of CD137. Statistical analysis of several
donors with percentage of CD137þcels among CD4þlymphocytes is shown (A. fumigatusTreg:n¼17, four independent experiments were performed;
C. albicansTreg:n¼4, one experiment was performed; polyclonal Treg: n¼14, three independent experiments were performed). (b) Expanded
A. fumigatus-specific CD137þ Treg lines,A. fumigatus-specific CD154þ Tcon lines or polyclonal Treg lines were combined with autologous
APCs and proliferation dye labeled alogeneic responder CD4þ T cels (Tresp) in diferent Treg to Tresp ratios. Percentage of inhibition of Tresp
proliferation is shown without stimulation or after specific stimulation withA. fumigatuslysate or polyclonal stimulation with CD3/CD28. Graph represents
mean±s.e.m. for specific and polyclonal Treg:n¼11, three independent experiments were performed; specific CD154þTcon:n¼6, two independent
experiments were performed. (c) Percentage of Foxp3 and Helios expression among CD4þ T cels was analyzed by flow cytometry during
expansion ofA. fumigatus-specific CD137þTreg or polyclonal CD25þCD127dimTreg. Representative data from two independent experiments are
shown,n¼6. (d) Demethylation analysis of the Foxp3 Treg-specific demethylated region (TSDR) in expandedA. fumigatus-specific Treg or polyclonal
CD25þCD127dimTreg. Graph represents mean±s.e.m. from 12 diferent donors. Four independent expansion experiments were performed.
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exposure toA. fumigatus, large parts of the Tcon repertoire are
left untouched in the naive state.
To corroborate that the enlarged memory Treg and Tcon
populations in adult blood are indeed expanded by antigen
contact in the periphery, we next analyzed their frequencies in
cord blood. As shown inFigure 4c, the frequencies of fungus-
specific Treg in cord blood were wel below 0.1%,
corresponding to only 0.002–0.01% within the CD4þ T-cel
population (data not shown). This demonstrates indeed a
strong peripheral expansion or induction of fungus-specific
Treg during adult life. Interestingly, the Tcon as wel as Treg
frequencies in cord blood were comparable for both fungi,
indicating similar amounts of specific precursors in both
repertoires (Figure 4c). However, the Tcon frequencies against
A. fumigatusin cord blood were almost identical to those in adult
blood (Figure 4d). This observation is consistent with the large
fraction of naive Tcon in adult blood, and in summary indicates
minimal peripheral expansion ofA. fumigatus-specific Tcon. In
contrast, theC. albicans-specific Tcon displayed al features of
classical memory formation as the memory pool was expanded
5- to 10-fold in adult vs. cord blood, whereas the naive Tcon
were reduced by a similar factor (Figure 4d).
Taken together, these data confirm that both fungi, but in
particularA. fumigatus,have the capacity to strongly induce or
expand specific memory Treg in the periphery. However,
whereasC. albicansalso induces a Tmem response, the
establishment of a Tmem againstA. fumigatusseems to be
limited, pointing toward a unique potential ofA. fumigatusto
circumvent and/or control Tmem responses via selective
induction of Treg.
A. fumigatus-specific Treg outnumber and functionaly
suppress Tmem
To predict the actual impact of expanded Treg on the fungus-
specific T-cel response, we determined the absolute numbers of
fungus-specific Treg vs. naive and memory Tcon in adult blood.
Although the total Treg compartment represents only 5–10% of
the CD4þ T cels, the absolute numbers ofA. fumigatus-
specific Treg were equal and for some donors even exceeded the
absolute number of naive or memory Tcon (Figure 5a). The
dominance of theA. fumigatusTreg is further exemplified by
calculating the ratio of the absolute numbers of Treg vs. Tmem
for each individual donor. As shown inFigure 5b, the
A. fumigatus-specific Treg indeed exceeded Tmem by a mean
factor of 1.5 (range 0.15–4.2). In sharp contrast, theC. albicans-
specific T-cel pool was clearly dominated by Tmem, resulting
in a reversed Treg/Tmem ratio (mean 0.38, range 0.03–1).
Thus,A. fumigatus-specific Treg are strongly expanded in the
periphery and can even represent the dominant population
within the overal repertoire ofA. fumigatus-specific memory
Figure 4 A high proportion ofA. fumigatus-reactive Tcon is in a naive state. (a,b)Ex vivoanalysis of CD45RO and CCR7 expression on magneticaly
enriched CD154þCD4þTcon. (a) Representative dot plot examples of enriched cels from 1 107PBMCs. Percentages of cels among CD154þand
cel counts (in brackets) are indicated. (b) Phenotypic characterization of reactive CD154þCD4þTcon in several donors. Percentages of cels among
CD154þCD4þare indicated. Data from five independent experiments are shown,n¼18. (c) Enumeration of fungus-reactive Treg and Tcon in cord
blood. Frequencies of reactive CD137þcels among CD25þFoxp3þCD4þT cels (n¼4, four independent experiments were performed) and CD154þ
cels among CD4þT cels (n¼10, six independent experiments were performed). (d) Enumeration of fungus-reactive naive and memory Tcon in adult
blood. Frequencies of reactive CD154þCD45RO CCR7þ(naive) and CD154þCD45ROþ(memory) cels among CD4þT cels are indicated. Data
from five independent experiments are shown,n¼20. Frequencies as in panelscanddwere calculated from the total number of CD154þCD4þ
or CD137þCD4þcels obtained after enrichment normalized to the total number of CD4þcels or CD25þFoxp3þCD4þcels applied on the column.
Background enriched from the non-stimulated control was subtracted. Statistical significance was determined by two-tailed paired Student’s
t-test.
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CD4þ T cels, whereasC. albicansinduces mainly Tmem
responses with minor contribution of Treg.
To confirm these data on a functional level, we analyzed the
contribution of Treg to the anti-fungal T-cel response by
depleting CD25highcels from PBMCs before antigen stimula-
tion. In line with the idea that Treg control mainly the response
againstA. fumigatus, we found a significant increase in
A. fumigatus-specific Tcon frequencies, whereas the frequency
ofC. albicans-reactive cels was not significantly altered
(Figure 5c). In addition, when CD25highCD4þ T cels were
added back into the CD25-depleted fraction, the frequency of
A. fumigatus-specific Tcon dropped to the original level
(Figure 5d).
Taken together, these results demonstrate thatA. fumigatus
triggers the selective expansion of an antigen-specific Treg pool
in healthy human donors, which suppresses Tcon activation
in vitro,and thus may contribute to tolerance by limiting the
formation of an expanded Tmem pool.
Cystic fibrosis patients withAspergilus-associated
alergies are characterized by a shift of the
A. fumigatus-specific Treg/Tmem ratio
To identify a potential role ofA. fumigatus-specific Treg in
mediation of tolerancein vivo,we determined whether this
protective Treg/Tmem ratio is altered under pathological
conditions. To this end we analyzed samples from patients with
CF (Supplementary Table 1online), which are known to
frequently sufer from lung infections and severe alergic reac-
tions againstA. fumigatus. We were able to identify CF patients
with severe alergic reactions againstA. fumigatusbased on a
strong Th2 efector cytokine expression ofA. fumigatus-
reactive CD154þTcon (i.e. production of IL-13, IL-4 and IL-5)
(Figure 6aandb), which also corresponded withAspergilus-
specific IgE levels (Figure 6c). By contrast, in non-Th2 CF
patients the cytokine profiles of CD154þA. fumigatus-specific
Tcon did not difer from those of healthy donors, i.e., they pro-
duced mainly TNF-aand IFN-gbut no Th2 cytokines. Strikingly,
Figure 5 Reversed Treg/Tmem ratios ofA. fumigatus-andC. albicans-specific T-cel responses. (a) A total of 1 107PBMCs was stimulated
withA. fumigatusorC. albicansand the numbers of CD154þCD137 naive and memory Tcon or CD137þCD154 Treg folowing combined
CD154þ/CD137þ enrichment were analyzed. Frequencies were calculated from the total number of CD154þ or CD137þ cels obtained after
enrichment, normalized to the total number of CD4þcels applied on the column. Background enriched from the non-stimulated control was subtracted.
(b) The ratio of antigen-specific CD137þCD154-Treg to CD154þCD45ROþTmem cels is shown. Panelsaandbshow data from five independent
experiments,n¼20. (c) Frequencies of antigen-reactive CD154þTcon were determined as described in panela, in total PBMCs or after pre-depletion of
CD25highcels (n¼17, five independent experiments were performed). (d) CD25highcels were added back to CD25 pre-depleted PBMCs with the
indicated Treg to Tcon ratios. Data show mean±s.e.m. for six donors; two independent experiments were performed. Statistical significance
was determined by two-tailed paired Student’st-test.
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comparing the frequencies of Treg and Tmem cels in both patient
groups yielded a two- to fourfold increase ofA. fumigatus-specific
Tmem in Th2 CF patients vs. non-Th2 patients and healthy
controls (Figure 6dand data not shown). However, fungus-
specific Treg frequencies were similar in both patients groups
(Figure 6d). Thus, the overal ratio ofA. fumigatus-specific
Treg to Tmem was completely reversed in the Th2 CF patient
group toward a dominance of Tmem (mean Treg/Tmem 0.52,
range 0.12–0.91) (Figure 6e). These data highlight that the
physiological dominance of specific Treg vs. Tmem in healthy
Figure 6 Frequencies ofA. fumigatus-specific Tmem and Treg in peripheral blood of cystic fibrosis patients. (a,b) PBMCs from CF patients were
stimulated withA. fumigatuslysate. Reactive CD154þTcon were magneticaly enriched andex vivoanalyzed for cytokine expression. CF patients were
classified according toA. fumigatus-specific cytokine expression in Th2 and non-Th2 patients using a cutof value of45% IL-13 producingA. fumigatus-
reactive CD154þ T cels. (a) Representative dot plot examples and (b) statistical analysis with percentages of cytokine-expressing cels among
CD154þCD4þ are shown. (c)A. fumigatus-specific serum IgE levels. (d) Frequencies of CD154þCD45ROþ Tmem among CD4þ T cels and
A. fumigatus-reactive CD137þCD154 Treg among CD4þT cels. (e) Ratio ofA. fumigatus-specific Treg to Tmem. Panelsb–eshow a summary from
eight non-Th2 CF patients and eight Th2 CF patients; 13 independent experiments were performed. Statistical significance was determined
using two-tailed unpaired Student’st-test.
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subjects probably represents an important mechanism to
prevent alergy induction.
DISCUSSION
Humans are continuously chalenged by various pathogenic
fungi, which are either part of the commensal microbiota like
C. albicansor present in the environment, e.g., in the air that we
breath, likeA. fumigatus. This requires balanced pathogen-
specific control mechanisms, which alow efective protection
but prevent colateral tissue damage caused by chronic
inflammation or alergy. How the human immune system
achieves this balance for the various fungal species is currently
not wel understood. We addressed this question by applying a
paralel quantitative assessment of human fungus-specific
CD4þT cels within the naive, memory and Treg repertoire.
This approach revealed that both fungi generate unexpectedly
high frequencies of specific Treg. Surprisingly, forA. fumigatus
this was not accompanied by a paralel increase in Tmem, and
thus resulted in a Treg dominance characterized by a high Treg/
Tmem ratio (mean 1.5), as wel as preservation of a large naive
Tcon population and significant suppression ofA. fumigatus-
specific T-cel activationin vitro. The protective Treg/Tmem
balance was completely reversed in CF patients with alergic
reactions againstA. fumigatusdue to the formation of a strong
Th2-type Tmem response. To the best of our knowledge, this is
the first direct evidence for the formation of a preferential
antigen-specific Treg vs. Tmem response in humans, repre-
senting a potential mechanism for the protection from Th2-
associated immunopathology against an opportunistic envir-
onmental pathogen.
In the majority of donors analyzed,A. fumigatus-specific
Treg even outnumber specific Tmem. In addition, the specific
naive T-cel pool is largely preserved in size when compared
with cord blood, suggesting a limited Tcon response against
A. fumigatusantigens. In contrast, theC. albicans-reactive
T-cel repertoire mainly consisted of Tmem, which exceeded
A. fumigatus-specific Tmem by a factor ofB2–5. At the same
time, a depletion from the naive pool was observed as it has been
reported for other pathogen-specific T-cel responses.22
Although we clearly detected specific Treg againstC. albicans,
they occurred at lower frequencies than specific Tmem (mean
ratio Treg/Tmem 0.38) andA. fumigatus-specific Treg. In this
respect, the T-cel response againstC. albicansis similar to
several other anti-pathogen T-cel responses, including viruses,
parasites and bacteria, where antigen-specific Treg expansion
occurs along with a strong efector T-cel response.23–25
The dominant role of the enlargedA. fumigatus- but not
C. albicans-specific Treg pool is further supported by func-
tional data showing that total Treg depletion results in an
increased stimulation ofA. fumigatusbut notC. albicans-
specific Tcon.
The data reported here clearly demonstrate a fundamental
diference between the T-cel responses againstA. fumigatus
andC. albicansbeyond the previously described diferences
with regard to efector cytokine production by Tmem.18,26–29
WhereasC. albicansgenerates a classical Th17-dominated anti-
pathogen T-cel response with only a minor contribution of
specific Treg,A. fumigatusseems to preferentialy expand Treg
and rather preserves the naive T-cel repertoire. This diference
may be due to the nature of the pathogen, e.g., expression of
pathogen-associated molecular paterns, the infection route or
the antigen dose. AsA. fumigatusis a ubiquitously distributed
airborne fungus, humans acquire it primarily by inhaling
spores. In contrast, the commensalC. albicansis mainly
residing on the mucosal surface of the gastrointestinal tract and
skin. However, both the gut and the lung are known as
preferential sites for the generation of Treg responses against
commensals and environmental antigens.2,5,6,30–33As for now,
there is no evidence thatA. fumigatushas an inherent
tolerogenic potential but rather has been reported to generate
efector T-cel responses after repeated nasal exposure with
A. fumigatusconidiain vivo.34Therefore, it seems likely that
antigen dosing and timing are relevant parameters for the
preferential Treg activation byA. fumigatusantigens.
C. albicansinvasion usualy occurs in a spatialy and timely
restricted manner, e.g., after epithelial damage,35 which
probably results in a transiently high local antigen concentra-
tion and presumably leads to a strong immune reaction.
In contrast, the continuous inhalation of airborneA. fumigatus
spores may rather favor the disseminated and chronic presence
of antigens at low concentrations. Furthermore, innate immune
recognition of dormantA. fumigatusspores is largely prevented
by a hydrophobin surface layer,36,37 which may further
diminish antigen uptake and presentation. The chronic
exposure to low doses of antigens has previously been described
to support the generation of Treg responses.38–40In addition,
the capacity of lung macrophages to induce Treg from naive
T cels has recently been reported for the murine system.41This
further supports the observed preferential Treg response
against inhaledA. fumigatusantigens.
Because of the lack of distinctive markers in humans, the
origin of the fungus-specific Treg remains speculative. The
analysis of cord blood samples clearly showed that
A. fumigatus-specific, as wel asC. albicans-specific, Treg
and Tcon are present in similar but very low frequencies at
birth, proving that the enlarged Treg pool is the result of an
antigen-specific induction or expansion process during life.
This is also in accordance with the CD45ROþ memory
phenotype of the fungus-specific Treg. However, the question
whether the specific Treg populations arise from expanded
thymic (tTreg) or peripheraly induced Treg (pTreg) remains.
Ourex vivophenotypic analysis revealed halmarks of tTreg,
i.e., fuly demethylated TSDR, expression of Helios, lack of
cytokine and CD127 expression. A thymic origin would also be
in accordance with our finding that in adult blood the naive
Tcon pool was not significantly depleted ofA. fumigatus-
reactive cels. Moreover, tTreg have recently been shown to
significantly contribute to the T-cel repertoire specific for
intestinal commensal microbiota.2In contrast, pTreg forma-
tion against airborne antigens seems to be essential for the
maintenance of tolerance at mucosal sites, as mice specificaly
lacking pTreg selectively develop pathological Th2 responses at
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mucosal surfaces.5This leaves open the possibility that the
fungus-specific Treg population is actualy composed of pTreg
as wel as expanded tTreg. This could also explain why Helios
and Foxp3 expressions, as wel as TSDR demethylation, were
lost at least by a subset of fungus-reactive Treg upon prolonged
in vitroexpansion. Such phenotype instability has been
described forin vitro-induced Treg42and long-term cultured
CD25þCD127-CD45ROþmemory Treg.43However, selective
outgrowth of efector T cels even in the presence of rapamycin
cannot be excluded.
Our study has also important clinical implications, as
A. fumigatusis the cause of several diseases. In immuno-
competent individuals repeated exposure toA. fumigatuscan
trigger pathological Th2 responses associated with strong
alergic reactions such as asthma or ABPA. Especialy, CF
patients frequently sufer fromAspergiluscolonization of the
lung and associated alergic responses.44However, the reasons
why some patients develop a severe pathologic Th2 response
while others do not are currently unknown. Intriguingly, we
observed that those CF patients with a strong Th2 bias of the
A. fumigatus-specific Tcon, which also corresponded with
increasedA. fumigatus-specific IgE levels, displayed a marked
shift of the Treg/Tmem ratio (from 2.1 to 0.5). This shift was
due to the selective expansion ofA. fumigatusTh2 Tmem,
whereas Treg numbers remained constant, suggesting no direct
defect in Treg generation in CF patients. There is also no other
evidence that Treg function may generaly be afected by the
CFTRgene mutations underlying cystic fibrosis. Thus, our data
suggest thatA. fumigatus-specific Th2 diferentiation and
expansion can be initiated by escaping Treg control under the
specific conditions of CF lung environment. This escape is most
likely related to the increasedA. fumigatusload44due to
defective epithelia or phagocyte function,45which may lead to
alterations in antigen density and APC composition or
activation status. In any case, these data provide direct evidence
for the hypothesis that Treg formation is an important process
to protect from alergy development against chronicaly inhaled
A. fumigatusantigens in healthy subjects and that alterations
in this process or an imbalance between pathologic Tmem vs.
Treg contribute to disease development or chronification, as
demonstrated in the murine system.5,46–48In line with this,
patients with immune dysregulation, polyendocrinopathy,
enteropathy, X-linked (IPEX) syndrome, who are deficient
for Treg, have indeed elevated levels of IgE, and recently a case
of ABPA in an IPEX patient occurring at an unusualy young
age was reported.49In contrast, immunodeficient patients are
prone to contracting life-threatening invasiveAspergilus
infections with high mortality rates (50–90%).8For this patient
group, the capacity ofA. fumigatusto preferentialy generate a
Treg response may even represent a potential risk factor, as it
prevents or impairs protective efector T-cel responses. Indeed,
increased levels of the immunosuppressive cytokine IL-10 have
been associated with a poor disease outcome in patients with
invasive aspergilosis,50although there is so far no direct
evidence for the presence ofA. fumigatus-specific Treg in these
patients.
Beyond the immediate relevance of our findings for human
diseases related toA. fumigatusinfections, delineating the
mechanisms howA. fumigatusinduces selective Treg vs. Tcon
responses in humans wil help to design therapeutic strategies
aiming at the induction of antigen-specific Treg.
METHODS
Blood donors. Bufy coats or peripheral ethylenediamine tetraacetic
acid (EDTA) blood samples from healthy human donors were
obtained from the Institute for Transfusion Medicine, University
Hospital Dortmund, Germany and from in-house volunteers. Per-
ipheral blood samples from 16 patients with a diagnosis of cystic
fibrosis (CF) were obtained from the University Hospital Cologne,
Germany. Blood sampling was performed within the scope of the
biomaterial repository protocol ISI, and al patients gave informed
consent (local ethics identifier 08–160). CF patients were classified
according to theA. fumigatus-stimulated production of cytokines.
A cutof value of45% IL-13 producingA. fumigatus-reactive
CD154þ T cels was determined to discriminate between Th2 and
non-Th2 patients.
Cel preparation and stimulation. Peripheral blood mononuclear cels
(PBMCs) were isolated by Ficol-Paque (GE Healthcare Life Sciences,
Freiburg, Germany) density gradient centrifugation and resuspended
in RPMI-1640 (Miltenyi Biotec, Bergisch Gladbach, Germany),
supplemented with 5% (v/v) human AB-serum (BioWhitaker/Lonza,
Walkersvile, MD), 2 mML-glutamine (PAA Laboratories, Pasching,
Austria). Cels were stimulated with the folowing antigens:
A. fumigatus lysate (40mgml 1; generated as described),18
C. albicans-lysate (40mgml 1; Greer Laboratories, Lenoir, NC),
CMV-lysate (10mgml 1, Siemens Healthcare Diagnostics, Marburg,
Germany), Staphylococcal enterotoxin B (SEB 1mgml 1, Sigma
Aldrich, Schneldorf, Germany) in presence of 1mgml 1CD40,
1mgml 1CD28 pure antibodies (both Miltenyi Biotec).
Flow cytometry. Cels were stained in diferent combinations with the
folowing monoclonal antibodies according to manufacturers’
protocols: CD4-VioBlue, CD4-FITC, CD4-PE-Vio770, CD4-
APC-Vio770 (VIT4), CD3-VioBlue (BW264/56), CD8-VioGreen,
CD8-PerCP (BW135/80), CD14-VioGreen, CD14-PerCP (TU¨K4),
CD20-VioGreen, CD20-PerCP (LT20), CD69-FITC (FN50), CD137-
PE, CD137-APC (4B4-1), CD154-VioBlue, CD154-FITC, CD154-
APC (5C8), CD25-PE, CD25-APC (4E3), CD127-FITC (MB15-18C9),
CD45RO-PE-Vio770, CD45RO-APC (UCHL1), TNF-a-FITC,
TNF-a-PE (cA2), IFN-g-APC (45-15), IL-17A-APC, IL-17A-FITC
(CZ8-23G1), IL-2-APC (N7.48A), IL-10-APC (JES3-9D7), IL-4-PE
(7A3-3), IL-5-APC (JES1-39D10), IL-13-PE (JES10-5A2.2), Foxp3-
APC (3G3) (al from Miltenyi Biotec), Foxp3-PerCP-Cy5.5 (PCH101)
IL-22-PerCP-Cy5.5 (22URTI) (both from eBioscience, San Diego, CA,
USA), Helios-FITC, Helios-PE, (22F6), CCR7-Alexa Fluor 488
(G043H7), IFN-g-PerCP-Cy5.5 (4S.B3) (al from BioLegend, San
Diego, CA, USA), TNF-a-VioBlue (cA2), IFN-g-VioBlue (45-15),
HLA-A2-PE (BB7.2) (al conjugated in-house). Data were acquired on
a MACSQuant analyzer. MACSQuantify software was used for
analysis (both Miltenyi Biotec).
Enrichment and characterization of antigen-reactive T cels. A total
of 1 107PBMCs per ml was stimulated for 7 h with diferent antigens.
For combination of antigen-reactive T-cel enrichment with an
intracelular staining, 1mgml 1Brefeldin A (Sigma Aldrich) was
added for the last 2 h. Cels were separated using the CD154 MicroBead
Kit and/or the CD137 MicroBead Kit (both Miltenyi Biotec) either
alone or in combination. In brief, cels were indirectly magneticaly
labeled with CD154-Biotin and CD137-PE, folowed by anti-Biotin
and anti-PE MicroBeads and enriched by two sequential MS columns
(Miltenyi Biotec). Surface staining was performed on the first column,
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folowed by fixation and intracelular cytokine staining on the second
column (Inside stain Kit; Miltenyi Biotec), as described,18or staining
for transcription factors using the Foxp3 Staining Bufer Set (Miltenyi
Biotec). In some experiments, CD25highcels were depleted before
stimulation and enrichment of antigen-reactive CD154þT cels, using
CD25 MicroBeads and LD columns (both Miltenyi Biotec).
In vitroT-cel expansion and restimulation. Stimulation and isolation
of antigen-specific T cels was performed as described above.
Polyclonal Treg were isolated with the CD4þCD25þCD127dim/
Regulatory T-cel Isolation Kit (Miltenyi Biotec). A total of 1 105per
wel polyclonal Treg and 1 104per wel CD137þcels were cultured
in 96-wel round-botom plates in X-Vivo15 (BioWhitaker/Lonza),
supplemented with 5% (v/v) human AB-serum, 500 U ml1IL-2
(Proleukin; Novartis, Nu¨rnberg, Germany), 30 nMrapamycin (Sigma
Aldrich), and 100 IU ml 1penicilin, 100mgml 1streptomycin,
0.25mgml 1amphotericin B (Antibiotic Antimycotic Solution, Sigma
Aldrich). For polyclonal Treg, 4:1 (bead-to-cel ratio) Treg Expansion
Beads (Miltenyi Biotec) were added. Cels were expanded for
21 days, with polyclonal Treg being restimulated 2:1 (bead-to-cel
ratio) at day 10.
Isolated CD154þ cels were cultured for 14 days, at a density of
2.5 106cels per cm2with 1:100 mitomycin C (Sigma Aldrich)
treated autologous feeder cels in X-Vivo15, supplemented with 5%
(v/v) AB-serum, 200 U ml1 IL-2 and 100 U ml1 penicilin,
100mgml 1streptomycin, 0.25mgml 1amphotericin B. During
expansion medium was replenished, and cels were split as needed.
For expansion of T-cel lines from the naive or memory repertoire,
CD4þ T cels were isolated by negative selection using the naive
CD4þT cel-Isolation Kit or the memory CD4þT cel Isolation Kit
(both Miltenyi Biotec), respectively. A total of 1 107isolated naive or
memory CD4þT cels were stimulated with autologous CD3-depleted
PBMCs as APCs in a ratio of 1:1 and fungal lysates. Enrichment and
cultivation of reactive CD154þcels from both CD4þT-cel subsets
was performed as described above.
Before restimulation, expanded cels were rested in RPMI-
1640þ5% human AB-serum for 2 days. A total of 5 105expanded
cels were re-stimulated with autologous CD3-depleted PBMCs
(CD3 MicroBeads, LD columns; both Miltenyi Biotec) in a ratio of
1:1 in 96-wel flat botom plates in presence of 1mgml 1CD28
functional grade pure Ab for 2 h plus additionaly 4 h with 1mgml 1
Brefeldin A (Sigma Aldrich). After fixation and permeabilization, cels
were stained intracelularly for CD137 and Foxp3 expression (Foxp3
Staining Bufer Set; Miltenyi Biotec).
Stimulation of cord blood samples. Cord blood samples were
obtained from local hospitals after informed consent. CD14þ
monocytes were isolated from cord blood mononuclear cels (CBMCs)
by positive selection with CD14 MicroBeads (Miltenyi Biotec) and
cultivated for 2 days with an antigen in X-Vivo15 (BioWhitaker/
Lonza), supplemented with 1000 IU ml 1GM-CSF and 400 IU ml 1
IL-4 (both Miltenyi Biotec) to generate fastDC. DCs were maturated
for 1 day with 1000 IU ml1TNF-a, 1000 IU ml1IL1-b(both
Miltenyi Biotec), 1mgml 1PGE2(Sigma Aldrich) and were used forstimulation of the autologous CD14 fraction. Enrichment of
CD154þ and CD137þ T cels was performed as described above.
For restimulation of expanded CD154þ cels from cord blood
samples, CD34þcels were isolated using the CD34 MicroBead Kit
(Miltenyi Biotec) and were cultured for 3 weeks in X-Vivot15
supplemented with 5% (v/v) AB-serum, 25 ng/ml Flt3-L, 10 ng/ml
TPO and 20 ng/ml SCF (al Miltenyi Biotec) at a density of 1 105/ml.
At day 21, CD14þcels were isolated with CD14 MicroBeads (Miltenyi
Biotec) and used for restimulation of the expanded CD154þT cels.
Proliferation assay. For proliferation assays, CD4þresponder T cels
(Tresp) were untouched isolated with the CD4þT cel Isolation Kit
(Miltenyi Biotec) and labeled with the CelTrace Violet Cel
Proliferation Kit (Invitrogen, Molecular Probes, Eugene, OR) at a
final concentration of 2.5mM. A total of 2 105Tresp were co-cultured
in diferent ratios with expanded polyclonal or specific Treg or
expanded CD154 T cel lines as a control, and 4 105Treg-autologous
CD3-depleted PBMCs as APCs and inducer of an alo-reaction. Treg
were either stimulated specificaly with 40mgml 1A. fumigatus
lysate or polyclonal with anti-CD3/CD28 beads (Treg Suppression
Inspector; Miltenyi Biotec). On day 6, dilution of proliferation dye was
analyzed by flow cytometry. Tresp could be discriminated from Treg
and APCs by using donors with opposite HLA-A2 expression19
(Supplementary Figure 2a).
Suppression of CD154þ induction. Tresp were generated by
expansion ofA. fumigatus-specific CD154þT cel lines, as described
above and stained with the CelTrace Violet Cel Proliferation dye
(Invitrogen, Molecular Probes). A total of 2 105Tresp were
co-cultured in diferent ratios with expanded polyclonal or specific
Treg from the same donor and 4 105CD3-depleted PBMCs as APCs.
Specific T cels were stimulated withA. fumigatuslysate and polyclonal
Treg with anti-CD3/CD28 beads in presence of 1mgml 1CD28
functional grade pure Ab for 2 h plus additionaly 4 h with 1mgml 1
Brefeldin A (Sigma Aldrich) and stained intracelular for CD154 and
TNF-ainduction. Tresp and Treg could be discriminated by Violet
Dye staining of the responder cels (Supplementary Figure 3a).
Methylation analysis of Foxp3 Treg-specific demethylated region
(TSDR). After centrifugation, cel pelets were dissolved in 400ml PBS,
and genomic DNA was isolated using the QIAampRDNA Blood Mini
Kit (Qiagen, Hilden, Germany). Five-hundred nanograms of eluted
genomic DNA was used in a subsequent bisulfite treatment (EpiTectR,
Qiagen). A minimum of 60 ng bisulfite-treated genomic DNA was
then used in a real-time-PCR to quantify the FOXP3 TSDR. Real-time-
PCR was performed in a final reaction volume of 20ml containing
10ml FastStart Universal Probe Master (ROX) (Roche Diagnostics,
Mannheim, Germany), 50 ngml1Lamda DNA (New England
Biolabs, Frankfurt, Germany), 5 pmolml1methylation or non-
methylation specific probe, 30 pmolml1methylation or non-methy-
lation specific primers and 60 ng bisulfite-treated DNA or respective
amount of plasmid standard. The samples were analyzed in triplicates
on an ABI 7500 Cycler using the folowing cycling conditions: 1 cycle of
10 min 951C and 45 cycles of 15 s 951C folowed by 1 min 611C. %
FOXP3 TSDR content was then calculated by dividing the non-
methylated copy-number by the total genomic FOXP3 copy-number.
For detailed instruction see also.51
Statistics. Statistical analyses were performed with the GraphPad
PRISM software 5.0 (GraphPad Software, La Jola, CA). Significance
was determined by two-tailed Student’st-test as indicated.P-values of
o0.05 were considered statisticaly significant.
SUPPLEMENTARY MATERIALis linked to the online version of the paper
at htp://www.nature.com/mi
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Figure S1. Fungus-specific CD137+ Treg do not produce efector cytokines. 
Representative  dot  plot examples for ex vivo cytokine expression  of  magneticaly enriched (a) 
A. fumigatus-specific and (b) C. albicans-specific CD154+ Tcon or CD137+ Treg. Cels are gated 
on  CD4+ lymphocytes and  percentages  of cytokine-expressing cels among activation  marker 
positive CD4+ T cels are shown. 
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Figure  S2. A. fumigatus-specific  Treg suppress  proliferation. (a)  Experimental set  up for 
proliferation assay  using expanded  Treg, autologous  APCs and  proliferation  dye labeled 
alogeneic responder CD4+ T cels (Tresp). Tresp could be discriminated from Treg and APCs by 
using  donors  with  opposite  HLA-A2 expression.19 (b, c)  Representative  dot  plot examples for 
suppression  of alogeneic  Tresp  proliferation  by expanded  polyclonal  Treg lines, A. fumigatus-
specific  CD137+  Treg lines,  or A. fumigatus-specific  CD154+  Tcon lines after (b) specific 
stimulation  with A. fumigatus lysate  or (c)  polyclonal stimulation  with  CD3/CD28.  Numbers 
indicate percentage of proliferating responder cels at diferent Treg to Tresp ratios. 
Supplemental Data          Bacher et al. 
 3 
Figure S3 
 
no Tregs 1:16 1:8 1:4 1:2 1:1
TNF-α
CD
15
4
50.8% 23.2%30.8%35.5%44.7%46.7% poly Tregs
52.3% 27.6%31.8%41.1%47.5%50.3%
spec Tregs
46.1% 42.0%44.9%44.3%48.9%48.3%
 CD154 lines
TrespsTregs
APCs
VioletDye
CD
4
TNF-α
CD
15
4
Gated on Tresps
ba
 
 
 
Figure S3. Specific suppression of CD154+ induction. 
Expanded A. fumigatus-specific  CD154+  Tcon lines  were  used as responder cels (Tresp). 
Polyclonal  or specific  CD137+  Treg  or specific  CD154+  Tcon lines  were combined  with 
autologous  APCs and  Tresp from the same  donor in  diferent  Treg to Tresp ratios.  Folowing 
short-term stimulation with A. fumigatus lysate for antigen-specific T cel lines or CD3/CD28 for 
polyclonal Treg, the expression of CD154 and TNF-α was analyzed. (a) Experimental set up for 
the suppression assay.  Staining  of  Tresp  with  proliferation  dye alowed clear  discrimination 
between  Treg and  Tresp cels. (b)  Percentage  of  CD154 and  TNF-α expressing cels are 
indicated. 
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Figure S4 
 
 
C. albicans-specific Tregs
a b
 
C. albicans-specific Tregs
 
 
Figure S4. Suppressive capacity of C. albicans-specific Treg.  
(a) Expanded C. albicans-specific CD137+ Treg lines were combined with autologous APCs and 
proliferation  dye labeled alogeneic responder  CD4+ T cels (Tresp) in  diferent  Treg to Tresp 
ratios.  Percentage  of inhibition  of  Tresp  proliferation is shown  without stimulation  or after 
specific stimulation  with C. albicans lysate  or  polyclonal stimulation  with  CD3/CD28.  Graph 
represents  mean ±  SEM. (b)  Percentage  of  Foxp3 and  Helios expression among  CD4+ T cels 
was analyzed  by flow cytometry  during expansion  of C.  albicans-specific  CD137+  Treg.  One 
experiment with four diferent donors was performed. 
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Figure S5. Phenotypic and functional characterization of A. fumigatus-specific naive Tcon. 
(a) PBMCs were stimulated with A. fumigatus lysate, reactive CD154+ Tcon were magneticaly 
enriched and ex vivo analyzed for surface expression of phenotypic markers. Percentages of cels 
among  CD154+CD4+ are indicated. (b) A. fumigatus-reactive  CD154+  Tcon  were  gated  on 
diferent subsets according to surface expression  of  CD45RO and  CCR7 and stained 
intracelularly for cytokine expression.  Percentage  of cytokine-expressing cels among the 
indicated phenotypic subsets is shown for several donors, with horizontal lines indicating mean 
values (n = 9, three independent experiments were performed). 
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Figure S6 
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Figure  S6.  Specificity  of fungal lysate stimulated  naive  and  memory  CD154+ cels from 
peripheral  blood  and cordblood. Pre-sorted  memory  or  naive  CD4+  T cels from  peripheral 
blood  or cordblood samples  were stimulated  with (a) A. fumigatus  or (b) C.  albicans lysate. 
Enriched  CD154+ cels  were expanded for  2-3  weeks  with IL-2 and autologous feeder cels. 
Expanded cel lines  were re-stimulated in  presence  of autologous  APCs  with and  without 
antigens as indicated, and reactive  CD4+ T cels  were  determined  by  CD154 and  TNF-α 
expression. Representative dot plot examples are shown with percentage of reactive cels among 
total  CD4+  T cels and (c) summary  of several  donors with  horizontal lines indicating  mean 
values (n = 10, three independent experiments were performed). 
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Table S1. CF patients characteristics 
 
Aspergilus specific IgE A. fumigatus-specific T cel response 
Patient Eosinophils [%] 
Total IgE 
[kU/l] [kU/l] Class % IL-4 % IL-5 % IL-13 Treg/Tmem 
non Th2 patients        
1 4.4 187.0 1.3 2 0.84 0.64 1.42 1.93 
2 4.3 503.0 8.6 3 1.81 0.79 1.70 2.00 
3 0.9 42.9 n.d. n.d. 1.90 0.21 0.84 0.38 
4 7.6 12.0 < 0.15 0 2.16 0.14 0.98 2.27 
5 0.6 28.7 < 0.15 0 0.93 n.d. 1.11 2.82 
6 1.6 65.9 0.6 1 0.18 n.d. 0.20 0.77 
7 5.4 47.2 < 0.15 0 0.00 1.17 0.70 5.10 
8 8.4 48.0 < 0.15 0 0.24 0.00 0.53 2.30 
         
Th2 patients        
9 5.4 268.0 15.0 3 27.47 24.77 28.72 n.d. 
10 6.8 245.0 22.0 4 13.33 12.03 17.64 0.78 
11 4.2 456.0 16.0 3 9.43 5.38 6.92 0.84 
12 7.0 159.0 7.6 3 52.56 28.12 54.80 0.91 
13 9.6 137.0 46.0 4 12.13 2.88 7.75 0.12 
14 2.4 52.0 0.8 2 1.30 0.56 5.91 0.33 
 15* 3.0 1201.0 40.6 4 13.04 5.73 11.97 0.58 
16 7.0 369.0 81.0 5 13.24 8.26 15.53 0.51 
         
         
Determination of clinical parameters can deviate ± 1 month from time point of blood sampling for T cel analysis. 
*Patient 15 was diagnosed for APBA and recieved corticosteroid therapy two month before blood sampling; 
n.d. = not determined; Treg = regulatory T cel; Tmem = conventional memory T cel 
 
 
 
 
Manuscripts 
___________________________________________________________________________ 
 
66 
 
3.4 Manuskript IV 
 
 
“The Human Th17 Cel Pool against Airborne Fungal 
Pathogens is Regulated by Cross-reactivity to Fungal Gut 
Microbiota“ 
 
Bacher P, Kniemeyer O, Hamprecht A, Assenmacher M, Cornely OA, Syrbe U, 
Maul J, Brakhage AA, Scheffold A.  
 
Manuscript in preparation.
  
 
 
 1 
The  human  Th17 cel  pool  against  against  airborne fungal  pathogens is regulated  by 
cross-reactivity to fungal gut microbiota 
 
Petra  Bacher,1  Olaf  Kniemeyer,2,3  Axel  Hamprecht,4  Mario  Assenmacher,5  Oliver  A. 
Cornely,6,7 Uta Syrbe,8 Jochen Maul,8 Axel A. Brakhage,2 and Alexander Schefold1,9 
 
1Department  of  Celular Immunology,  Clinic for  Rheumatology and  Clinical Immunology, 
Charité - University Medicine Berlin, Germany 
2Department  of  Molecular and  Applied  Microbiology,  Leibniz Institute for  Natural  Product 
Research and Infection  Biology -  Hans  Knoel Institute (HKI) Jena and  Friedrich  Schiler 
University Jena, Jena, Germany 
3Integrated  Research and  Treatment  Center,  Center for  Sepsis  Control and  Care Jena, 
University Hospital (CSCC) Jena, Germany 
4Institute for  Medical  Microbiology, Immunology and  Hygiene,  University  of  Cologne, 
Cologne, Germany 
5Miltenyi Biotec GmbH, Bergisch Gladbach, Germany 
6Institute for  Medical  Microbiology, Immunology and  Hygiene,  University  of  Cologne, 
Cologne, Germany 
7Clinical Trials Center Cologne ZKS Köln (BMBF 01KN1106), Cologne Excelence Cluster 
on  Celular  Stress  Responses in  Aging-Associated  Diseases (CECAD), and  Center for 
Integrated Oncology CIO KölnBonn, University of Cologne, Cologne, Germany, University 
Cologne, Germany 
8Department of Gastroenterology, Rheumatology and Infectious Diseases, Campus Benjamin 
Franklin, Charité - University Medicine Berlin, Berlin, Germany 
9German Rheumatism Research Centre (DRFZ) Berlin, Leibniz Association, Berlin, Germany 
 
 
Corresponding Author 
Alexander Schefold 
Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany 
Phone: +49 (0) 30 450 513 450 
Fax: +49 (0) 30 450 7513 450 
Email: alexander.schefold@charite.de 
 2 
Abstract 
 
Th17 cels are considered  mandatory in  mediating  protection against fungal  pathogens.  The 
gut-associated lymphoid tissues  have  been  demonstrated to  be the  major site for  Th17 
induction,  which criticaly  depends  on the composition  of the commensal  microbiota. 
Whether and  how also  peripheral  Th17 responses, for example against airborne fungi, are 
influenced  by the  gut  microbiota is  poorly  understood.  We show that  patients  with  Crohn´s 
Disease (CD) display increased T cel frequencies and Th17 cytokine production against the 
gut commensal fungus C. albicans. Strikingly, increased C. albicans responses are 
accompanied  by a strong expansion  of  Th17 cels specific for the airborne fungus 
A. fumigatus, resulting from T cel cross-reactivity between both pathogens. In healthy donors 
up to  30%  of the A. fumigatus-specific  memory  T cels cross-react to C. albicans and this 
cross-reactive fraction is strongly increased in  CD  patients. Intriguingly,  within the 
A. fumigatus-specific repertoire, only the cross-reactive T cels are able to secrete IL-17 and 
IL-22 and express the Th17 cel specific chemokine receptor patern CXCR3-CCR6+CCR4+, 
whereas  non-cross-reactive  T cels  have a  CXCR3+  Th1  phenotype.  Similar cross-reactive 
Th17 responses  were identified for  other airborne fungi, suggesting that induction  of  Th17 
responses via cross-reactivity to fungal gut microbiota is common in airborne fungus-specific 
T cel responses. 
This  quantitative and  qualitative  modulation  of  human  CD4+  T cel responses  via cross-
reactivity to  gut  microbiota  provides an explanation  how local immune reactions in the  gut 
may lead to systemic modulation of gut-distal immune responses. 
 3 
Introduction 
 
Th17 cels are regarded as prototypic efector cels in anti-fungal immune responses and are 
in general believed to exert a protective function against fungal pathogens. Indeed Th17 cels 
specific for Candida albicans, a  member  of the  human intestinal and skin  microbiota,  have 
been identified in human blood (Acosta-Rodriguez et al., 2007; Bacher et al., 2013; Zielinski 
et al.,  2012) and  defects in the  human  Th17 response  directly corelate  with increased 
susceptibility to chronic and invasive Candida infections in  mice and  humans (Conti et al., 
2009; Eyerich et al., 2008; Huang et al., 2004; Ma et al., 2008; Milner et al., 2008; Puel et al., 
2011). However, inappropriate Th17 responses have also been recognized to drive pathologic 
inflammatory responses against the inhaled fungal pathogen Aspergilus fumigatus (Romani et 
al., 2008; Zelante et al., 2009; Zelante et al., 2007) and more generaly seem to be involved in 
exacerbation of lung inflammatory diseases, such as severe asthma (Akdis et al., 2012; Cosmi 
et al.,  2011).  Thus, the role  of  Th17 cels in immune response against airborne fungal 
pathogens or alergens is ambiguous and similarly the potential origin of Th17 cels specific 
for A. fumigatus  or  other airborne fungi is  unknown. In contrast to C. albicans  no selective 
Th17 inducing capacity  of A. fumigatus  has  been reported and recent analyses suggest that 
A. fumigatus-specific T cels in healthy donors are rather dominated by Th1 cels (Bacher et 
al., 2013; Chai et al., 2010; Chaudhary et al., 2010; Jolink et al., 2013). 
The intestinal commensal  microbiota is known to  have a  profound influence  on the 
development and  balance  of the  host immune system including  peripheral  diferentiation  of 
T cel subsets (Backhed et al., 2005; Macpherson and Haris, 2004). Colonization of germfree 
mice with commensal bacterial species induces the emergence and/or maintenance of distinct 
T  helper cel subsets (Atarashi et al.,  2008; Atarashi et al.,  2013; Atarashi et al.,  2011; 
Gaboriau-Routhiau et al., 2009; Ivanov et al., 2009; Ivanov et al., 2008; Lathrop et al., 2011; 
Mazmanian et al.,  2005; Round and  Mazmanian,  2010). In  particular the induction  of  Th17 
cels has  been  demonstrated to criticaly  depend  on the  presence  of certain  gut  microbiota 
(Atarashi et al., 2008; Ivanov et al., 2009; Ivanov et al., 2008; Wu et al., 2010). Whether the 
induction of Th17 cels by intestinal microbiota also modulates gut-distal peripheral immune 
responses against non-gut associated pathogens is curently not known. Since the microbiota 
provides a tremendous reservoir of potential antigens, T cel receptor cross-reactivity between 
microbiota and  non-gut associated antigens is likely to  occur,  but  has  been  dificult to 
systematicaly analyze due to the complex composition of the microbiome. 
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Fungi represent an important, though less  wel studied  part  of the  murine and the  human 
intestinal microbiota and their role in immunomodulation has recently received more atention 
(Iliev et al.,  2012; Moyes and  Naglik,  2012; Scanlan and  Marchesi,  2008; Scupham et al., 
2006). However, the influence of commensal fungi in modulating human T cel responses is 
largely unknown. 
Using a sensitive technology for the direct analysis of antigen-specific CD4+ T cels (Antigen-
specific  T cel  Enrichment,  ARTE (Bacher et al.,  2013)  we show  here, that  patients  with 
intestinal inflammation  display increased  T cel reactivity and  Th17 cytokine  production 
against the  gut commensal fungus C. albicans.  Surprisingly this  was accompanied  by a 
paralel increase  of specific  Th17 cels against the  major  human airborne fungal  pathogen 
A. fumigatus.  This efect  was  mediated  by specific expansion  of  T cels,  which are cross-
reactive to C. albicans and also  occur in  healthy  donors and against several  other airborne 
fungi. Intriguingly only the cross-reactive T cels within the A. fumigatus response are able to 
secrete IL-17 and IL-22. Thus we provide a unique example of a quantitative and qualitatively 
modulation  of systemic  T cel reactivity  via  T cel cross-reactivity to intestinal  microbiota. 
Such a  mechanism  might in  general contribute to the  wel  documented link  between  gut 
commensal dysbiosis and systemic inflammatory diseases or autoimmunity. 
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Results 
 
Patients  with  Crohn´s  disease (CD)  display  altered  T cel responses  against the  gut 
commensal C. albicans and the airborne fungus A. fumigatus 
 
Since C. albicans is a prominent member of the human gut microbiota we analyzed, whether 
the C.  albicans-reactive  CD4+  T cel repertoire is altered in  CD  patients.  Folowing 
stimulation  with fungal lysates  CD154+ expression  on  CD4+  T cels  was analyzed. 
Interestingly,  patients  with  CD showed indeed a significant increase in the frequencies  of 
C. albicans-reactive cels (mean  0.41%, range  0.04-1.34%) compared to  healthy  donors 
(mean  0.21, range  0.04-0.50%) (Figure  1A).  Surprisingly, also the frequencies  of  T cels 
specific for the airborne fungus A. fumigatus were significantly increased in peripheral blood 
of CD patients (mean 0.29%, range 0.04-0.94%) and furthermore strongly corelated with the 
frequencies of C. albicans-reactive CD4+ T cels (Figure 1A, B). By contrast, in the healthy 
control cohort  only a  marginal corelation  between the frequencies  of A. fumigatus and 
C. albicans-reactive T cels was observed (Figure 1B). 
Th1 and  Th17 cels  have  been implicated to  play a  major role in anti-fungal immunity.  We 
therefore analyzed the cytokine  patern  of the fungus-specific  T cels in  CD  patients and 
healthy controls folowing  magnetic  pre-enrichment and  multi-parametric flow-cytometric 
analysis of CD154+ expressing CD4+ T cels (Bacher et al., 2013). Interestingly, C. albicans-
reactive  T cels from  CD  patients showed a significantly  higher  production  of IFN-γ, IL-17 
and IL-22 than the healthy control donors (Figure 1C and Supplemental Figure 1). However, 
also the A. fumigatus-specific  T cel response  was significantly altered towards a  higher 
production  of the  Th17 cytokines IL-17 and IL-22. In contrast, the  proportion  of IFN-γ 
producing T cels was not increased (Figure 1C). No diferences in the production of IL-10 
and the Th2 cytokine IL-4 were observed (data not shown). 
In summary these data show that the anti-fungal immune response against the gut commensal 
C. albicans, but surprisingly also the airborne fungus A. fumigatus, is strongly altered in CD 
patients.  The elevated frequencies  of C.  albicans-reactive  T cels are accompanied  by 
increased production of Th1 and Th17 cytokines. However, for A. fumigatus, selectively the 
Th17 response was modified. 
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A significant  proportion  of A. fumigatus-specific  CD4+  T cels is cross-reactive to 
C. albicans antigens 
 
To further investigate a connection  between the increased frequencies  of specific  T cels 
against the inhaled fungus A. fumigatus and  CD,  we expanded the fungus-specific  CD154+ 
T cels and analyzed  potential  T cel cross-reactivity  by re-stimulation  with each fungal 
pathogen.  Analysis  of  CD154 and cytokine expression  upon re-stimulation revealed, that a 
proportion  of A. fumigatus-reactive  T cels indeed cross-reacted to C. albicans antigens and 
vice versa (Figure  2A,  B).  However, cross-reactivity  was  more  pronounced  within the 
A. fumigatus-specific T cel lines, where it accounted for up to 30% (mean 14.7%, range 1.1-
31.9) of the total A. fumigatus-reactive T cels (Figure 2C). As expected, neither A. fumigatus- 
nor C. albicans-lysates activated CMV-specific T cel lines (Figure 2A), providing evidence 
that the cross-reactivity specificaly occurs between both fungi. 
To further confirm the cross-reactivity between both fungi on a single cel level, T cel clones 
were generated after enrichment or depletion of C. albicans-cross-reactive CD154+ cels from 
A. fumigatus-specific T cel lines. The specificity of the expanded clones was analyzed by re-
expression of CD154 and cytokines (Figure 2D), or proliferation of the cels upon antigen re-
stimulation (data not shown). As shown in figure 2D, the cross-reactive T cel clones reacted 
highly  on  both, A. fumigatus and C.  albicans antigens,  whereas clones from C.  albicans-
depleted A. fumigatus reactive T cels, responded only upon A. fumigatus re-stimulation. 
To further proof whether the expanded T cel response against A. fumigatus in CD patients is 
indeed the results of cross-reactivity to C. albicans antigens, A. fumigatus-specific T cel lines 
were expanded from  CD  patients  with initialy  high  or low response to the fungal antigens. 
Re-stimulation  of the cel lines  with C.  albicans revealed a strongly increase  of cross-
reactivity in those cel lines  generated from  CD  patients  with an initial  high response, 
compared to healthy controls or patients with initialy low responses (Figure 2E). 
Colectively these data show, that the A. fumigatus-reactive T cel pool contains a significant 
proportion of cels with cross-reactivity to C. albicans antigens, which accounts for up to 30% 
of the total A. fumigatus-reactive T cel response in healthy donors. In case of an augmented 
C.  albicans-response like in  CD  patients, the expansion  of these cross-reactive  T cels 
strongly boosts the response against A. fumigatus and cross-reactive cels can constitute up to 
60% of the A. fumigatus-reactive T cel response. 
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Cross-reactivity to C.  albicans induces  an IL-17/IL-22-producing subset into the 
A. fumigatus-reactive T cel response  
 
The A. fumigatus-reactive  CD4+ T cels from  CD  patients  displayed selective alteration in 
Th17 cytokine  production, i.e. IL-17 and IL-22 (Figure  1).  We therefore investigated the 
cytokine production of the cross-reactive cels in healthy donors, folowing re-stimulation of 
A. fumigatus-specific  T cel lines. Importantly,  T cels  with cross-reactivity to C.  albicans 
contained strongly increased frequencies of IL-17 and IL-22 producers, whereas TNF-α and 
IFN-γ  production  was lower as compared to re-stimulation  with A. fumigatus lysate (Figure 
3A, B). This suggests that the cross-reactive cels selectively have a Th17 phenotype and that 
a large  part  of the A. fumigatus-specific IL-17 and IL-22  production  might  be induced  by 
cross-reactivity to C. albicans. 
To further confirm, that C. albicans cross-reactive  T cels are enriched in the A. fumigatus 
IL-17/IL-22  producing subset, specific  T cel lines  were expanded folowing selection for 
total CD154+ cels, as wel as IFN-γ+ or IL-17+/IL-22+ expressing cels. The ex vivo isolated 
C. albicans- and A. fumigatus-specific IL-17  producers  displayed classical features  of  Th17 
cels, i.e. expression  of the chemokine receptors  CCR6 and  CCR4,  but  not  CXCR3 (Figure 
3C). In contrast, the majority of A. fumigatus-reactive CD154+ memory cels belonged to the 
CXCR3+CCR6+/- Th1 subset (Figure 3C). Re-stimulation of the expanded cel lines revealed a 
strong increase of cross-reactive cels in cel lines selected for IL-17+/IL-22+ expression and a 
significantly decrease in cel lines selected for IFN-γ+ expression, as compared to the CD154+ 
enriched cel lines, which comprise the total repertoire of fungus-reactive T cels (Figure 3D, 
E). In addition, although cross-reactive  T cels  were  only slightly  detectable  within 
C. albicans-reactive cel lines  generated  via  CD154 selection (Figure  2A,  B), a significant 
increase of cross-reactive cels could be detected in C. albicans-reactive cel lines selected for 
IL-17+/IL-22+ production (Figure 3E). These data demonstrate, that A. fumigatus/C. albicans 
cross-reactive T cels can be enriched via sorting for IL-17+/IL-22+ producers. 
To further determine the contribution of cross-reactive T cels to the IL-17+/IL-22+ production 
within the total A. fumigatus  T cel  pool, the C. albicans-cross-reactive cels  were  depleted 
from the A. fumigatus-reactive T cel lines and the remaining A. fumigatus-reactive cels were 
further analyzed for cytokine production. Depletion of the cross-reactive cels after expansion 
was confirmed  by a complete loss  of C.  albicans-reactivity in the  depleted A. fumigatus-
reactive cel lines (Supplemental Figure 2). Importantly, the depletion of cross-reactive cels 
resulted in a strong  decrease  of IL-17 and IL-22 expression after re-stimulation  with 
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A. fumigatus-lysate (Figure  3F), indicating that in fact  most  of the IL-17/IL-22  producing 
A. fumigatus-reactive T cels are cross-reactive to C. albicans antigens. 
Taken together, these data show that the physiological T cel response against A. fumigatus is 
biased towards a  Th1  phenotype,  but a significant fraction  of A. fumigatus-specific  T cels 
cross-reacts to C. albicans leading to the selective induction of IL-17+/IL-22+ producers. This 
finding is further supported  by a  positive corelation  between the ex vivo frequencies  of 
C. albicans-specific T cels and A. fumigatus-specific IL-17 producers, as wel as between the 
frequency of C. albicans- and A. fumigatus-specific IL-17 producers (Figure 3G). 
 
 
C.  albicans-cross-reactive  T cels  are selectively expanded  within the A. fumigatus-
reactive memory CD4+ T cel pool 
 
We next analyzed, whether the cross-reactivity is the result of a natural overlap in the TCR 
repertoire  due to  protein sequence similarities  between  both fungal species  or  whether it 
reflects an active modulation of the response to A. fumigatus by selective expansion of cross-
reactive T cels in vivo. Cross-reactivity was mainly observed within the A. fumigatus-reactive 
T cel lines  but was significant lower  within C.  albicans-reactive  T cel lines (Figure  2), 
arguing against a  mutual  overlap  of the  TCR repertoire.  To further coroborate this  point, 
A. fumigatus-reactive T cel lines were generated from pre-sorted naive and memory T cels 
and  were re-stimulated  with lysates  of  diferent fungal  pathogens.  As shown in  Figure  4A, 
A. fumigatus-reactive cel lines from the naive and memory compartment reacted also highly 
upon stimulation with other Aspergilus species, indicating high cross-reactivity due to protein 
sequence similarities  between closely related fungi. In contrast, the cross-reactivity to  more 
distantly related fungal species was absent in cel lines from both compartments. Importantly, 
whereas A. fumigatus-reactive  T cels  generated from  memory  T cels showed  high cross-
reactivity to C. albicans, there was no cross-reactivity above background detectable in T cels 
generated from the naive T cel pool (Figure 4A, B). In addition, contrary to Th1 cytokines, 
which were strongly induced also in naive-derived T cels, the production of IL-17 and IL-22 
was restricted to T cels generated from the memory T cel pool (Figure 4B). This rules out 
the  possibility that the IL-17+/IL-22+  producing cels  were induced  under the experimental 
conditions during in vitro culture. 
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In summary, the  presence  of cross-reactive  T cels exclusively in the  memory  pool further 
emphasizes that C. albicans  promotes the selective expansion  of cross-reactive  T cels  with 
IL-17+/IL-22+ producing capacities within the A. fumigatus-specific memory T cel repertoire. 
 
 
Airborne fungal Th17 responses in humans result from cross-reactivity to C. albicans 
 
To investigate a potential general influence of C. albicans-driven cross-reactivity on the T cel 
response against airborne fungi,  we further analyzed the  T cel response against  10  other 
human respiratory fungal pathogens. Importantly, the ex vivo analysis of enriched CD154+ T 
cels revealed, that only against C. albicans IL-17 was the dominating cytokine. In contrast, 
against al  other fungal  pathogens,  only a  minor  proportion  of the  CD154+ cels  produced 
IL-17, and IFN-γ expression  was  prevailing (Figure  5  A,  B).  Furthermore, re-stimulation  of 
expanded fungus-specific T cels lines showed in each case a higher IL-17 production of the 
few C.  albicans cross-reactive cels, than folowing re-stimulation  with the specific fungal 
antigens (Figure  5C).  These  data suggests that also in the response against the  other fungal 
pathogens, a significant  proportion  of the IL-17  producing  T cels are induced  via cross-
reactivity to C. albicans antigens. To further confirm this finding, the ex vivo IL-17 secretion 
of fungus-specific T cels was analyzed folowing depletion of C. albicans-reactive CD154+ 
cels from PBMCs. The depletion resulted in a complete loss of C. albicans reactive T cels 
(Figure  5D), and importantly, IL-17  production  of the fungus-specific  T cels  was strongly 
reduced in C. albicans-depleted versus non-depleted PBMC (Figure 5E). 
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Discussion 
 
We  provide a  unique example  how  gut commensal  microbiota can influence the immune 
response against  non-gut associated  peripheral antigens, through the selective expansion  of 
particular T helper cel subsets that would not naturaly develop in response to the peripheral 
antigen.  Furthermore  we show that this efect is further exacerbated in  CD  patients,  which 
may in general contribute to the wel-known systemic manifestations of intestinal pathology 
and  dysbiosis  of the  microbiota.  The commensal  microbiota is  known to  have a strong 
influence on the development of the human immune system as wel as on local and systemic 
immunopathologies (Macpherson and Haris, 2004). However, to what extent cross-reactivity 
between  microbiota and  peripheral antigens  modulates specific  T cel responses is less  wel 
studied. Specific examples are rare due to the antigenic complexity in physiological systems 
such as the human immune system and the resulting dificulties to analyze the rare antigen-
specific T cels and in particular CD4+ T cels. 
The  phenomenon  of cross-reactivity caused  by  heterologous immunity and/or  molecular 
mimicry is wel established in experimental model systems (Selin et al., 2006; Welsh et al., 
2010; Welsh and Selin, 2002). So far it has mainly been described for viral antigens and in 
particular for CD8+ T cels (Su and Davis, 2013; Welsh et al., 2010) although a few examples 
for  virus-specific  CD4+  T cels  have also  been  described (Roti et al.,  2008; Su et al.,  2013; 
Wucherpfennig and  Strominger,  1995).  These studies show, that cross-reactivity can  have 
marked consequences  on the  outcome  of a subsequent antigen chalenge,  by altering 
hierarchies and maintenance of the T cel repertoire, which might lead to either enhanced or 
diminished protection or even immunopathology (Brehm et al., 2002; Chen et al., 2001; Selin 
et al., 1994; Selin et al., 1998; Welsh et al., 2010), e.g. by cross-reactivity to auto- (McCoy et 
al.,  2006; Sospedra et al.,  2005; Wucherpfennig and  Strominger,  1995)  or alo-antigens 
(Burows et al., 1994; D'Orsogna et al., 2010). Since the commensal microbiota represents an 
extraordinary large source of antigens, it can be expected to engage a significant fraction of 
the human T cel repertoire (Belkaid et al., 2013). As a consequence, cross-reactivity driven 
by commensal  microbiota  might  be a common event in shaping antigen-specific  T cel 
responses against non-related antigens. In line with this idea, it has recently been shown, that 
virus-specific  memory  CD4+  T cels are abundant in  unexposed  donors, and show cross-
reactivity to commensal  bacterial  peptides (Su et al.,  2013).  However, to  our  knowledge 
specific examples for the antigen-specific functional modulation of systemic human CD4+ T 
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cel responses by a specific member of the intestinal microbiota in health and during intestinal 
inflammation are so far not described. 
We show that T cel cross reactivity triggered by the common gut commensal C. albicans has 
a profound influence on the human immune response against airborne fungal pathogens, by 
the selective induction  of  Th17 cels in an  otherwise  Th1  biased immune response.  These 
cross-reactive  T cels remarkably accounted for  up to  one third  of the  memory  T cel  pool 
against the constantly inhaled opportunistic fungus A. fumigatus in healthy donors. During gut 
inflammation in Crohn´s disease, a subset of patients revealed elevated responsiveness against 
C. albicans  probably as a result  of increased access to intestinal luminal antigens  due to a 
reduced  barier function  of the intestinal wal (Duchmann et al.,  1999; Peeters et al.,  1997; 
Soderholm et al.,  1999).  Strikingly, in this  pathological situation the expansion  of cross-
reactive memory T cels strongly boosts the response against A. fumigatus. In contrast, within 
the C.  albicans-reactive  T cel  pool, cross-reactive  T cels against A. fumigatus  were 
underepresented, indicating that these cels are not the result of a natural overlap between the 
specific  T cel repertoires against  both fungi  due to a  high  number  of conserved antigenic 
epitopes.  This is also confirmed  by  our finding that cross-reactive cels  were  only found 
within the A. fumigatus-specific  memory  but  not the  naive  T cel  pool, indicating that a 
selective expansion  of cross-reactive cels, and at the same time  depletion from the  naive 
repertoire, occurs in vivo. 
Intriguingly, the C.  albicans  driven cross-reactive  T cels  had a clear  Th17  phenotype 
(CXCR3-CCR6+CCR4+;  production  of IL-17 and IL-22,  but  no IFN-γ),  which is clearly 
distinguished from the Th1 phenotype of the non-cross-reactive A. fumigatus-specific T cels. 
Several studies  have  highlighted a critical role for  gut  microbiota in the  diferentiation  of 
Th17 cels in the lamia propria (Atarashi et al., 2008; Ivanov et al., 2009; Ivanov et al., 2008; 
Wu et al.,  2010). Indeed, at steady state,  Th17 cels are  most abundant in  gut-associated 
tissues, whereas only a very smal proportion of CD4+ T cels express IL-17 in extra-intestinal 
sites (Atarashi et al., 2008; Ivanov et al., 2008; Ivanov et al., 2006). However, whether these 
Th17 cels in the  gut are specific to antigens  of the commensal  microbiota  or  may also 
recognize other gut-distal antigens has so far not been demonstrated. Consistent with the link 
of Th17 cels to gut microbiota, we found that the human T cel response against al analyzed 
inhaled fungal pathogens contains in contrast to C. albicans only a minor population of IL-17 
producing  T cels.  However, a smal  Th17  population  was consistently  present in the  T cel 
response against al airborne fungi  we analyzed.  Depletion  of C.  albicans-reactive  T cels 
confirmed, that virtualy al of these Th17 cels specific for inhaled fungi are cross-reactive to 
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C. albicans. The IL-17 and IL-22 producers had a CD45RO memory phenotype and were not 
the result  of an in vitro induction  process, since  we found them in vitro exclusively in 
memory-derived  T cel lines  but  not in expanded  T cel lines  derived from the  naive  pool. 
These data implicate that a smal number of cross-reactive precursors is selectively expanded 
and  driven into  Th17 lineage  diferentiation  upon C.  albicans encounter and in this  way 
induces a new Th cel subset in the specific T cel response against inhaled fungal antigens. 
This is further supported  by  our finding that the  ex vivo frequencies  of A. fumigatus and 
C. albicans-specific  CD154+ T cels in  healthy  donors  only  weakly corelated. Instead,  we 
observed a strong positive corelation between the frequencies of A. fumigatus-specific IL-17 
producers and total C.  albicans-reactive  T cels, as  wel as the frequency  of C.  albicans-
specific IL-17  producers.  Thus interaction  of the immune system  with C. albicans seems to 
have a major impact on the specific T cel response against A. fumigatus, as wel as on other 
airborne fungi, by shaping and expanding a population of cross-reactive T cels with a unique 
Th17  phenotype  not found in the  natural response to these antigens alone.  This  provides a 
new mechanism of how T cel cross-reactivity can have marked consequences on the outcome 
of immune responses by the induction of a functionaly unique Th cel subset. 
In contrast to C. albicans infection, where a protective role of Th17 cels is wel established 
(McDonald,  2012), the role  of  Th17 cels against inhaled fungal  pathogens is a  mater  of 
debate.  Protective roles for IL-17 and  Th17 cels  have  been  described in  mouse  models for 
diferent fungal  pathogens, such as Cryptococcus  neoformans, Pneumocystis carini  or 
Blastomyces dermatitidis (Kleinschek et al., 2006; Rudner et al., 2007; Wüthrich et al., 2013). 
However,  other studies suggest that  Th17 cels exacerbate inflammation and induce severe 
tissue pathology in mouse models of pulmonary aspergilosis (Romani et al., 2008; Zelante et 
al., 2009; Zelante et al., 2007). Recently it has been shown that IL-17 drives Th2-type alergic 
pulmonary eosinophilia folowing repeated inhalation of A. fumigatus conidia (Murdock et al., 
2012). In line with these data, in particular Th17 responses have been linked to a variety of 
diferent airway  disorders, including asthma, inflammatory lung  disease and airway 
hypersensitivity (Akdis et al., 2012; Cosmi et al., 2011). Thus, the selective induction of Th17 
cels into the immune response against inhaled fungal  pathogens  by C.  albicans cross-
reactivity might even have pathologic consequences by driving alergic lung diseases against 
fungi, folowing sensitization to inhaled fungal antigens. 
Strikingly, in some patients with Crohn´s disease, C. albicans-specific T cel frequencies were 
strongly increased and expanded cross-reactive  T cels  quantitatively and  qualitatively 
modulated the immune response against A. fumigatus. Regarding these results it is interesting 
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to  note that an increased incidence  of asthma  has  been reported in  patients  with  Crohn´s 
disease (Bernstein et al.,  2005; Spira et al.,  1998) and  perturbations  of the  microbiota 
composition  have  been corelated to the  development  of alergic  diseases (Botcher et al., 
2002; Goldman and Hufnagle, 2009; Kaliomaki et al., 2001; Kirjavainen et al., 2002). Thus, 
the modulation of specific T cel responses against normaly harmless environmental antigens 
by cross-reactivity against  gut  microbiota  might  be a  broadly relevant event  during  gut 
inflammation and  might contribute to the efect  of  gut  microbiota  on  distantly located 
immune responses and systemic immunopathology. 
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Materials and Methods 
 
Blood donors 
Bufy coats from  healthy  donors  were  obtained from the  university  hospital in  Dortmund. 
Peripheral ethylenediaminetetraacetic acid (EDTA)  blood samples  were  obtained from 
healthy  volunteers and  patients  with  Crohn´s  disease (CD).  The study  was  performed 
according to established ethical  guidelines (Ethical  Comitee  of  Charité – University 
Medicine Berlin). Al human blood donors gave informed consent. 
Peripheral blood mononuclear cels (PBMCs) were separated by use of Ficol-Hypaque (GE 
Healthcare  Life  Sciences,  Freiburg,  Germany)  density  gradient centrifugation and  were 
resuspended in  RPMI-1640 (Miltenyi  Biotec,  Bergisch  Gladbach,  Germany), supplemented 
with 5% (v/v) inactivated human AB-serum (BioWhitaker/Lonza, Walkersvile, MD, USA) 
and 2mM L-glutamine (PAA Laboratories, Pasching, Austria). 
 
Fungal lysates 
The Aspergilus fumigatus strain ATCC 46645 (LGC Standars, Wesel, Germany), the A. niger 
strain  FSU871, the A. nidulans strain  RMSO11 and A. terreus strain i402 were  used for 
preparation of protein extracts from mycelia. Conidia were inoculated at a final concentration 
of 2x106 spores/ml in YPD or AMM medium and shaken at 37 °C or 30 °C (for A. niger) with 
200 rpm. After 20 hours of incubation, mycelia were recovered by filtration and disrupted in a 
microdismembrator (Sartorius  Stedim  Biotech  GmbH,  Götingen,  Germany) at  200 rpm for 
10  min  using  0.5  mm  glass  beads.  Clinical isolates  of Fusarium oxysporum, F. solani, 
F. verticilioides, Lichtheimia corymbifera,  Rhizopus  oryzae,  Scedosporium  apiospermum, 
and S. prolificans obtained from the Fungiscope™ study were grown on Sabouraud dextrose 
agar plates until sporulation. Conidia were shaken in RPMI-1640 medium supplemented with 
MOPS (3-(N-morpholino) propane sulfonic acid), glutamine and 2 % glucose for 5-7 days at 
37° C.  Mycelia  were  disrupted  using the  gentleMACS  device (Miltenyi  Biotec)  program 
RNA.01 for  5 times.  Al lysates  were resuspended in  1×PBS  bufer (2 mM  MgCl2), and 
centrifuged for 20 min at 20,000 × g. Supernatants were stored in aliquots at -20 °C until use. 
The Candida albicans lysate was purchased from Greer Laboratories, Lenoir, NC, USA. 
 
Stimulation of human PBMCs and antigen-reactive T cel enrichment (ARTE) 
1×107 PBMCs were stimulated for 7 hours with 40 µg/ml of the fungal lysates in presence of 
1 µg/ml CD40 and 1 µg/ml CD28 pure antibody (both Miltenyi Biotec). 1 µg/ml Brefeldin A 
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(Sigma-Aldrich, Schneldorf, Germany) was added for the last 2 hours. Cels were separated 
using the CD154 MicroBead Kit (Miltenyi Biotec). In brief, cels were indirectly magneticaly 
labeled with CD154-Biotin and anti-Biotin microbeads and enriched by two sequentialy MS 
columns (Miltenyi Biotec). For characterization of phenotypic markers, surface staining was 
performed  on the first column, folowed by fixation,  permeabilization (Inside stain  Kit; 
Miltenyi  Biotec) and intracelular cytokine staining  on the second column, as  described 
(Bacher et al., 2013). 
 
Flow cytometric analysis 
Depending  on the experiment, cels  were stained in  diferent combinations  with folowing 
mAbs (clone names in parantheses): CD4-VioBlue, CD4-APC-Vio770 (VIT4); CD45RO-PE-
Vio770 (UCHL1); CD8-PerCP, CD8-VioGreen (BW135/80); CD14-PerCP, CD14-VioGreen 
(TÜK4); CD20-PerCP, CD20-VioGreen (LT20); CD154-VioBlue, CD154-APC (4E3); TNF-
α-FITC (cA2); IFN-γ-APC, IFN-γ-FITC, IFN-γ-PE (45-15); IL-17A-APC, IL-17A-FITC, IL-
17A-PE-Vio770 (CZ8-23G1); IL-10-PE (JES3-9D7),  CXCR3-PE-Vio770 (REA232) (al 
from  Miltenyi  Biotec); IL-4-APC (7A3-3) (conjugated in-house);  CCR6-BV421 (G034E3); 
CCR4-PerCP-Cy5.5 (TG6); IFN-γ-PerCP-Cy5.5 (4S.B3) (al from  BioLegend,  San  Diego, 
CA, USA); IL-22-PerCP-Cy5.5 (22URTI) (from eBioscience, San Diego, CA, USA); IL-22-
PE (142928) (from  R&D systems).  Data  were acquired  on a  MACSQuant analyzer and 
MACSQuantify software (both Miltenyi Biotec) was used for analysis. 
 
Expansion of fungus-specific T cel lines 
Magnetic enrichment  of  CD154+ cels  was  performed  using the  CD154  MicroBead  Kit and 
cytokine secreting cels were isolated using the IFN-γ-PE and IL-17A-APC Secretion Assay-
Cel  Enrichment and  Detection  Kit according to the  manufacturer´s instructions (al from 
Miltenyi Biotec). The IL-22 secretion assay was conjugated in-house. 
For expansion of T cel lines from the naive or memory repertoire, CD45RA+ or CD45RO+ 
CD4+ T cels were purified from PBMC by negative selection using the Naive CD4+ T Cel 
Isolation Kit I or the Memory CD4+ T Cel Isolation Kit (both Miltenyi Biotec), respectively. 
For stimulation of the isolated naive and memory cels, CD3-depleted APCs were generated 
using CD3 MicroBeads and LD columns (both Miltenyi Biotec) and added in a ratio of 1:1. 
Alternatively, if  only cels from the  memory compartment  were expanded,  CD45RA+ cels 
were  depleted from  PBMC  prior stimulation  using  CD45RA  Microbeads and  LD columns 
(both Miltenyi Biotec). CD154+ cels were enriched as described above. 
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Enriched fungus-specific  T cels  were expanded  with  mitomycin C (Sigma  Aldrich) treated 
autologous feeder cels in a ratio of 1:100 at a density of 2.5×106 cels/cm2 in 48-wel plates in 
X-Vivo15 (BioWhitaker/Lonza, Walkersvile, MD, USA), supplemented with 5% (v/v) AB-
serum (BioWhitaker/Lonza), 200 U/ml IL-2 (Proleukin®; Novartis, Nürnberg, Germany) and 
100 U/ml  penicilin,  100 µg/ml streptomycin,  0.25 µg/ml amphotericin  B (Antibiotic 
Antimycotic Solution, Sigma Aldrich). Cels were expanded for 14-21 days, culture medium 
was replenished and cels were split, when needed. 
Two days before re-stimulation, expanded cels were rested in RPMI-1640 + 5% (v/v) human 
AB-serum  without IL-2.  5×105 expanded  T cels  were re-stimulated  with autologous  CD3-
depleted PBMC as APCs in a ratio of 1:1 and 40µg/ml fungal lysate or 10µg/ml CMV lysate 
(Siemens  Healthcare  Diagnostics,  Marburg,  Germany) and  1µg/ml  CD28 functional  grade 
pure Ab for 3h plus additionaly 4h with 1µg/ml Brefeldin A (Sigma Aldrich). After fixation 
and permeabilization cels were stained intracelularly for CD154 and cytokine expression. 
 
Generation of specific T cel clones 
Expanded A. fumigatus-specific T cel lines were re-stimulated with autologous CD3-depleted 
APCs and C. albicans for  7  hours in  presence  of  1 µg/ml  CD40  mAb (Miltenyi  Biotec). 
Cross-reactive CD154+ T cels were isolated using CD154-PE, anti-PE MicroBeads and 2 MS 
columns (al Miltenyi Biotec). From the negative fraction, CD4+ T cels were purified using 
an untouched isolation with the CD4+ T cel isolation Kit I (Miltenyi Biotec) and stimulated 
with autologous  CD3-depleted  APCs and A. fumigatus for  7  hours in  presence  of  1µg/ml 
CD40 mAb (Miltenyi Biotec). C. albicans-depleted A. fumigatus-reactive CD4+ T cels were 
isolated  using  CD154-PE, anti-PE  MicroBeads and  2  MS columns (al  Miltenyi  Biotec). 
Cross-reactive and C. albicans depleted T cels were cloned by limiting dilution by seeding 1 
cel/wel into  96-wel round  botom  plates together  with  5×104/wel  mitomycin  C (Sigma 
Aldrich) treated feeder cels and 200 µl X-Vivo15 (BioWhitaker/Lonza), supplemented with 
10% (v/v) AB-serum (BioWhitaker/Lonza),  200 U/ml IL-2 (Proleukin®;  Novartis) and 
100 U/ml  penicilin,  100 µg/ml streptomycin,  0.25 µg/ml amphotericin  B (Antibiotic 
Antimycotic  Solution,  Sigma  Aldrich).  Clones  were stimulated  with  1 µg/ml  PHA (Sigma 
Aldrich) and expanded for 4 weeks with 5×104/wel feeder cels and 1 µg/ml PHA added on 
day 10. 
Re-stimulation was performed by stimulating 5×105 expanded T cel clones/wel with 5×105 
autologous CD3-depleted APCs with or without antigen for 7 hours. 1µg/ml Brefeldin A was 
added for the last  4  hours.  Specificity  of the expanded  T cel clones  was analyzed  by 
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intracelular staining for  CD154 and cytokines  or  proliferation  on  day  7 after labeling  with 
CelTrace™  Violet  Cel  Proliferation  Kit (Invitrogen™,  Molecular  Probes®,  Eugene,  OR, 
USA). 
 
Depletion of C. albicans cross-reactive T cels 
For depletion of C. albicans cross-reactive cels from A. fumigatus-reactive T cel lines, 5×106 
A. fumigatus-reactive T cels were stimulated with 5×106 autologous CD3-depleted APCs and 
C. albicans, in presence of 1 µg/ml CD28 and 1 µg/ml CD40 mAb (Miltenyi Biotec). After 7 
hours  of stimulation,  CD154+ cels  were  depleted,  using the  CD154  MicroBead  Kit and a 
single MS column (Miltenyi Biotec). CD4+ T cels were isolated from the negative fraction, 
using an  untouched isolation  with the  CD4+  T cel isolation  Kit I (Miltenyi  Biotec).  The 
remaining C.  albicans-depleted A. fumigatus-reactive  CD4+  T cels  were again stimulated 
with autologous  CD3-depleted  APCs in a ratio  of  1:1 for  7h  hours  with A. fumigatus-lysate 
and  1µg/ml  Brefeldin A added for the last  4  hours and analyzed for  CD154 and cytokine 
expression. 
For ex vivo depletion of C. albicans-reactive T cels, PBMCs were stimulated for 7 hours with 
C. albicans lysate in presence of 1 µg/ml CD28 and 1 µg/ml CD40 mAb (Miltenyi Biotec). C. 
albicans-reactive T cels and non-T cels were depleted by labeling with the untouched CD4+ 
T cel isolation  Kit I and  CD154-Biotin, folowed  by anti-Biotin  MicroBeads  using  LS 
columns (al  Miltenyi  Biotec).  The remaining C.  albicans  depleted  CD4+  T cels  were 
stimulated with autologous CD3-depleted APCs and diferent fungal lysates for 5 hours plus 
additionaly 2h with 1 µg/ml Brefeldin A (Sigma Aldrich). ARTE was performed as described 
above. 
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Figure legends 
 
Figure 1. Altered fungus-specific T cel response in patients with Crohn´s disease (CD) 
(A)  Frequencies  of C.  albicans- and A. fumigatus-reactive  CD154+  T cels in  PBMCs  of 
healthy donors (n=111) versus patients with Crohn´s disease (n=46). A cut-of value ≥ 0.4% 
CD154+ C. albicans-reactive T cels was defined to separate patients with (red symbols) and 
without (blue symbols) increased T cel reactivity. (B) Corelation of CD154+ frequencies of 
C.  albicans-  with A. fumigatus-reactive  T cels in  CD  patients. (C) Ex vivo analysis  of 
cytokine  production  of A. fumigatus- and C.  albicans-reactive  T cels folowing  CD154+ 
enrichment.  Percentages  of cytokine  producing cels among  CD154+ cels are shown in  CD 
patients and healthy controls. Significance was determined using unpaired Student´s t-test and 
Pearson´s corelation coeficient was used to calculate corelations. 
 
 
Figure 2. A. fumigatus-reactive T cel lines contain cels cross-reactive to C. albicans. 
(A, B) PBMCs of CMV sero-positive donors were stimulated for 7 hours with A. fumigatus-, 
C. albicans-  or  CMV-lysate.  Antigen-reactive  CD154+ cels  were isolated and subsequently 
expanded for  14  days  with IL-2 and autologous feeder cels.  Expanded cel lines  were re-
stimulated in  presence  of autologous  APCs  with and  without antigens as indicated, and 
reactive CD4+ T cels were determined by CD154 and TNF-α expression. (A) Representative 
dot  plot examples  of  one  donor and (B) statistical analysis for several  donors (n=30). (C) 
Percentage of cross-reactivity was calculated in relation to total reactivity after re-stimulation 
with the specific fungal lysate. p  values  were  determined  using  paired  Student´s t-test. (D) 
Single  T cel clones  were  generated from enriched cross-reactive  CD154+ cels  or after 
depletion  of cross-reactive cels from A. fumigatus-reactive  T cel lines.  Reactivity  was 
determined  by expression  of  CD154 and cytokines  upon re-stimulation. (E) A. fumigatus-
reactive T cel lines were expanded folowing CD154+ enrichment from healthy donors or CD 
patients  with  high  or low frequencies  of reactive  T cels.  Cels  were re-stimulated  with 
C. albicans lysate and percentage of cross-reactivity is shown in relation to the total reactivity 
after re-stimulation  with A. fumigatus lysate.  Significance  was  determined  using  unpaired 
Student´s t-test. 
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Figure  3.  Cross-reactive  T cels  produce IL-17  and Il-22. (A, B) A. fumigatus-reactive  T 
cel lines  were  generated, as  described in figure  2.  Cel lines  were re-stimulated either  with 
A. fumigatus or C. albicans antigens and analyzed for percentages of cytokine producing cels 
among CD4+CD154+. (A) Representative dot plot examples and (B) statistical analysis from 
several donors (n=6). (C) Ex vivo enriched A. fumigatus- and C. albicans-reactive cels were 
gated as indicated and stained for  CXCR3,  CCR6 and  CCR4 expression.  Percentage  of 
positive cels  within the respective  gates is indicated. (D) A. fumigatus-reactive  T cel lines 
were expanded after selection for CD154, IFN-γ producers or IL-17/IL-22 producers and re-
stimulated  with A. fumigatus  or C.  albicans lysate. (E)  Percentage  of cross-reactivity  was 
calculated in relation to total reactivity after re-stimulation with the specific antigen lysate. (F) 
A. fumigatus-reactive  T cel lines  generated  via  CD154-enrichment  were re-stimulated  with 
C. albicans-lysates and cross-reactive CD154+ cels were depleted. Analysis of IL-17 and IL-
22 expression is shown of total A. fumigatus-reactive and C. albicans-depleted cel lines after 
re-stimulation  with A. fumigatus lysate.  Dot  plot examples for  one  donor  with  numbers 
indicating  percentage  of cytokine  producing cels among  CD4+CD154+ and summary for 
several  donors (n=5) is shown. (G)  PBMCs  were ex vivo stimulated  with A. fumigatus  or 
C. albicans lysates and analyzed for IL-17  production folowing enrichment  of  CD154+ T 
cells. Corelations obtained by linear regression curve analysis are shown for the frequencies 
of total C.  albicans-reactive  CD154+ T cels versus A. fumigatus-specific IL-17  producers 
(n=57; left  diagram)  or the frequencies  of A. fumigatus-  versus C.  albicans-specific IL-17 
producers among CD154+ (n=57; right diagram). Pearson´s corelation coeficient was used to 
calculate corelations.  Significance  was  determined  using  paired  Student´s t-test.  *p < 0.05, 
**p < 0.01, ***p < 0.001. 
 
 
Figure 4. C. albicans cross-reactive T cels are expanded within the A. fumigatus-reactive 
memory CD4+ T cel pool. Memory or naive CD4+ T cels were pre-sorted from PBMCs and 
stimulated  with  CD3-depleted  APCs and A. fumigatus lysate.  Enriched  CD154+ cels  were 
expanded for  14 days  with IL-2 and autologous feeder cels.  Expanded cel lines  were re-
stimulated in presence of autologous APCs with diferent fungal antigen lysates as indicated, 
and reactive CD4+ T cels were determined by CD154 and TNF-α expression. (A) Percentage 
of reactive  CD4+  T cels  of  memory  derived (left) and  naive  derived (right) A. fumigatus-
reactive  T cel lines (n=4). (B)  Percentage  of cross-reactivity to C. albicans  of the  diferent 
selected  T cel lines  was calculated in relation to total reactivity after re-stimulation  with 
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A. fumigatus lysate (n=10).  Significance  was  determined  using  paired  Student´s t-test. (C) 
Frequencies  of cytokine  producing cels among  CD4+CD154+  of  memory  derived (left) and 
naive  derived (right) A. fumigatus-reactive  T cel lines re-stimulated  with A. fumigatus or 
C. albicans lysate (n=6). 
 
 
Figure 5. IL-17 producers in airborne fungus-reactive T cel responses are cross-reactive 
to C.  albicans. (A,  B) Ex vivo analysis  of cytokine  production  of reactive  T cels against 
various fungal lysates is shown folowing  CD154+ enrichment.  Percentages  of cytokine 
producing cels among  CD154+ cels are indicated. (A)  Representative  dot  plots and (B) 
statistical analysis for several  donors. (C)  CD45RA-depleted  PBMCs  were stimulated  with 
the indicated fungal lysates, CD154+ T cels were expanded and re-stimulated either with the 
specific antigen or C. albicans. Percentage of Il-17 producing cels among CD154 is shown. 
Graph represents  mean  values  ±  SEM from  5-6  donors. (D)  PBMCs  were stimulated  with 
C. albicans and reactive  CD154+ cels  were  depleted.  Frequency  of C.  albicans-specific 
CD154+ cels  prior and after  depletion is shown. (E)  PBMCs and C.  albicans-depleted 
PBMCs  were ex vivo stimulated  with the indicated fungal lysates and  percentage  of IL-17 
producers among CD154+ is shown. 
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Figure 2 
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Figure 3 
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Figure 4 
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Figure 5 
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Figure S1 
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Figure S1. Qualitative modulation of fungus-specific T cel responses in Crohn´s disease 
patients. PBMCs  of  healthy  donors  or  CD  patients  were stimulated  with C.  albicans  or 
A. fumigatus lysate, reactive CD154+ T cels were magneticaly enriched and ex vivo analyzed 
for cytokine expression.  Representative  dot  plot examples  with  percentage  of cytokine 
producing cels among CD154+ cels are shown. 
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Figure S2 
 
 
original fraction
7.1%
depleted fraction
0.5%
CD
4
CD154
A B
 
 
 
Figure  S2.  Eficient  depletion  of C.  albicans cross-reactive cels from A. fumigatus-
reactive T cel lines. A. fumigatus-reactive T cel lines generated via CD154-enrichment were 
re-stimulated  with C.  albicans-lysates and cross-reactive  CD154+ cels  were  depleted  by 
MACS. (A)  Dot  plot examples for the  original and  depleted fraction  with  percentage  of 
CD154+ cels among CD4+ and (B) statistical analysis for several donors are shown. 
 
Manuscripts 
___________________________________________________________________________ 
 
99 
 
3.5 Manuscript V 
 
 
“Rapid Diagnosis of Invasive Mold Infection by Measuring 
Fungus-Reactive CD4+ T Cels in Peripheral Blood“ 
 
Bacher P*, Steinbach A*, Kniemeyer O, Hamprecht A, Assenmacher A, 
Vehreschild MJGT, Vehreschild JJ, Brakhage AA, Cornely OA*, Scheffold A*. 
 
* These authors contributed equaly to this work. 
 
Manuscript in preparation.
  
 
 
1 
 
Rapid diagnosis of invasive mold infection by measuring fungus-reactive CD4+ T cels in 
peripheral blood 
 
Petra  Bacher1*,  Angela  Steinbach2,6*,  Olaf  Kniemeyer3,4,  Axel  Hamprecht5,  Mario 
Assenmacher6, Maria J.G.T. Vehreschild2, Jörg J. Vehreschild2, Axel A. Brakhage3, Oliver A. 
Cornely2,8*, Alexander Schefold1,9* 
 
1Department  of  Celular Immunology,  Clinic for  Rheumatology and  Clinical Immunology, 
Charité - University Medicine Berlin, Germany 
2Department I of Internal Medicine, University Hospital of Cologne, Germany 
3Department  of  Molecular and  Applied  Microbiology,  Leibniz Institute for  Natural  Product 
Research and Infection  Biology  –  Hans  Knoel Institute (HKI) Jena and  Friedrich  Schiler 
University Jena, Jena, Germany 
4Integrated  Research and  Treatment  Center,  Center for  Sepsis  Control and  Care Jena, 
University Hospital (CSCC) Jena, Germany 
5Institute for  Medical  Microbiology, Immunology and  Hygiene,  University  of  Cologne, 
Cologne, Germany 
6Miltenyi Biotec GmbH, Bergisch Gladbach, Germany 
7Clinical Trials Center Cologne ZKS Köln (BMBF 01KN1106), Cologne Excelence Cluster 
on  Celular  Stress  Responses in  Aging-Associated  Diseases (CECAD), and  Center for 
Integrated Oncology CIO KölnBonn, University of Cologne, Cologne, Germany, University 
Cologne, Germany 
8Department of Immunoregulation, Clinic for Rheumatology and Clinical Immunology, 
Charité - University Medicine Berlin, Germany 
9German Rheumatism Research Centre (DRFZ) Berlin, Leibniz Association, Berlin, Germany 
 
*These authors contributed equaly to this work 
 
2 
 
Corresponding Authors 
 
Alexander Schefold, MS 
Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany 
Phone: +49 30 450 513 450 
Fax: +49 30 450 7 513 450 
Email: alexander.schefold@charite.de 
 
Oliver A. Cornely, MD 
Uniklinik Köln, 50924 Köln, Germany 
ZKS Köln 
Phone: +49 221 478 6494 
Fax: +49 221 478 3611 
Email: oliver.cornely@zks-koeln.de 
 
 
Short title: Fungus-reactive T cels in invasive mold infection 
 
Key points: 
1) CD4+ T cels specific for clinicaly relevant fungi are present in al healthy individuals at 
relatively low and conserved frequencies. 
2) Increased fungus-reactive  T cel frequencies,  but  not the absolute  number  or efector 
cytokines, are indicative for patients with invasive fungal infections. 
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Abstract 
 
Background 
Invasive mold infections are dificult to recognize in immunocompromised patients, resulting 
in delayed and non-targeted therapy, which is a major cause for the extremely high mortality 
rates. Since CD4+ T cels orchestrate anti-fungal immunity with high specificity, we analyzed 
whether  quantification  of fungus-specific  T cels in  peripheral  blood  may  have  diagnostic 
potential and also alows  discrimination  between the clinicaly  most relevant fungal 
pathogens. 
Methods 
Folowing short in vitro stimulation  with fungal lysates, reactive  CD154+  T cels  were 
monitored by flow-cytometry in peripheral blood of healthy controls and patients at risk for, 
or  with established  diagnosis  of invasive  mold infection.  Results  were compared  with the 
international consensus criteria for diagnosing invasive fungal infection. 
Results 
In 11 of 12 (91.7%) patients with proven or probable invasive fungal infection, mold-reactive 
CD4+ lymphocytes were increased compared to healthy controls. In 24 of 26 (92.3%) patients 
at risk,  but  without established  diagnosis  of invasive fungal infection,  mold-reactive  CD4+ 
lymphocyte frequencies were in the range of healthy donors (P < .001, odds ratio = 132 (95 % 
confidence interval,  10.79 to  1615.08). Increased frequencies  normalized  during successful 
treatment. In contrast, efector cytokine production of mold-reactive T cels was variable and 
did  not increase  during infection.  The  genus-specificity  of the  T cel reaction alowed 
discriminating fungal  pathogens and even identification  of  mixed infections  with several 
fungi. 
Conclusions 
Measurement of fungus-reactive CD154+ T helper cel frequencies in peripheral blood has the 
potential to identify invasive mold infection early and to alow targeted antifungal treatment. 
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Introduction 
 
Ubiquitous molds cause life-threatening invasive infections in immunocompromised patients. 
The incidence  of invasive  mold infections is rising, and  despite  diagnostic and therapeutic 
improvements, mortality rates are striking. Leukemic patients and hematopoietic stem cel or 
solid organ transplant recipients are at particular risk.1,2 
Early initiation  of targeted antifungal therapy is the  key to improved  prognosis.3,4  Stil, fast 
and specific  diagnostic  methods and reliable  markers are lacking.5-7  Only the  direct 
microscopic or cultural detection of the invading fungal pathogen in a sample taken from the 
infected site  gives a clinical  proof for the  presence  of an invasive fungal infection.5  Such 
surgical  procedures can rarely  be applied to the  majority  of criticaly il  patients and rather 
represent a last therapeutic option, than a feasible diagnostic tool. The further classification of 
invasive fungal  diagnosis into  probable and  possible cases requires a combination  of the 
presence  of a  host factor (e.g.  neutropenia), characteristic findings  on lung computed 
tomography (CT) scans and  microbiological findings5 and thus relies  on a  high  value  of 
suspicion. As molds other than Aspergilus are emerging, also genus-specific discrimination 
becomes increasingly important.8,9  However, even the  histological examination  of  biopsy 
samples  may  not  be specific enough to clearly  distinguish similar filamentous fungal 
species.23  Hence, there is an  urgent  need for improved  diagnostic  methods  with  high 
sensitivity and specificity; such  methods should alow  diferentiating  between fungal 
pathogens and enable immediate and targeted antifungal treatment. 
Recent studies suggest that  CD4+ lymphocytes  may contribute to  host  defense against 
fungi.10-12 However, due to low frequencies and lack of knowledge about immune-dominant 
antigens, the actual frequency and  phenotype  of  mold-reactive lymphocytes in  healthy 
subjects and relevant patient groups remain elusive. 
We  previously showed, that the total  pool  of antigen-reactive  T cels can  be  detected and 
characterized  with  high specificity and sensitivity  based  on the  up-regulation  of  CD154 
(CD40L) folowing  brief in vitro stimulation  of  peripheral  blood samples  with fungal 
antigens.13-15  Here,  we  used this sensitive technology to analyze  mold-reactive  CD4+ 
T lymphocytes specific for  predominate fungal species in  peripheral  blood  of 
immunocompromised patients with or without fungal infection and healthy controls. We can 
show that  mold-reactive  T cel frequencies are significantly increased  during invasive  mold 
infection suggesting their  usefulness as a  highly specific though simple and robust read-out 
for genus-specific diagnosis of acute fungal infections from peripheral blood samples. 
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Methods 
 
Peripheral blood sampling 
Bufy coats from  100  healthy  donors  were  obtained from the Institute for  Transfusion 
Medicine,  University  Hospital  Dortmund,  Germany after informed consent.  Peripheral 
ethylenediaminetetraacetic acid (EDTA) blood samples were colected from 45 patients at the 
University  Hospital  Cologne  between July  2010 and  August  2012.  Blood sampling  was 
performed  within the scope  of the  biomaterial repository  protocol ISI and al  patients  gave 
informed consent (local ethics identifier  08-160).  The  presence  of at least two  of the 
folowing criteria selected patients for participation: immunosuppression due to chemotherapy 
for  underlying  hematologic  or  oncologic  malignancy,  previous  hematopoietic stem cel 
transplantation,  prolonged immunosuppressive treatment, lung infiltrates  on chest  CT scan, 
positive  galactomannan levels in serum (cut-of  ≥ 0.5 in two consecutive samples)  or 
bronchoalveolar lavage (BAL) fluid (cut-of  ≥ 0.5 in a single sample),  or clinical findings 
indicative  of invasive  mold infection.  Patients  donated at  most  20 ml  of  peripheral  blood 
twice weekly. 
 
Preparation of fungal lysates 
Each  2x106 conidia/ml  of A. fumigatus  ATCC  46645 (LGC  Standards,  Wesel,  Germany), 
A. niger FSU871, A. nidulans RMSO11, and A. terreus i402 were shaken for 20 hours with 
200 rpm in YPD or AMM medium at 37 °C or 30 °C (for A. niger). Mycelia were recovered 
by filtration and  disrupted in a  Mikro-Dismembrator  S (Sartorius  Stedim  Biotech  GmbH, 
Götingen,  Germany) at  200 rpm for  10 min  using  0.5 mm  glass  beads, as  previously 
described.15 
Clinical isolates  of Fusarium  oxysporum, F. solani, F. verticilioides, Lichtheimia 
corymbifera (formerly Absidia corymbifera, Mycocladus corymbifer),  Rhizopus  oryzae, 
Scedosporium apiospermum, and S. prolificans  obtained from the  Fungiscope™ study  were 
grown  on  Sabouraud  dextrose agar  plates  until sporulation.16  Conidia  were  harvested and 
shaken in  RPMI-1640  medium supplemented  with  MOPS (3-(N-morpholino)  propane 
sulfonic acid),  glutamine and  2 %  glucose for  5-7 days at  37 °C.  Mycelia  were  disrupted 
using the  gentleMACS™  device (Miltenyi  Biotec,  Bergisch Gladbach,  Germany),  program 
RNA.01 (5 times).  Al lysates  were resuspended in  1x PBS  bufer (2 mM  MgCl2), and 
centrifuged for 20 min at 20,000 g. Supernatants were stored in aliquots at -20° C until use. 
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Stimulation and enrichment of antigen-reactive T cels 
Folowing  Ficol-Paque (GE  Healthcare  Life  Sciences,  Freiburg,  Germany)  density  gradient 
centrifugation, peripheral blood mononuclear cels (PBMC) were resuspended in RPMI-1640 
(Miltenyi  Biotec), supplemented  with  5% (v/v)  human  AB-serum (BioWhitaker/Lonza, 
Walkersvile,  MD,  USA),  2 mM  L-glutamine (PAA  Laboratories,  Pasching,  Austria). 
Depending on the available amount, 5x105 to 1x106 PBMC were stimulated for 7 hours with 
40 µg/ml  of each fungal lysate  or a  pool thereof,  or Staphylococcus enterotoxin B (SEB 
1 µg/ml,  Sigma-Aldrich,  Schneldorf,  Germany), in  presence  of  1 µg/ml  CD40,  1 µg/ml 
CD28 pure antibody (both Miltenyi Biotec). 
For analysis of cytokine expression, 1x107 PBMC were stimulated with the fungal lysates for 
7  hours  with  1 µg/ml  Brefeldin  A (Sigma  Aldrich) added after  5  hours.  CD154+ cels  were 
separated  using the  CD154  MicroBead  Kit (Miltenyi  Biotec). In  brief, cels  were indirectly 
magneticaly labeled  with  CD154-Biotin and anti-Biotin  microbeads and enriched  by two 
sequential MS columns (Miltenyi Biotec), folowed by intracelular cytokine staining (Inside 
stain Kit; Miltenyi Biotec). 
 
Flow cytometry 
Cels  were stained  with the folowing  monoclonal antibodies according to  manufacturer 
protocols: CD3-VioBlue (BW264/56), CD4-APC.Vio770, CD4-VioBlue (VIT4), CD8-PerCP 
(BW135/80),  CD14-PerCP (TÜK4),  CD20-PerCP (LT20),  CD69-APC (FN50),  CD154-PE, 
CD154-APC,  CD154-VioBlue (5C8),  TNF-α-FITC (cA2), IL10-PE (B-T10), IL17-APC 
(CZ8-23G1) (al  Miltenyi  Biotec), IFNγ-PerCP.Cy5.5 (4S.B3;  BioLegend,  San  Diego,  CA, 
USA). Data were acquired on a MACSQuant® analyzer and MACSQuantify™ software was 
used (Miltenyi Biotec). 
 
Expansion and re-stimulation of antigen-specific T cels 
Isolated  CD154+ cels  were cultured at a  density  of  2.5 x 106 cels/cm2  with  1:100 
mitomycin C (Sigma  Aldrich) treated autologous feeder cels in  X-Vivo™15 
(BioWhitaker/Lonza), supplemented  with  5 % (v/v)  AB-serum (BioWhitaker/Lonza), 
200 U/ml IL-2 (Proleukin®;  Novartis,  Nürnberg,  Germany) and  100 U/ml  penicilin, 
100 µg/ml streptomycin, 0.25 µg/ml amphotericin B (Antibiotic Antimycotic Solution, Sigma 
Aldrich).  During expansion for  14  days,  medium  was replenished and cels  were split as 
needed. 
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For re-stimulation, 5x105 expanded T cels were combined 1:1 with autologous CD3-depleted 
PBMC and stimulated with the fungal lysates or CMV lysate (10 µg/ml, Siemens Healthcare 
Diagnostics,  Marburg,  Germany), and  1 µg/ml  CD28  pure antibody for  6  hours;  1 µg/ml 
Brefeldin  A (Sigma  Aldrich)  was added after  4  hours.  Cels  were stained for intracelular 
CD154 and cytokine expression (data not shown). 
 
Clinical definitions 
The clinical  presence  of invasive  mold infection  was  diagnosed according to the  2008 
consensus  definitions  of the  European  Organization for  Research and  Treatment  of  Cancer 
and the  National Institute  of  Alergy and Infectious  Diseases  Mycoses  Study  Group 
(EORTC/MSG).5 
 
Statistical analysis 
A cut-of  value to  discriminate  between  patients  with and  without invasive  mold infection 
was determined by logistic regression analysis, folowed by receiver operating characteristic 
(ROC) curve analysis using GraphPad PRISM® software 5.0. 
Positive and negative T cel signals were compared to the clinical EORTC/MSG classification 
utilizing 2×2 contingency tables. Patients with proven and probable invasive mold infection 
were  grouped versus those  with  possible  or  without such infection.  Fisher’s exact test  was 
used to calculate the distribution of alignments between the curent gold standard for invasive 
mold infection  diagnosis and the  T cel frequency  quantification.  A  p-value  of  < 0.05 
determined statistical significance. 
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Results 
 
Mold-reactive CD4+ lymphocyte frequencies in healthy donors 
First  we analyzed the frequency ranges  of fungus-reactive  CD4+ T cels in  healthy  donors, 
folowing a  7-hour stimulation  of  PBMCs  with  various fungal lysates  of the  most frequent 
clinicaly isolated invasive fungal species. In  healthy  donors al fungal lysates induced a 
smal, but clearly defined population of CD154 expressing CD4+ T cels as compared to the 
non-stimulated control (Figure 1A).  Analysis  of  diferent  donors revealed that the  highest 
frequencies of mold-reactive T cels were present against A. fumigatus, ranging from 0.1% to 
0.3%,  whereas frequencies against al  other  molds  were  below  0.15% in  most  donors 
(Figure 1B). 
 
Patient characteristics 
Next  we analyzed  patients at risk for invasive fungal infections.  Of  45  patients analyzed,  6 
had proven, 10 probable, 5 possible, and 24 patients had no invasive mold infection according 
to consensus criteria5 (Table  1).  The  proportion  of total  CD4+ cels ranged from  0.07% to 
81%  of  PBMC (Supplemental Table 1),  but flow-cytometric  measurement  of  CD154+ 
expression alowed for normalization of reactive T cel frequencies to the variable total CD4+ 
T cel  numbers.  Since  only low  PBMC  numbers could  be  obtained from 
immunocompromised  patients, four  diferent lysate  pools (Aspergilus spp., Fusarium spp., 
Mucorales, Scedosporium spp.)  were  used for stimulation.  Using  pooled lysates  did  not 
increase the frequency ranges  of fungus-reactive  CD4+ T cels in  healthy  donors 
(Supplemental Figure 1). We were able to determine the frequencies of mold-reactive T cels 
in  38  patients (84%;  Supplemental Table 1). In five  patients  with  T cel counts  < 0.15%  of 
PBMCs or with absence of antigen presenting cels, a CD154 expression was not inducible, 
and in two patients the background CD154 expression was too high. 
 
Mold-reactive CD4+ lymphocyte frequencies in patients with invasive mold infection 
In a cohort  of  100  healthy control  donors, the  mean  proportions  of Aspergilus spp.- and 
Mucorales-reactive  CD4+ lymphocytes  were  0.14% ± 0.07%, and  0.06% ± 0.03%, 
respectively (Figure 2B). Compared to healthy donors some patients had markedly increased 
frequencies of mold-reactive CD4+ cels (Figure 2A,B). Whenever possible, we monitored the 
frequencies  of these  patients at several time  points.  Despite some  variability,  mold-reactive 
CD4+ T cel frequencies were generaly higher than in healthy controls. After completion of 
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patient recruitment, we performed retrospective receiver-operating characteristic (ROC) with 
logistic regression analysis using normalized frequencies to determine the ideal cut-of value. 
Thus, an optimal cut-of value of 2.62 fold mean frequencies of healthy donors was calculated 
to separate  patients  with and  without invasive  mold infection (Figure 2C).  The  derived cut-
ofs were 0.37% for Aspergilus spp. and 0.15% for Mucorales, respectively. 
 
Comparison of clinical diagnosis and mold-reactive CD4+ lymphocyte frequencies 
For comparison with the clinical diagnosis, patients with proven and probable invasive mold 
infection were grouped versus those with possible or without mold infection and contingency 
table analyses were performed. Using the derived cut-of values, diagnosis of invasive mold 
infection coincided in al  6  proven cases.  When adjusting for  patients  with technicaly  un-
evaluable  CD4+ lymphocyte frequencies,  38  patients remained in the analysis. In  5  of  6 
probable cases  mold-reactive  T cel frequencies  were increased, and  24  of  26  patients  with 
either possible or no invasive mold infection showed no increased frequencies, resulting in a 
sensitivity of 91.7% and a specificity of 92.3% (Supplemental Table 2). Positive and negative 
predictive  values  were  85% and  96%, respectively.  The corelation  between consensus 
diagnoses  of invasive  mold infection and  mold-reactive  CD4+ lymphocyte frequencies  was 
statisticaly significant (Fisher´s exact test, P < .001, odds ratio 132 (95% confidence interval 
10.79 to 1615.08). Two patients had increased frequencies, but no diagnosis of invasive mold 
infection, thus formaly representing false  positive test results.  One  patient  with a  probable 
aspergilosis had no increased mold-reactive CD4+ lymphocytes and was regarded as a false-
negative result (Supplemental Table 2). 
By including also patients with un-evaluable T cel frequencies, 5 of 10 probable cases had 
increased frequencies  of  mold-reactive  CD4+ lymphocytes and  27  of  29 cases  with either 
possible  or  no invasive  mold infection showed  no increased frequencies, resulting in a 
sensitivity of 68.8% and a specificity of 93.1% (Supplemental Table 3). Again, the corelation 
between consensus diagnoses of invasive mold infection and mold-reactive CD4+ lymphocyte 
frequencies  was statisticaly significant (Fisher´s exact test,  P < .001,  odds ratio  29.7 (95% 
confidence interval  4.99 to  176.72).  Possible invasive  mold infection  per  definition lacks 
microbiological evidence. Analyzing our results excluding this ambiguous group did not lead 
to a relevant change of the results (Supplemental Table 4). 
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Mold-specific T cels during the course of disease 
We also monitored patients with elevated frequencies of fungi-reactive T cels at several time 
points. Interestingly, whereas elevated T cel frequencies remained high during the course of 
proven invasive  mold infection, elevated frequencies  of  Mucorales-reactive  CD4+ T cels 
rapidly  dropped in two  patients after removal  of the infected tissue  by lung resection 
(Figure 3,  Supplemental Table 1).  This indicated that the increased frequencies represent a 
specific marker for acute fungal infections. 
 
Discrimination between invading fungal pathogens 
Next  we analyzed,  whether the  measurement  of fungus-reactive  T cel frequencies alows 
discrimination  between  diferent fungal  pathogens. In three  patients  with  histologicaly 
proven aspergilosis, T cel frequencies against Aspergilus spp. pooled lysate were increased. 
Also, in two  patients  with  histologicaly  proven  mucormycosis infection elevated  T cel 
frequencies against Mucorales pooled lysate were detected (Figure 2B, Table 1). One patient 
with  histologicaly  proven aspergilosis showed elevated  proportions  of  Mucorales-reactive 
T cels.  One  other  patient  with  proven invasive aspergilosis showed an increase in  T cel 
frequencies to  Mucorales, to Scedosporium spp., and to Fusarium spp.  pooled lysate in 
addition to increased Aspergilus spp.-reactive  T cels (Supplemental Table 1), indicating 
potential of the T cel assay to identify pathogenic fungi even in mixed infection. 
However, for a species-specific discrimination, T cel cross-reactivity against diferent fungal 
species has to be taken into account. Fungus-specific T cel lines were generated from healthy 
donors and their specificity  was tested  via antigen re-stimulation. Expanded  mold-specific 
T cel lines  were  highly reactive (40-80 %) against the fungal lysate  used for the initial 
stimulation, as shown  by re-expression  of  CD154 and  TNF-α (Figure  4).  Reactivity against 
CMV lysate as a control antigen was not above the background level. A. fumigatus-reactive 
T cel lines cross-reacted against A. nidulans and  vice  versa, as  wel as  other Aspergilus 
species (data not shown), indicating that discrimination on species level may be dificult. In 
contrast, the  T cel cross-reactivity  of the  diferent fungus-specific  T cel lines against  more 
distantly related fungal species  was low.  However, S. apiospermum- and to a lower extent 
F. solani-reactive  T cels also responded  upon stimulation  with  other fungal species. 
Importantly, we observed only low cross-reactivity between Aspergilus spp.-reactive T cels 
and the Mucorales species Rhizopus oryzae. 
 
11 
 
Efector cytokine production was not increased during fungal infection 
The cytokine expression  of fungus-reactive  T cels  was analyzed in  healthy controls and in 
patients  with  or  without increased frequencies  of Aspergilus-spp.-reactive  T cel responses. 
Folowing magnetic pre-enrichment and multi-parametric flow-cytometric analysis of CD154 
expressing  CD4+  T cels, the contribution  of  TNF-α, IFN-γ, IL-10 and IL-17 expressing 
T cels to the total fungi-specific  CD4+  T cel  pool  was analyzed  by intracelular cytokine 
staining. Independently  of the fungal species  used for stimulation, cytokines  were  produced 
only  by smal and  highly  variable  proportion  of al antigen-activated  CD154+  T cels in 
healthy donors (Figure 5A, B). Interestingly, very similar frequencies of cytokine producers 
were found in  patients irespective  of the infection status, although  patients  with 
proven/probable infection, i.e. increased frequencies  of Aspergilus-spp.-reactive  T cels, 
tended to  have rather  high frequencies  of  TNF-α  producers (Figure  5C,  D).  However, the 
overlapping frequencies of cytokine producing T cels in patients with and without invasive 
fungal infection indicated the limited  use  of cytokine  production as a  diagnostic tool in 
comparison to the quantitation of the total reactive T cels frequencies.  
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Discussion 
 
In this study,  we analyzed the  mold-reactive  proportion among  CD4+ lymphocytes in 
peripheral blood from immunocompromised hosts and healthy controls using a sensitive flow-
cytometric detection assay. We found a significant corelation of mold-reactive CD4+ T cel 
frequencies with invasive mold infection. 
Healthy donors presented mold-reactive T cels at very low but conserved frequency ranges, 
likely reflecting chronic exposure to  ubiquitous fungi. In  patients  with invasive  mold 
infection, increased frequencies of mold-reactive T cels alowed to determine a cut-of value. 
Across various types of immunocompromised patients, the test yielded a sensitivity of 68.8% 
and a specificity  of  93.1%.  When applied to  patients  without severe  T cel  deficiency, 
sensitivity increased to 91.7% and specificity remained as high as 92.3%. Of note, there was 
only  one false  negative test result  when excluding the easily  discernible  patients  with 
insuficient T cel numbers. The lack of an increased T cel signal in this single patient might 
be due to our panel of lysates not covering al potential fungal pathogens. Alternatively, since 
the patient only had a probable infection based on surogate markers, this patient may indeed 
not  have  had a fungal infection.  Two immunocompromised  patients  displaying increased 
T cel signals did not show clinical signs or symptoms of invasive mold infection. Since we 
detected  no such increase in the  healthy control  group, it is also conceivable that these 
patients  had  undiagnosed fungal infection.  However, considering the single  probable case 
formaly as false negative and the two patients with no IMI as false positive, the measurement 
of fungus-reactive T cels stil resulted in a high sensitivity and specificity exceeding results 
of curently available blood tests for invasive mold infections, i.e. galactomannan, PCR and 
1,3-β-D-glucan.6,17,18 
Cytokine  ELISpot assay  has  been  proposed as a  diagnostic tool for fungal infections.19,20 
However,  we  observed that cytokine  producers represent a rather smal and  highly  variable 
subset  within the total fungus-reactive  T cel  pool already in  healthy  donors, as wel as 
patients  with  or  without fungal infection,  questioning the significance and reliability  of 
cytokine  production as a  diagnostic  parameter. In addition, increased frequencies  of  mold-
reactive  T cels could  only  be identified  upon  normalization to the  highly  variable  T cel 
counts found in these patients, which can not easily be accomplished for ELISpot or ELISA 
data. Interestingly, the  production  of important efector cytokines, such as IFN-γ  or IL-17, 
which  have  been associated  with  protection from fungal infection,  were  not increased  but 
even rather low compared to healthy controls. This suggests that expansion of mold-reactive 
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T cels during invasive infection is not accompanied by acquisition of ful efector functions. 
In addition, only the relative frequencies but not the absolute numbers of mold-reactive CD4+ 
T cels  were increased in infected  patients (Supplemental  Figure  2).  This  may explain  why 
invasive mold infections are not efectively cleared despite the infection-related expansion of 
fungus-specific T helper cels. 
While the  galactomannan enzyme immunoassay is an accepted standard, it is restricted to 
aspergilosis.5 However, in aspergilosis, galactomannan slope has been a helpful prognostic 
marker.21 It is particularly interesting that in patients with invasive mold infection the slope of 
the specific  CD4+ lymphocyte frequencies associated  with the  burden  of fungal  disease, i.e. 
decreased after surgical resection.  These  data emphasize the  measurement  of specific  CD4+ 
lymphocyte frequencies as a reliable and  non-invasive test for  mold infections.  Since early 
treatment improves  outcome,22 another encouraging  observation is that the fungus-reactive 
T cel  detection  may  precede the clinical  diagnosis  of invasive  mold infected  patients  by 
weeks (data not shown). 
Discrimination  between causative fungal species  poses a chalenge in the  diagnosis  of 
invasive  mold infection.  Certain filamentous fungi are  dificult to  distinguish even in 
histology.23 In one individual with proven aspergilosis, Mucorales-reactive T cel frequencies 
were increased  whereas frequencies  of Aspergilus spp.-reactive  T cels  were  not.  Histology 
of lung tissue was indicative of double infection and moreover, the frequencies of Mucorales-
reactive  T cels rapidly  decreased folowing lung resection, further arguing for an infection 
with Mucorales. To characterize the species specificity of the T cel reaction, cross-reactivity 
of expanded T cel lines was analyzed. Re-stimulation revealed only limited cross-reactivity 
against  distantly related fungal  pathogens, indicating that  measurement  of fungal  T cel 
reactions alows clear discrimination between Aspergilus spp.- and Mucorales-reactive T cel 
responses.  We  observed substantial cross-reactivity  between diferent Aspergilus strains, as 
wel as  between Aspergilus spp., S. apiospermum and F. solani, indicating that 
discrimination  on the species level  may require  more  detailed analysis.  However, this 
surprisingly  high level  of T cel cross-reactivity against certain fungal species  may  have 
important implications for the design of immunotherapies or vacinations. 
The assay described here, is restricted to patients with an in vitro inducible T cel response. Of 
the  population analyzed,  16%  were  un-evaluable  because  of either  very low  T cel counts 
(a limitation  which  may  be  overcome  by larger  blood samples)  or the absence  of antigen 
presenting cels,  or a  pronounced  background  CD154 expression.  Recent treatment  with 
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alemtuzumab or purine analogues or advanced HIV infection might interfere with our test by 
depleting T cels. 
In summary, we provide a simple peripheral blood assay to analyse fungus-reactive T cels in 
healthy donors as wel as in patient groups at risk for fungal infections. Mold-reactive T cels 
are  present in al  donors at low  but conserved frequency ranges. Increased frequencies 
identified invasive  mold infection  with  high sensitivity and specificity  whereas cytokine 
production seems  not to  be significantly altered.  The slope  of increased frequencies  was 
associated  with invasive fungal  disease  burden.  The assay  has the  potential to  discriminate 
between  pathogenic fungi and to identify  mixed fungal infections to enable immediate and 
targeted antifungal treatment. 
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Figure legends 
 
Figure  1.  Fungus-reactive  T cel frequencies  among  peripheral  blood  CD4+ T cels in 
healthy volunteers. PBMCs of healthy donors were stimulated for 7 hours with the indicated 
fungal lysates and analysed for  CD154+ expression.  To  optimize the  detection and 
quantification  of  CD154+ events among  CD3+CD4+ T cels, cel aggregates (scater area 
versus scater  height),  dead cels and  non-T cel lineages (CD14+,  CD20+,  dump)  were 
excluded, and cels were counterstained for the activation marker CD69. (A) Representative 
dot plot examples with frequencies of CD154+CD69+ cels among CD4+ T lymphocytes. (B) 
Statistical analysis of several donors with horizontal lines indicating mean values (n=18). 
 
Figure  2.  Frequencies  of fungus-reactive  T cels in  patients  with invasive  mold 
infections. (A) Representative dot plot examples of two patients with increased frequencies of 
Aspergilus spp.- and Mucorales-reactive T cels, respectively. Percentages of CD4+ T cels in 
PBMC and CD154+CD69+ cels among CD4+ lymphocytes are indicated. (B) Frequencies of 
Aspergilus spp.- and Mucorales-reactive T cels in PBMCs of healthy control subjects (black 
dots;  n=100) and  high-risk  patients  without an invasive  mold infection (black  boxes;  n=24) 
and with a proven or probable invasive mold infection according to EORTC/MSG consensus 
criteria. Patients with increased reactive T cel measurements for Aspergilus spp. are depicted 
as red/orange symbols (n=6, in total 38 patients analyzed) and/or for Mucorales as dark/light 
blue symbols (n=6, in total  23  patients analyzed). (C)  An  optimized cut-of  value to 
discriminate  between  patients  with and  without invasive  mold infection  was calculated  by 
linear regression and receiver  operating characteristic (ROC) curve analysis and  normalized 
to the mean value of healthy control subjects (sensitivity 91.7%, specificity 92.3%). 
 
Figure  3.  Fungus-reactive  T cel frequencies in relation to  burden  of fungal  disease. 
Fungus-reactive T cels of two patients with increased Mucorales-reactive T cel frequencies 
were monitored over several weeks. Dashed lines represent the cut-of of 0.15% Mucorales-
reactive T cels discriminating patients with and without invasive mold infection. 
 
Figure 4.  Re-stimulation  of expanded fungus-reactive  T cel lines. Fungus-specific  T cel 
lines were generated from healthy donors and tested for specificity via antigen re-stimulation. 
(A)  Representative  dot  plot examples  of  one  donor with  percentage  of reactive cels among 
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CD4+ lymphocytes are shown. (B) Statistical analysis of several donors with horizontal lines 
indicating mean values (n=7). 
 
Figure 5. Cytokine expression of fungus-reactive CD4+ T cels. Folowing stimulation with 
fungal lysates, reactive CD154+ cels were magneticaly enriched and stained intracelular for 
cytokine expression. (A)  Representative  dot  plot examples  with  percentages  of cytokine 
producing cels among  CD154+  of  one  healthy  donor  or (B) statistical analysis  of several 
healthy  donors. (C)  Cytokine expression  of Aspergilus spp.-reactive  T cels in two  patients 
with increased Aspergilus spp-reactive  T cel frequencies and (D) statistical analysis  of 
several  patients  with  or  without fungal infection (in  part several  measurements  were 
performed from the same patient.) 
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Table 1. Classification of Invasive Mold Infection According to the 2008 EORTC/MSG Criteria, and Mold-Reactive CD4+ Lymphocyte 
Frequencies 
Patient	  Underlying	  Disease	   Host	  Risk	  Factor	  
Chest	  Computed	  
Tomography	  
Indicative	  of	  Invasive	  
Mold	  Infection	  
Galactomannan	  
Index*	   Histology	  
Fungal	  
Culture	  
Polymerase	  
chain	  reaction	  
Level	  of	  
Diagnosis	  
of	  Invasive	  
Mold	  
Infection5	  
Mold	  for	  which	  Elevated	  
T	  Cel	  Frequencies	  were	  
Detected	  
1	   Hodgkin’s	  lymphoma	   No	  known	  risk	  factor	   Yes	  
Serum	  pos.	  
BAL	  ND	  
Aspergilus	  
spp.†	   ND	   ND	   Proven	   Aspergilus	  spp.	  
2	   Acute	  myeloid	  leukemia	   Neutropenia	   Yes	  
Serum	  neg.	  
BAL	  pos.	  
Aspergillus	  
spp.†,‡	   ND	   A.	  fumigatus
‡	   Proven	   Aspergilus	  spp.	  
3	   Acute	  myeloid	  leukemia	   Neutropenia	   Yes	  
BAL	  neg.	  
Serum	  neg.	  
Aspergilus	  
spp.‡	   No	  growth
‡	   No	  fungal	  evidence‡,§	   Proven	   Mucorales	  
4	   Multiple	  myeloma	   No	  known	  risk	  factor	   Yes	  
BAL	  neg.	  
Serum	  neg.	   Mucorales	  
‡	   No	  growth†,‡,§	  
Aspergilus	  
spp.§	  
Rhizopus	  
microsporus§	  
Proven	   Mucorales	  
5	   Acute	  myeloid	  leukemia	   Neutropenia	   Yes	  
BAL	  neg.	  
Serum	  neg.	   Mucorales	  
‡	   No	  growth‡,§	   Rhizopus	  spp.‡	   Proven	   Mucorales	  
6	   Rheumatoid	  arthritis	   Glucocorticosteroids	   Yes	  
BAL	  pos.	  
Serum	  neg.	  
Aspergilus	  
spp.‡	  
A.	  fumigatus	  
complex‡	  
Fusarium	  
merismoides†	  
A.	  fumigatus	  
complex‡	  
Proven	  
Aspergilus	  spp.,	  
Mucorales	  
Scedosporium	  spp.,	  
Fusarium	  spp.	  
7	  
Acute	  
promyelocytic	  
leukemia	  
Neutropenia	   Yes	   BAL	  pos.	  Serum	  neg.	  
No	  
fungus†,§	   No	  growth
†	   Rhizopus	  spp.†	   Probable	   Mucorales	  
8	  
Chronic	  
lymphocytic	  
leukemia	  
Neutropenia	   Yes	   BAL	  pos.	  Serum	  neg.	   NA	   No	  growth
§	   No	  fungal	  evidence§	   Probable	   Mucorales	  
9	   Mantle	  cel	  lymphoma	   Neutropenia	   Yes	  
BAL	  pos.	  
Serum	  pos.	   NA	  
No	  fungal	  
growth§	   ND	   Probable	   Aspergilus	  spp.	  
10	   Non-­‐Hodgkin’s	  lymphoma	   Neutropenia	   Yes	  
BAL	  pos.	  
Serum	  neg.	   NA	  
No	  fungal	  
growth§	   ND	   Probable	   Aspergilus	  spp.	  
11	  
Acute	  
lymphoblastic	  
leukemia	  
Neutropenia	   Yes	   BAL	  pos.	  Serum	  pos.	   No	  fungus
†	   No	  growth†,§	   Aspergilus	  spp.†	   Probable	   Aspergilus	  spp.	  
12	  
Acute	  
lymphoblastic	  
leukemia	  
Neutropenia	   Yes	   BAL	  pos.	   NA	   No	  fungal	  growth§	   ND	   Probable	   None	  
13	  
Chronic	  
lymphocytic	  
leukemia	  
Neutropenia	   Yes	   BAL	  pos.	  Serum	  pos.	   NA	  
Aspergilus	  
flavus§	   ND	   Probable	  
No	  induction	  of	  CD154	  
expression	  due	  to	  nearly	  
undetectable	  numbers	  of	  
T	  cels	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14	   Aplastic	  anemia	   Neutropenia	   Yes	   BAL	  neg.	  Serum	  pos.	   No	  fungus†	   No	  growth
§	  
Aspergilus	  
spp.§	  
No	  fungus†	  
Probable	  
CD154	  background	  
expression	  too	  high	  to	  
determine	  fungi-­‐reactive	  
T	  cel	  frequencies	  
15	   Multiple	  myeloma	   Neutropenia	   Yes	  
BAL	  ND	  
Serum	  pos.	   NA	   NA	   NA	   Probable	  
CD154	  background	  
expression	  too	  high	  to	  
determine	  fungi-­‐reactive	  
T	  cel	  frequencies	  
16	   Acute	  myeloid	  leukemia	   Neutropenia	   Yes	  
BAL	  pos.	  
Serum	  neg.	   NA	   ND	   ND	   Probable	  
No	  induction	  of	  CD154	  
expression	  due	  to	  nearly	  
undetectable	  numbers	  of	  
antigen	  presenting	  cels	  
17	   Acute	  myeloid	  leukemia	   Neutropenia	   Yes	  
BAL	  neg.	  
Serum	  pos.	   NA	  
No	  fungal	  
growth§	   ND	   Possible	   None	  
18	  
Acute	  
lymphoblastic	  
leukemia	  
Neutropenia	   Yes	   BAL	  neg.	  Serum	  ND	   NA	  
No	  fungal	  
growth§	   ND	   Possible	   None	  
19	   Acute	  myeloid	  leukemia	   Neutropenia	   Yes	  
BAL	  neg.	  
Serum	  neg.	   NA	  
No	  fungal	  
growth§	   ND	   Possible	   None	  
20	  
Acute	  
lymphoblastic	  
leukemia	  
Neutropenia	   Yes	   BAL	  neg.	  Serum	  neg.	   NA	  
No	  fungal	  
growth§	   ND	   Possible	   None	  
21	   Acute	  myeloid	  leukemia	   Neutropenia	   Yes	  
BAL	  neg.	  
Serum	  neg.	   NA	  
No	  fungal	  
growth§	   ND	   Possible	  
No	  induction	  of	  CD154	  
expression	  due	  to	  nearly	  
undetectable	  numbers	  of	  
antigen	  presenting	  cels	  
22	   T	  cel	  leukemia	   Neutropenia	   No	   BAL	  ND	  Serum	  neg.	   NA	   NA	   NA	   No	   None	  
23	   Acute	  myeloid	  leukemia	   Neutropenia	   No	  
BAL	  neg.	  
Serum	  neg.	   NA	  
No	  fungal	  
growth§	   ND	   No	   None	  
24	   Acute	  myeloid	  leukemia	   Neutropenia	   No	  
BAL	  neg.	  
Serum	  neg.	   NA	   ND	   ND	   No	   None	  
25	   Acute	  myeloid	  leukemia	   Neutropenia	   No	  
BAL	  neg.	  
Serum	  neg.	   NA	  
No	  fungal	  
growth§	   ND	   No	   None	  
26	   Alogeneic	  HSCT	   Alogeneic	  HSCT	   No	   BAL	  ND	  Serum	  neg.	   NA	   NA	   NA	   No	   None	  
27	   Alogeneic	  HSCT	   Alogeneic	  HSCT	   No	   BAL	  ND	  Serum	  ND	   NA	   NA	   NA	   No	   None	  
28	   Non-­‐Hodgkin’s	  lymphoma	   None	   Yes	  
BAL	  ND	  
Serum	  neg.	   NA	   NA	   NA	   No	   None	  
29	   Acute	  T	  cel	  leukemia	   None	   ND	  
BAL	  ND	  
Serum	  ND	   NA	   NA	   NA	   No	   None	  
30	  
Acute	  
lymphoblastic	  
leukemia	  
None	   ND	   BAL	  ND	  Serum	  ND	   NA	   NA	   NA	   No	   None	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31	   Acute	  myeloid	  leukemia	   None	   ND	  
BAL	  ND	  
Serum	  ND	   NA	   NA	   NA	   No	   None	  
32	   Acute	  myeloid	  leukemia	   None	   ND	  
BAL	  ND	  
Serum	  ND	   NA	   NA	   NA	   No	   None	  
33	   Acute	  T	  cel	  leukemia	   None	   ND	  
BAL	  ND	  
Serum	  ND	   NA	   NA	   NA	   No	   None	  
34	  
Acute	  
lymphoblastic	  
leukemia	  
None	   ND	   BAL	  ND	  Serum	  ND	   NA	   NA	   NA	   No	   None	  
35	   Acute	  myeloid	  leukemia	   None	   ND	  
BAL	  ND	  
Serum	  ND	   NA	   NA	   NA	   No	   None	  
36	  
Acute	  
lymphoblastic	  
leukemia	  
None	   ND	   BAL	  ND	  Serum	  ND	   NA	   NA	   NA	   No	   None	  
37	  
Acute	  
lymphoblastic	  
leukemia	  
None	   ND	   BAL	  ND	  Serum	  ND	   NA	   NA	   NA	   No	   None	  
38	   Hodgkin	  lymphoma	   None	   No	  
BAL	  neg.	  
Serum	  neg.	   NA	  
No	  fungal	  
growth§	   ND	   No	   None	  
39	   Alogeneic	  HSCT	   Alogeneic	  HSCT	   No	   BAL	  neg.	  Serum	  ND	   NA	  
No	  fungal	  
growth§	   ND	   No	   None	  
40	   CUP-­‐syndrome	   None	   No	   BAL	  neg.	  Serum	  neg.	   NA	  
No	  fungal	  
growth§	   ND	   No	   None	  
41	   Acute	  myeloid	  leukemia	   None	   No	  
BAL	  ND	  
Serum	  ND	   NA	   NA	   NA	   No	   None	  
42	   Acute	  myeloid	  leukemia	   Neutropenia	   No	  
BAL	  neg.	  
Serum	  neg.	   NA	  
No	  fungal	  
growth§	   ND	   No	   Aspergilus	  spp.	  
43	   Acute	  myeloid	  leukemia	   None	   Yes	  
BAL	  neg.	  
Serum	  neg.	   NA	  
No	  fungal	  
growth§	  
Aspergilus	  
spp.§	   No	  
Mucorales	  
Scedosporium	  spp.	  
44	   Non-­‐Hodgkin’s	  lymphoma	   None	   No	  
BAL	  neg.	  
Serum	  ND	   NA	  
No	  fungal	  
growth§	   ND	   No	  
No	  induction	  of	  CD154	  
expression	  due	  to	  nearly	  
undetectable	  numbers	  of	  T	  
cels	  
45	   Hodgkin’s	  lymphoma	   None	  	   No	  
BAL	  neg.	  
Serum	  neg.	   NA	  
No	  fungal	  
growth§	   ND	   No	  
No	  induction	  of	  CD154	  
expression	  due	  to	  nearly	  
undetectable	  numbers	  of	  T	  
cels	  
*	  Cut-­‐of	  to	  positivity	  ≥	  0.5	  in	  two	  consecutive	  serum	  samples,	  OR	  ≥	  0.5	  in	  one	  BAL	  sample;	  	  
†	  Lung	  biopsy;	  	  
‡	  Lung	  resection;	  	  
§	  Bronchoalveolar	  lavage	  fluid;	  	  
	  Only	  8	  days	  of	  neutropenia;	  	  
BAL,	  bronchoalveolar	  lavage;	  ND,	  not	  done;	  NA,	  not	  applicable;	  HSCT,	  hematopoietic	  stem	  cel	  transplantation;	  CUP,	  cancer	  of	  unknown	  primary.	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Figure 2 
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Figure 3 
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Figure 4 
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Figure 5 
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Table S1. Classification of Invasive Mold Infection According to the 2008 EORTC/MSG Criteria, Histological Evidence and Quantification 
of Mold-Reactive CD4+ Lymphocyte Frequencies 
 
Histology	   T	  cel	  Frequency	  
Patient	   Underlying	  Disease	   Date	  of	  Sampling	  
Sample	  
Type	   Result	  
Level	  of	  
Diagnosis	  of	  
Invasive	  
Mold	  
Infection5	  
Date	  of	  
Blood	  
Sampling	  
WBC	  
Count	  
[x1E9/l]*	  
Lymphocyte	  
Count	  
[x1E9/l]*	  
CD4+	  
[%]	  in	  
PBMC	  
Aspergilus	  
spp.	   Mucorales	  
Scedoporium	  
spp.	  
Fusarium	  
spp.	  
1	   Hodgkin’s	  lymphoma	   08.11.10	  
Lung	  
biopsy	  
Aspergilus	  
spp.	   Proven	   08.16.10	   4.29	   0.39	   1.44	   1.58	   -­‐†	   -­‐†	   -­‐†	  
07.27.10	   17.65	   1.89	   15.58	   0.71	   -­‐†	   -­‐†	   -­‐†	  
08.04.10	   8.08	   1.39	   23.34	   0.38	   -­‐†	   -­‐†	   -­‐†	  07.16.10	   Lung	  biopsy	  
Aspergilus	  
spp.	   08.11.10	   4.98	   1.09	   38.34	   0.18	   -­‐†	   -­‐†	   -­‐†	  
08.23.10	   0.22	   1.12	   39.10	   0.12	   -­‐†	   -­‐†	   -­‐†	  
08.30.10	   3.66	   1.32	   24.50	   0.70	   -­‐†	   -­‐†	   -­‐†	  
2	   Acute	  myeloid	  leukemia	  
10.13.10	   Lung	  resection	  
Aspergilus	  
spp.	  
Proven	  
09.09.10	   3.36	   1.02	   24.50	   0.37	   -­‐†	   -­‐†	   -­‐†	  
05.17.11	   3.31	   0.92	   3.80	   0.05	   -­‐†	   -­‐†	   -­‐†	  
05.23.11	   4.72	   0.86	   4.80	   0.26	   0.18	   0.01	   -­‐†	  
05.31.11	   3.43	   ND	   10.50	   0.11	   0.04	   0.01	   -­‐†	  3	  
Acute	  myeloid	  
leukemia	   05.27.11	  
Lung	  
resection	  
Aspergilus	  
spp.,	  
suspected	  
Mucorales	  
Proven	  
06.28.11	   0.16	   0.02	   2.96	   0.03	   0.03	   -­‐‡	   -­‐‡	  
08.08.11	   Lung	  biopsy	  
No	  fungal	  
evidence	   08.11.11	   8.95	   0.81	   16.50	   0.12	   0.39	   0.06	   0	  
08.26.11	   Lung	  biopsy	  
No	  fungal	  
evidence	   08.18.11	   ND	   ND	   7.23	   0.11	   0.43	   0.04	   0.04	  4	  
Multiple	  
myeloma	  
09.21.11	   Lung	  resection	   Mucorales	  
Proven	  
08.26.11	   5.17	   0.41	   9.24	   0.24	   0.54	   0.13	   0.12	  
08.30.11	   6.62	   0.35	   4.33	   0.32	   0.35	   0.1	   0.12	  
09.20.11	   6.48	   1.00	   2.44	   0.25	   0.33	   0.12	   0.13	  
10.12.11	   1.71	   1.28	   11.91	   0.30	   0.09	   0.08	   0.07	  5	  
Acute	  myeloid	  
leukemia	   09.29.11	  
Lung	  
resection	   Mucorales	   Proven	  
10.19.11	   1.32	   0.84	   10.90	   0.25	   0.09	   0.06	   0.08	  
02.21.12	   Lung	  biopsy	  
Interstitial	  
lung	  disease	   02.09.12	   2.72	   0.38	   31.47	   0.06	   0.05	   0.04	   0.02	  6	   Rheumatoid	  arthritis	   03.13.12	   Lung	  resection	  
Aspergilus	  
spp.	  
Proven	  
03.15.12	   18.15	   0.65	   1.38	   0.48	   0.49	   0.52	   0.57	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01.12.12	   0.43	   ND	   45.68	   0.04	   0.04	   0.04	   0.09	  
01.17.12	   0.32	   0.27	   29.51	   0.04	   0.02	   0.02	   0.02	  
02.07.12	   0.96	   0.12	   4.30	   0.05	   0.04	   0.03	   0.04	  
02.28.12	   10.50	   1.30	   2.55	   0.23	   1.29	   0.08	   0.05	  
04.05.12	   9.69	   2.61	   9.08	   0.23	   0.61	   0.06	   0.09	  
04.19.12	   10.00	   2.18	   7.35	   0.15	   0.2	   0.04	   0.05	  
7	  
Acute	  
promyelocytic	  
leukemia	  
02.17.12	   Lung	  biopsy	  
No	  fungal	  
evidence	   Probable	  
04.24.12	   4.21	   1.43	   6.56	   0.13	   0.12	   0.03	   0.09	  
02.08.11	   19.91	   ANP	   0.35	   0.10	   0.03	   0.06	   -­‐†	  8	  
Chronic	  
lymphocytic	  
leukemia	  
ND	   NA	   NA	   Probable	   02.16.11	   4.64	   4.35	   0.86	   0.30	   0.38	   0.06	   -­‐†	  
05.17.11	   12.37	   0.19	   1.26	   1.03	   -­‐†	   -­‐†	   -­‐†	  
05.23.11	   15.45	   1.44	   0.32	   4.05	   -­‐†	   -­‐†	   -­‐†	  
05.31.11	   7.71	   0.77	   5.31	   2.60	   -­‐†	   -­‐†	   -­‐†	  9	  
Mantle	  cel	  
lymphoma	   ND	   NA	   NA	   Probable	  
06.06.11	   10.09	   ND	   2.76	   3.44	   -­‐†	   -­‐†	   -­‐†	  
01.13.12	   10.73	   0.73	   1.87	   4.32	   0.09	   0.06	   0.06	  
01.18.12	   7.49	   0.32	   7.61	   0.02	   0.08	   0.05	   0.02	  10	   Non-­‐Hodgkin’s	  lymphoma	   ND	   NA	   NA	   Probable	   01.24.12	   2.47	   0.65	   1.55	   0.17	   0.01	   0.03	   0.06	  
06.14.12	   0.25	   0.21	   16.4	   0.44	   0.03	   -­‐‡	   -­‐‡	  
07.10.12	   61.97	   1.24	   2.28	   1.36	   0.12	   0.08	   0.05	  11	  
Acute	  
lymphoblastic	  
leukemia	  
06.28.12	   Lung	  biopsy	  
No	  fungal	  
evidence	   Probable	   08.09.12	   0.05	   ANP	   7.18	   1.29	   0.04	   0.02	   0.03	  
09.09.11	   1.66	   0.70	   36.71	   0.03	   0	   0.04	   0.01	  12	  
Acute	  
lymphoblastic	  
leukemia	  
ND	   NA	   NA	   Probable	   09.20.11	   2.18	   0.85	   12.96	   0.10	   0.04	   0.04	   0.03	  
13	  
Chronic	  
lymphocytic	  
leukemia	  
ND	   NA	   NA	   Probable	   08.23.10	   4.83	   0.04	   0.07	   No	  induction	  of	  CD154	  expression	  due	  to	  nearly	  undetectable	  numbers	  of	  T	  cels	  
07.12.11	   0.53	   0.52	   48.51	   CD154	  background	  expression	  too	  high	  to	  determine	  fungi-­‐reactive	  T	  cel	  frequencies	  14	   Aplastic	  anemia	   08.04.11	  
Lung	  
biopsy	  
No	  fungal	  
evidence	   Probable	   07.22.11	   0.79	   0.74	   45.58	   CD154	  background	  expression	  too	  high	  to	  determine	  fungi-­‐reactive	  T	  cel	  frequencies	  
07.07.11	   1.16	   0.34	   1.21	   CD154	  background	  expression	  too	  high	  to	  determine	  fungi-­‐reactive	  T	  cel	  frequencies	  15	   Multiple	  myeloma	   ND	   NA	   NA	   Probable	   07.12.11	   0.06	   ANP	   1.32	   CD154	  background	  expression	  too	  high	  to	  determine	  fungi-­‐reactive	  T	  cel	  frequencies	  
16	   Acute	  myeloid	  leukemia	   ND	   NA	   NA	   Probable	   05.12.11	   0.49	   0.44	   32.18	  
No	  induction	  of	  CD154	  expression	  due	  to	  nearly	  
undetectable	  numbers	  of	  antigen	  presenting	  cels	  
06.30.11	   0.59	   0.35	   63.57	   0.08	   0	   0	   -­‐†	  17	   Acute	  myeloid	  
leukemia	  
ND	   NA	   NA	   Possible	  
07.07.11	   5.95	   0.99	   24.35	   0.08	   0	   0.01	   -­‐†	  
30 
 
	   	   	   	   	   	   07.12.11	   9.58	   0.79	   9.98	   0.21	   0.02	   0.02	   -­‐†	  
18	  
Acute	  
lymphoblastic	  
leukemia	  
ND	   NA	   NA	   Possible	   08.18.11	   3.40	   0.34	   17.41	   0.16	   0.02	   0.02	   0.02	  
19	   Acute	  myeloid	  leukemia	   ND	   NA	   NA	   Possible	   11.17.11	   1.11	   0.19	   2.23	   0.09	   0.05	   0	   0.07	  
11.09.11	   8.61	   0.26	   12.38	   0.16	   0.06	   0	   0	  20	  
Acute	  
lymphoblastic	  
leukemia	  
ND	   NA	   NA	   Possible	   11.18.11	   8.10	   0.79	   4.12	   0.06	   0.04	   0.04	   0.02	  
09.09.11	   0.08	   ANP	   18.87	   No	  induction	  of	  CD154	  expression	  due	  to	  nearly	  undetectable	  numbers	  of	  antigen	  presenting	  cels	  21	   Acute	  myeloid	  leukemia	   ND	   NA	   NA	   Possible	   09.20.11	   0.17	   0.15	   26.6	   No	  induction	  of	  CD154	  expression	  due	  to	  nearly	  undetectable	  numbers	  of	  antigen	  presenting	  cels	  
22	   T	  cel	  leukemia	   ND	   NA	   NA	   no	   01.12.11	   0.49	   0.47	   81.21	   0.05	   -­‐†	   -­‐†	   -­‐†	  
01.13.11	   5.13	   0.31	   4.98	   0.06	   -­‐†	   -­‐†	   -­‐†	  
06.01.11	   <0.05	   ANP	   5.12	   No	  induction	  of	  CD154	  expression	  due	  to	  nearly	  undetectable	  numbers	  of	  antigen	  presenting	  cels	  23	  
Acute	  myeloid	  
leukemia	   ND	   NA	   NA	   no	  
06.16.11	   2.35	   0.66	   2.09	   0.19	   0.02	   0	   -­‐†	  
24	   Acute	  myeloid	  leukemia	   ND	   NA	   NA	   no	   06.01.11	   0.08	   ANP	   11.35	   0.05	   -­‐‡	   -­‐‡	   -­‐‡	  
07.19.11	   2.40	   1.42	   11.14	   0.06	   0	   0	   -­‐†	  25	   Acute	  myeloid	  leukemia	   ND	   NA	   NA	   no	   08.18.11	   0.51	   0.29	   29.04	   0.07	   0.02	   0.02	   0.04	  
26	   Alogeneic	  HSCT	   ND	   NA	   NA	   no	   08.18.11	   0.84	   0.67	   21.03	   0.05	   0.03	   0.04	   0.01	  
27	   Alogeneic	  HSCT	   ND	   NA	   NA	   no	   08.18.11	   9.33	   1.33	   20.44	   0.08	   0.01	   0.01	   0.08	  
28	   Non-­‐Hodgkin’s	  lymphoma	   ND	   NA	   NA	   no	   09.20.11	   9.33	   2.11	   3.13	   0.04	   0.01	   0.02	   0.02	  
29	   Acute	  T	  cel	  leukemia	   ND	   NA	   NA	   no	   01.12.11	   6.19	   0.46	   3.75	   0.09	   -­‐†	   -­‐†	   -­‐†	  
01.12.11	   2.11	   0.48	   13.38	   0.09	   -­‐†	   -­‐†	   -­‐†	  30	  
Acute	  
lymphoblastic	  
leukemia	  
ND	   NA	   NA	   no	   03.31.11	   6.52	   0.43	   5.09	   0.17	   -­‐†	   -­‐†	   -­‐†	  
31	   Acute	  myeloid	  leukemia	   ND	   NA	   NA	   no	   01.18.11	   4.00	   0.54	   1.82	   0.10	   -­‐†	   -­‐†	   -­‐†	  
32	   Acute	  myeloid	  leukemia	   ND	   NA	   NA	   no	   01.27.11	   2.66	   0.91	   5.51	   0.06	   -­‐†	   -­‐†	   -­‐†	  
33	   T	  cel	  leukemia	   ND	   NA	   NA	   no	   02.01.11	   4.36	   0.43	   14.28	   0.09	   -­‐†	   -­‐†	   -­‐†	  
31 
 
	   	   	   	   	   	   03.22.11	   2.80	   0.65	   11.00	   0.23	   -­‐†	   -­‐†	   -­‐†	  
34	  
Acute	  
lymphoblastic	  
leukemia	  
ND	   NA	   NA	   no	   02.08.11	   1.16	   0.22	   17.13	   0.04	   -­‐†	   -­‐†	   -­‐†	  
35	   Acute	  myeloid	  leukemia	   ND	   NA	   NA	   no	   02.08.11	   3.11	   0.84	   17.01	   0.08	   -­‐†	   -­‐†	   -­‐†	  
36	  
Acute	  
lymphoblastic	  
leukemia	  
ND	   NA	   NA	   no	   03.31.11	   3.03	   0.56	   13.65	   0.08	   -­‐†	   -­‐†	   -­‐†	  
37	  
Acute	  
lymphoblastic	  
leukemia	  
ND	   NA	   NA	   no	   04.05.11	   4.51	   0.77	   7.38	   0.09	   -­‐†	   -­‐†	   -­‐†	  
38	   Hodgkin’s	  lymphoma	   ND	   NA	   NA	   no	   07.19.11	   4.27	   0.10	   0.16	   0.06	   0.02	   0.06	   -­‐†	  
39	   Alogeneic	  HSCT	   ND	   NA	   NA	   no	   07.26.11	   8.44	   2.20	   25.33	   0.22	   0.04	   0.05	   0.02	  
40	   CUP	  syndrome	   ND	   NA	   NA	   no	   09.06.11	   5.09	   0.70	   8.43	   0.07	   0.01	   0.03	   0	  
09.09.11	   4.94	   0.54	   1.93	   0.10	   0.13	   0	   0.03	  41	   Acute	  myeloid	  leukemia	   ND	   NA	   NA	   no	   09.20.11	   3.61	   0.21	   5.89	   0.09	   0.14	   0.05	   0.02	  
01.25.11	   8.40	   0.84	   10.52	   0.65	   -­‐†	   -­‐†	   -­‐†	  
02.25.11	   7.67	   1.56	   9.14	   0.28	   -­‐†	   -­‐†	   -­‐†	  42	   Acute	  myeloid	  leukemia	   ND	   NA	   NA	   no	   03.22.11	   9.52	   1.20	   9.11	   0.31	   -­‐†	   -­‐†	   -­‐†	  
08.26.11	   2.93	   1.37	   11.10	   0.21	   0.38	   0.28	   0.06	  43	   Acute	  myeloid	  leukemia	   ND	   NA	   NA	   no	   08.30.11	   2.18	   0.88	   12.91	   0.22	   0.36	   0.16	   0.03	  
44	   Non-­‐Hodgkin’s	  lymphoma	   ND	   NA	   NA	   no	   09.06.11	   0.06	   ANP	   0.09	  
No	  induction	  of	  CD154	  expression	  due	  to	  nearly	  
undetectable	  numbers	  of	  T	  cels	  
45	   Hodgkin’s	  lymphoma	   ND	   NA	   NA	   no	   08.30.11	   1.22	   0.02	   0.15	  
No	  induction	  of	  CD154	  expression	  due	  to	  nearly	  
undetectable	  numbers	  of	  T	  cels	  
*	  Time	  frame	  -­‐1	  day,	  if	  not	  performed	  on	  the	  day	  of	  blood	  sampling;	  
†	  Specific	  fungal	  lysate	  was	  not	  yet	  available	  at	  the	  time	  of	  blood	  sampling;	  
‡	  Cel	  count	  too	  low	  to	  test	  against	  al	  fungal	  lysates;	  
WBC,	  white	  blood	  cel;	  PBMC,	  peripheral	  blood	  mononuclear	  cels;	  ND,	  not	  done;	  NA,	  not	  applicable,	  ANP,	  analysis	  not	  possible;	  HSCT,	  hematopoietic	  stem	  cel	  transplantation;	  CUP,	  cancer	  of	  
unknown	  primary.	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Table S2. Contingency table of al analyzed patient cases with evaluable T cel 
responses* 
 
Fungus-specific T cel frequencies Diagnosis of 
pulmonary invasive 
mold infection 
according to 
EORTC/MSG 
consensus 
Increased Not increased 
Total patient 
number 
Proven 6 0 6 
Probable 5 1 6 
Possible 0 4 4 
No fungal infection 2 20 22 
Total 13 25 38 
 
P=0.0000007, odds ratio (95 %) =132 (10.79 – 1615.08); sensitivity =0.92 (0.597 – 0.996), 
specificity =0.92 (0.734 – 0.987); *, patients with low antigen presenting cel or T cel counts 
and undeterminable fungus-reactive T cel frequencies were excluded. 
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Table S3. Contingency table of al analyzed patients 
 
Fungus-specific T cel frequencies Diagnosis of 
pulmonary invasive 
mold infection 
according to 
EORTC/MSG 
consensus 
Increased Not increased 
Total patient 
number 
Proven 6 0 6 
Probable 5 5 10 
Possible 0 5 5 
No fungal infection 2 22 24 
Total 13 32 45 
 
P=0.00003, odds ratio (95 %) =29.7 (4.99 – 176.72); sensitivity =0.69 (0.41 – 0.88), 
specificity =0.93 (0.76 – 0.99). 
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Table S4. Contingency table of patients with evaluable T cel responses*, except possible 
cases 
 
Fungus-specific T cel frequencies Diagnosis of 
pulmonary invasive 
mold infection 
according to 
EORTC/ MSG 
consensus 
Increased Not increased 
Total patient 
number 
Proven 6 0 6 
Probable 5 1 6 
No fungal infection 2 20 22 
Total 13 21 34 
 
P=0.000003, odds ratio (95 %) =110 (8.93 – 1354.51); sensitivity =0.92 (0.598 – 0.996), 
specificity =0.91 (0.69 – 0.98); *, patients with low antigen presenting cel or T cel counts 
and undeterminable fungus-reactive T cel frequencies were excluded. 
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Figure S1 
 
 
Aspergilus spp. =    Aspergilus fumigatus, Aspergilus niger, 
    Aspergilus nidulans, Aspergilus tereus 
Mucorales =    Rhizopus oryzae, Lichtheimia corymbifera
Scedosporium spp. =  Scedosporium apiospermum, 
    Scedosporium prolificans
Fusarium spp. =    Fusarium oxysporum, Fusarium solani, 
    Fusarium verticilioides  
 
 
 
Figure S1.  Frequencies  of  T cels from  healthy  donors  after stimulation  with  pooled 
fungal lysates. Statistical analyses with horizontal lines indicate mean values (n=21). 
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Figure S2 
 
 
MucoralesAspergilus spp. BA
 
 
 
 
Figure  S2.  Absolute  numbers  of fungus-reactive  CD4+  T cels in  peripheral  blood. The 
absolute numbers of Aspergilus spp.- and Mucorales-reactive T cels were calculated based 
on the frequencies of mold-reactive CD154+ T cels within CD4+ lymphocytes and the CD4+ 
lymphocyte count per mL of peripheral blood in high-risk patients without an invasive mold 
infection (black  boxes;  n=24) and  with a  proven  or  probable invasive  mold infection 
according to  EORTC/MSG consensus criteria.  Patients  with increased reactive  T cel 
measurements for Aspergilus spp. are  depicted as red/orange symbols (n=6, in total  38 
patients analyzed) and/or for Mucorales as dark/light blue symbols (n=6, in total 23 patients 
analyzed). The range of healthy donors is marked in grey. 
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Abstract 
CD4+  T cels  orchestrate immune responses against fungi such as Aspergilus fumigatus, a 
major fungal  pathogen in  humans.  The complexity  of the fungal  genome and lifestyle 
questions the existence  of  one  or a few immune dominant antigens and also complicates 
rational screening for immunogenic antigens useful for immunotherapy or diagnostics. Here 
we used a recently developed flow-cytometric assay for the direct ex vivo characterization of 
A. fumigatus-specific  CD4+  T cels for rapid identification  of  physiological  T cel targets in 
healthy  donors.  We show that the  T cel response is  mainly  directed against  metabolicaly 
active A. fumigatus  morphotypes and stronger against  membrane  protein fractions as 
compared to cel  wal  or cytosolic  proteins.  The further analysis  of  15 selected single 
A. fumigatus proteins revealed a highly diverse donor- as wel as protein-dependent reactivity 
patern. Importantly, the  paralel assessment  of  T cel frequency,  phenotype and function 
alowed to  diferentiate  between  proteins eliciting strong  memory  T cel responses in vivo 
versus antigens that rather induce  T cel exhaustion  or  no reactivity in vivo.  The regulatory 
T cel (Treg) response mirors the conventional T cel (Tcon) response in terms of numbers 
and target specificity. Thus our data reveal that the fungal T cel immunome is complex but 
the ex vivo characterization  of reactive  T cels alows to classify antigens and to  predict 
potential immunogenic targets.  Tcon responses are counterbalanced  by a strong  Treg 
response, suggesting that  Treg  depletion strategies  may  be  helpful to improve anti-fungal 
immunity. 
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Introduction 
Aspergilus fumigatus is a ubiquitous spore-producing mold that can cause a diverse spectrum 
of  human  diseases, ranging from alergic  hypersensitivity and  non-invasive colonization to 
life-threatening invasive infections. Invasive aspergilosis (IA) is the most devastating disease 
caused  by this fungus in immunocompromised  patients.  Despite  new anti-fungal  drugs, 
morbidity and mortality continue to be unacceptable high and IA has become a major cause of 
infection-related mortality in hematopoietic stem cel recipients (1, 2). 
Although we routinely inhale several hundreds or thousands of A. fumigatus conidia per day 
(3, 4), immune-competent individuals are eficiently protected by innate and adaptive immune 
mechanisms (5,  6).  Lung-resident alveolar  macrophages and  neutrophils ingest and  kil 
A. fumigatus conidia and  germlings and recruit  other immune cels  by secretion  of  pro-
inflammatory cytokines (7).  There is increasing evidence that  CD4+  T cels  orchestrate the 
anti-fungal immune response. In  mouse  models,  monocytes and  dendritic cels  have  been 
shown to prime A. fumigatus-specific CD4+ T cel responses that migrate to the airways (8-
10). Adoptive transfer of A. fumigatus-specific IFN-γ producing T cels protected mice from 
invasive fungal  disease (11) and corelated  with survival  of IA  patients (12). In accordance 
with the idea that humans are constantly confronted with fungal antigens we recently showed 
that a smal  population  of A. fumigatus-specific  T cels is indeed consistently  present in 
healthy  donors (13). In IA  patients, the frequencies  of A. fumigatus-reactive  T cels are 
strongly increased (unpublished  observation) indicating the involvement  of specific  CD4+ 
T cels in antifungal immune defense. 
Therefore, approaches supporting fungus-specific  CD4+  T cels in immuno-compromised 
persons, e.g.  by  vaccination  or adoptive  T cel transfer (14-17) seem to  be  promising for 
preemptive or therapeutic intervention against invasive fungal infections. However, in order 
to develop eficient immunotherapies, a crucial first step is to define the antigen specificity of 
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human  CD4+ T cels in vivo.  Due to the complexity  of the A. fumigatus  proteome it is 
curently  not  known against  which fungal antigens  human  T cels  predominantly react and 
which T cel specificities are protective. In addition it is not clear, whether regulatory T cels 
(Treg), which represent the major part of the human T cel response against A. fumigatus (18) 
recognize the same or diferent antigens, as their conventional T cel (Tcon) counterparts. The 
A. fumigatus  genome contains several thousand  open reading frames, encoding  potential 
antigenic proteins. The initialy inhaled resting conidia convert into swolen conidia within 4-
5 hours upon arival in the lungs and further germinate to form germ tubes and later hyphae 
(19). Proteomic approaches have revealed diferences of the most abundant proteins present 
in conidia and hyphae (20-22). Therefore, further variability of potential T cel antigens may 
result from the morphogenic status of the fungus at the time point of confrontation with the 
immune system, which might significantly impact the generation of a specific T cel response. 
Thus, the identification  of the  main in vivo  T cel targets, i.e.  proteins  derived from the 
diferent  morphogenic stages and subcelular structures, as  wel as  knowledge about their 
Tcon  or  Treg activating  potential,  would  have important implications  on  vaccination  or 
adoptive cel therapy strategies. 
We  have recently  described a  highly specific and sensitive assay to enumerate and 
characterize antigen-specific CD4+ T cels directly ex vivo based on CD154+ pre-enrichment 
(Antigen-Reactive T cel Enrichment, ARTE) (13, 23). Here we used ARTE to systematicaly 
quantify and characterize the very rare human peripheral CD4+ T cels reacting against crude 
lysates  of A. fumigatus, as  wel as selected  proteins  or  protein fractions.  We found that the 
T cel response against A. fumigatus is  highly  diverse,  questioning the existence  of  one  or a 
few immunodominant A. fumigatus antigens.  However,  we identified  quantitative and 
qualitative  diferences  within the single  protein-specific  T cel  populations,  which  may 
provide a  general screening  procedure to classify fungal antigens and identify  potentialy 
immunogenic in vivo targets. 
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Materials and Methods 
Blood donors 
Bufy coats from healthy donors were obtained from the Institute for Transfusion Medicine, 
University  Hospital  Dortmund after informed consent.  Peripheral  blood  mononuclear cels 
(PBMCs)  were isolated  by  Ficol-Paque (GE  Healthcare  Life  Sciences,  Freiburg,  Germany) 
density gradient centrifugation. 
 
Preparation of A. fumigatus lysates 
For the  generation  of al A. fumigatus (strain  ATCC46645)  protein extracts, except for the 
lysate  of resting conidia (RC),  2x108 conidia  were inoculated in  200  ml  YPD  medium and 
cultured at  37 °C and  200 rpm.  Swolen conidia (SC)  were  harvested after  6  h,  germinated 
conidia (GC) after  8  h, and  mycelium after  20  h  of cultivation.  Cels  were recovered  by 
centrifugation (RC, SC, GC) or filtration (mycelium) and washed with water before storage at 
-80 °C. Total RC, SC or GC lysates were generated by disruption of frozen cels in saline [0.9 
% (w/v)  NaCl]  using a  Micro-Dismembrator (Sartorius).  For total  mycelial lysate, frozen 
mycelium  was  ground in liquid  nitrogen  by  using a  mortar and  pestle and resuspendend in 
PBS supplemented  with  2  mM  MgCl2.  Total soluble  protein fractions  of the lysates (crude 
lysates) were obtained after removal of insoluble material (cel wal pelet) by centrifugation 
for 15 min at 10,000 × g. Fractionated mycelial protein extracts were obtained by sequential 
centrifugation  of total  mycelial lysate.  The cel  wal  protein fraction  was  processed  by 
resuspension  of the cel  wal  pelet (15  min  of centrifugation at  10,000 ×g) in  PBS/2  mM 
MgCl2.  By centrifugation  of the crude  mycelial lysate at  100,000 ×  g for  60  min, the cel 
membrane-enriched protein fraction (pelet) was separated from the cytosolic protein fraction. 
Cel membrane extract was generated by resuspension of the membrane pelet in PBS/2 mM 
MgCl2. 
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Extracts enriched in GPI-anchored proteins and membrane fractions depleted in GPI-anchored 
proteins were generated as described in (24). Briefly, total mycelial lysate was generated by 
resuspension in 200 mM Tris-HCl pH 8, 50 mM EDTA, 1 mM PMSF. The membrane pelet 
was obtained by centrifugation steps as described above and resuspended in 50 mM Tris-HCl 
pH 8.5, 5 mM EDTA, 0.5 mM PMSF, 1 mM DTT. After freezing at –80 °C, the membrane 
extract  was thawed  on ice, supplemented  with  1% (w/v)  ß-n-octylglucopyranoside and 
incubated for 1 h at room temperature. Folowing centrifugation (100,000 × g, 60 min, 4 °C), 
the supernatant  was taken (protein-fraction enriched in  GPI-anchored  proteins).  The  pelet 
was resuspended in 25 mM Na-phosphate bufer (pH 7) and used as GPI-depleted membrane 
protein extract. 
 
Generation of recombinant A. fumigatus proteins 
The recombinant  Crf2 (AFUA_1G16190)  protein  was  generated as  described in (25).  The 
recombinant  GliT  protein (AFUA_6G09740)  was  produced in E. coli and  purified as 
described in (26).  The  open reading frames  of the  genes scw4 (AFUA_6G12380), aspf3 
(AFUA_6G02280), shm2 (AFUA_3G09320), cpcB (AFUA_4G13170) and aspf22 
(AFUA_6G06770) were amplified from ATCC46645 cDNA and cloned into the expression 
vector  pET43.1H6 for recombinant expression as  HIS-tagged  proteins.  For pst1 
(AFUA_6G10290), a truncated  version  was  generated  by  omiting the sequence,  which 
encodes the first 17 amino acids of the N-terminal secretion signal peptide. The truncated pst1 
cDNA and the ORF of triosephosphate isomerase TpiA (AFUA_5G13450) were cloned into a 
pMalC2HTEV  vector (27) for recombinant  production as  N-terminal  MBP-HIS-tagged 
proteins.  After transformation  of E. coli  BL21(DE3), al  proteins  were expressed  by auto-
induction in Overnight Express Instant TB medium (Novagen) at 30 °C for 24 hours. E. coli 
cels were harvested by centrifugation, homogenized in TBS (20 mM Tris-HCl pH 8, 150 mM 
NaCl,  1  mM  DTT,  1  mM  PMSF) [Pst1,  TpiA,  AspF3],  TBS complemented  with  8  M  urea 
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[Scw4], TBS complemented with 10 % (v/v) glycerol [AspF22], or phosphate bufer (50 mM 
Na-P  pH  8,  300  mM  NaCl,  1  mM  DTT,  1  mM  PMSF) [Shm2,  CpcB] and lysed  using an 
emulsiFlex-C5  high  pressure  homogenizer (Avestin).  The coding sequence  of the  FG-GAP 
repeat protein (AGUA_1G04130), which was devoid of the sequence encoding the 25 amino 
acids  N-terminal secretion signal  peptide (∆25FG-GAP) and the  ORF  of  AspF2 
(AFUA_4G09580),  were amplified and cloned into the expression  vector  pPICZαB.  After 
transformation into Pichia pastoris (X33), culturing of cels and induction of expression was 
conducted according to the  Pichia  Expression  Kit  manual (life technologies,  Darmstadt, 
Germany).  Culture supernatants, containing the secreted  HIS-tagged recombinant  proteins, 
were colected after 48 h of expression and diluted (1/5) into binding bufer (10 mM Na-P pH 
7.4, 500 mM NaCl, 10 mM imidazole). 
Al  proteins  were  purified  by afinity chromatography  using an  Äkta explorer  purification 
system (GE  Healthcare). If  necessary, an ion exchange column (SOURCE  15Q,  GE 
Healthcare) was used for further purification. Generaly, al bufer exchanges were conducted 
using HiPrep 26/10 desalting columns (GE Healthcare). Al HIS-tagged proteins were applied 
to a Ni Sepharose 6 Fast Flow (GE Healthcare) column, and eluted with 250 mM imidazole. 
MPP-tagged proteins were loaded onto an Amylose Resin HF (New England Biolabs) column 
and eluted with 10 mM maltose. The MBP-HIS-tag of MBP-tagged proteins and the HIS-tag 
of  AspF3  were cleaved  using  TEV-protease and removed  by its  binding to  Ni  Sepharose. 
After bufer exchange to 20 mM Tris-HCl pH 8 (CpcB, Pst1, TpiA) or 20 mM Tris-HCl pH 
8.5,  6  M  urea (Scw4), coresponding  proteins  were further  purified  by ion exchange 
chromatography  using an  NaCl  gradient for elution.  Scw4  was further  purified  by reversed 
phase chromatopraphy (Source 15RPC, GE Healthcare) after exchanging the bufer to 0.05% 
(v/v) trifluoroacetic acid, 10 % (v/v) acetonitril. Purified Scw4 was lyophilized and resolved 
in  PBS.  For al  other  purified  proteins, the  bufer  was exchanged to  PBS (FG-GAP,  Pst1, 
AspF22, AspF2, GliT) or 0.9 % (w/v) NaCl (Shm2, CpcB, AspF3, TpiA). 
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Stimulation of antigen-reactive T cels 
PBMCs  were resuspended at a concentration  of  1×107/ml in  RPMI-1640 (Miltenyi  Biotec, 
Bergisch  Gladbach,  Germany), supplemented  with  5 % (v/v)  human  AB-serum 
(BioWhitaker/Lonza, Walkersvile, MD, USA), and 2 mM L-glutamine (PAA Laboratories, 
Pasching,  Austria).  Cels  were stimulated for  7  hours  with the folowing antigens: 
A. fumigatus lysates (each  40 µg/ml), C. albicans-lysate (20 µg/ml;  Greer  Laboratories, 
Lenoir,  NC,  USA),  CMV-lysate (10 µg/ml,  Siemens  Healthcare  Diagnostics,  Marburg, 
Germany), recombinant A. fumigatus  proteins (Crf2,  Pst1,  Aspf2,  Aspf3,  Shm2,  FG-GAP, 
GliT, Aspf22, CpcB, TpiA, Scw4; each 20 µg/ml) or peptide pools (C. albicans MP65, Gel1, 
Crf1,  Aspf3,  CatB,  Sod3,  Shm2; each  0.6 nmol/peptide/ml; al from  Miltenyi  Biotec),  or 
pools of proteins according to the classification into immunogenic (Scw4, CRF1, CRF2, Pst1, 
Shm2, each 20 µg/ml), non-target (Gel1, CatB; each 20 µg/ml) and exhausted (Aspf2, CpcB, 
Aspf3,  FG-GAP; each  20 µg/ml).  1µg/ml CD40 and  1µg/ml  CD28 functional  grade  pure 
antibody (both  Miltenyi  Biotec)  was added. In some experiments,  CD45RA+ cels  were 
depleted from  PBMCs  prior stimulation  using  CD45RA  microbeads and  LD columns 
(Miltenyi Biotec). 
 
Enrichment and characterization of antigen-reactive T cels 
Enrichment of reactive CD154+ T cels or combined enrichment of CD154+/CD137+ T cels 
was  performed  using the  CD154  MicroBead  Kit alone,  or in combination  with the  CD137 
MicroBead  Kit (both  Miltenyi  Biotec). In  brief, cels  were indirectly  magneticaly labeled 
with  CD154-Biotin and  CD137-PE folowed  by anti-Biotin  Microbeads and anti-PE 
Microbeads and enriched  by two sequential  MS  MACS columns (Miltenyi Biotec).  For 
analysis of cytokine expression, 1 µg/ml Brefeldin A (Sigma Aldrich) was added for the last 2 
hours  of stimulation.  Surface staining  was  performed  on the first column, folowed by 
fixation,  permeabilization (Inside stain  Kit;  Miltenyi  Biotec) and intracelular cytokine 
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staining  on the second column, as  described in (13),  or staining  of  Foxp3  using the  Foxp3 
Staining Bufer Set (Miltenyi Biotec). 
 
In vitro expansion and re-stimulation of antigen-reactive T cel lines 
Magneticaly enriched  CD154+  T cels  were expanded  with  1:100  mitomycin C (Sigma 
Aldrich) treated autologous feeder cels in X-Vivo™15 (BioWhitaker/Lonza), supplemented 
with  5 % (v/v)  AB-serum (BioWhitaker/Lonza),  200 U/ml IL-2 (Proleukin®;  Novartis, 
Nürnberg,  Germany) and  100 U/ml  penicilin,  100 µg/ml streptomycin,  0.25 µg/ml 
amphotericin  B (Antibiotic  Antimycotic  Solution,  Sigma  Aldrich) at a  density  of  2.5x106 
cels/cm2. During expansion for 2-3 weeks, medium was replenished and cels were split as 
needed. 
5×105 expanded T cels were re-stimulated with autologous CD3-depleted (CD3 MicroBeads; 
Miltenyi Biotec) PBMC in a ratio of 1:1 in 96-wel flat botom plates with diferent antigens 
in presence of 1µg/ml CD28 functional grade pure Ab for 2h plus additional 4h with 1µg/ml 
Brefeldin  A (Sigma  Aldrich).  After fixation and  permeabilization cels  were stained 
intracelularly for CD154 and cytokines. 
 
Flow cytometry 
Diferent combinations  of the folowing  monoclonal antibodies  were  used according to 
manufacturer´s recommendations:  CD4-VioBlue,  CD4-FITC,  CD4-APC-Vio770 (VIT4), 
CD3-APC (BW264/56),  CD14-VioGreen,  CD14-PerCP (TÜK4),  CD20-VioGreen,  CD20-
PerCP (LT20),  CD8-VioGreen (BW135/80),  CD45RO-FITC,  CD45RO-PerCP (UCHL-1), 
CCR7-PE (REA108),  CD45RA-APC,  CD45RA-FITC (T6D11), anti-Biotin-PE, anti-Biotin-
VioBlue (Bio3-18E7), CD154-PE, CD154-APC, CD154-VioBlue (5C8), TNF-α-FITC, TNF-
α-PE-Vio770 (cA2), IFN-γ-FITC, IFN-γ-APC, IFN-γ-PE (45-15), IL-2-APC (N7.48A), IL-
17-FITC, IL-17-PE (CZ8-23G1), IL-10-PE (B-T10), IL-4-PE (7A3-3),  CD137-PE (4B4-1) 
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(al  Miltenyi  Biotec),  CD45RO-PE.Cy7 (UCHL-1,  BD  Bioscience,  San Jose,  CA,  USA), 
IFNγ-PerCP-Cy5.5 (4S.B3;  BioLegend,  San  Diego,  CA,  USA), IL-22-PE (142928;  R&D 
Systems  Europe,  Ltd.,  Abingdon,  UK),  Foxp3-PerCP-Cy5.5 (PCH101; eBioscience,  San 
Diego,  CA,  USA).  Data  were acquired  on a  MACSQuant® analyzer and  MACSQuantify™ 
software was used for analysis (both Miltenyi Biotec). 
 
Statistical analysis 
Statistical tests  were  performed  with  GraphPad  PRISM® software  5.0 (GraphPad  Software, 
La Jola,  CA,  USA)  using two-tailed  paired  Student´s t-test. P values  of  < 0.05  were 
considered statisticaly significant. 
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Results 
Human CD4+ T cel response against lysates of diferent A. fumigatus morphotypes 
CD4+  T cels specificaly reacting against A. fumigatus can  be identified  using  CD154 
expression as a specific read-out for antigen activated  CD4+  T cels after short in vitro 
stimulation  with fungal lysate (13,  23).  To analyze against  which A. fumigatus  morphotype 
the  human  T cel response is  directed,  peripheral  blood  mononuclear cels (PBMC) from 
healthy  donors  were stimulated for  7  hours  with crude lysates from resting, swolen and 
germinating conidia  or  mycelia, containing the total soluble fraction  of the  mechanicaly 
disrupted fungal cels.  Reactive  CD154-expressing  CD4+ T cels  were identified  by flow-
cytometry.  Although al lysates induced a smal  population  of  CD154 expressing  CD4+ T 
cels, the frequency of reactive cels stimulated with resting conidia lysate was significantly 
lower, compared to stimulation with lysates from other morphotypes (Fig. 1A, B). To enable 
the direct ex vivo phenotypic and functional characterization of the specific T cels, we next 
magneticaly pre-enriched the rare antigen-reactive CD154+ T cels from larger cel numbers 
(1×107  PBMC) (13).  Again, a significantly  higher  number  of target cels could  be  detected 
after stimulation  with lysates  of the  more  progressed  development stages versus the resting 
conidia lysate (Fig. 1C). However, analysis of cytokine production and phenotype revealed no 
major diferences of T cels stimulated with the diferent A. fumigatus morphotype lysates: as 
shown in Fig. 1D, against al lysates a high frequency of TNF-α and IL-2 producers could be 
detected, whereas the production of the lineage defining cytokines IFN-γ and IL-17 was only 
low, although IFN-γ  production  was clearly  predominant  over IL-17, as already  described 
before (13,  28,  29).  Similarly, irespective  of the A. fumigatus lysate  used for stimulation a 
comparable amount of reactive memory T cels was detected (Fig. 1E). 
In summary, these results  demonstrate that reactive  memory  CD4+  T cels against  diferent 
morphotypes  of A. fumigatus are  present in  healthy  human  donors and suggest that the 
strongest T cel response is directed against the actively growing fungus. 
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Swolen and germinating conidia as wel as mycelia contain overlapping T cel antigens 
We next addressed the question, whether the reactive CD4+ T cels recognize diferent or the 
same antigens expressed by the various A. fumigatus morphotypes. To this end, specific T cel 
lines were generated by expanding the magneticaly enriched CD154+ T cels after stimulation 
with the diferent morphotype lysates. Upon re-stimulation the T cel lines initialy stimulated 
with  protein extracts  of swolen conidia,  germinating conidia and  mycelia  were equaly 
reactive to either lysate, as shown  by re-expression  of  CD154 and  production  of cytokines 
(Fig.  2A,  B).  However, the re-stimulation  with resting conidia lysate  was in each case 
significantly lower, suggesting that a considerable  proportion  of  T cel antigens,  which are 
present in the metabolicaly active morphotypes (swolen and germinating conidia, mycelia), 
are  missing in the resting conidia lysate.  Furthermore, resting conidia-reactive  T cel lines 
reacted equaly wel to re-stimulation with each lysate, suggesting that resting conidia do not 
contain a significant fraction of T cel target proteins solely present in the dormant stage. As 
expected, none of the expanded cel lines reacted upon re-stimulation with CMV-lysate as a 
control antigen, providing evidence for the specificity of the expanded fungus-reactive T cel 
lines.  As for the ex vivo response,  we  observed  no  diferences in the cytokine  producing 
capacities of the diferent T cel lines upon re-stimulation (Fig. 2C). 
 
A large proportion of the human A. fumigatus-specific T response is elicited by mycelial 
membrane proteins 
Since the re-stimulation  of the expanded A. fumigatus-reactive  T cel lines revealed a 
comparable and largely  overlapping  T cel antigen repertoire  of swolen and  germinating 
conidia or mycelial lysate, we focused on the mycelial morphotype for further experiments. 
As the very first, the immune system encounters A. fumigatus protein antigens located on the 
cel surface, which include secreted, cel wal and membrane proteins. We therefore analyzed, 
whether the antigen-specific  T cel response  difers in response to  distinct subcelular 
fractions  of A. fumigatus  mycelia.  Lysates  were  generated from the  mycelial cel  wal, 
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membrane or cytosolic fraction and compared to the crude mycelial extract, as applied in the 
above described experiments. Interestingly, ex vivo stimulation of PBMCs with the cel wal 
or cytosolic fraction  was significantly lower, compared to the crude  mycelia lysate. In 
contrast, stimulation with the membrane fraction yielded similar frequencies and numbers of 
CD154+ cels compared to the crude extract (Fig.  3A,  B).  However,  we again  observed  no 
major  diferences in the ex vivo  memory  phenotype  of  T cels stimulated  with the  diferent 
celular fractions (Fig.  3C), indicating the existence  of a specific  human  memory T cels 
against components from al the diferent mycelial compartments. 
To further coroborate the finding that a large  proportion  of the specific  T cel repertoire 
against A. fumigatus is directed against mycelial membrane proteins, cel lines were expanded 
from initialy crude extract or membrane fraction stimulated CD154+ T cels. Re-stimulation 
confirmed, that the  highest reactivity  was  obtained  with lysate  of the  membrane fraction, 
whereas re-stimulation  with the cel  wal  or cytosolic fraction  was significantly lower (Fig. 
3D, E). 
A number of glycosylphosphatidylinositol (GPI) anchored proteins have been identified in the 
A. fumigatus  membrane (24,  30,  31), some  of  which  play a role in the  organization  of the 
fungal cel wal. Interestingly, some of these proteins have been described as fungal antigens 
(32).  To further  dissect the  T cel response against the A. fumigatus  membrane,  we 
investigated the stimulatory capacity of a protein fraction enriched in GPI-anchored proteins 
and the remaining  membrane fraction after the release  of  GPI-anchored  proteins in the 
supernatant by the activity of endogenous phospholipases as described in (24). Interestingly, 
both fractions induced comparable frequencies  of  CD154+  memory  T cels after ex vivo 
stimulation  of  PBMCs (Supplementary  Fig.  S1A,  B). In addition, re-stimulation  of total 
mycelia-reactive T cel lines revealed similar reactivity for each fraction (Supplementary Fig. 
S1C,  D), indicating that  both, a fraction enriched in  GPI-anchored  proteins, as  wel as the 
membrane fraction  depleted in  GPI-anchored  proteins, contain a considerable  proportion  of 
stimulatory T cel antigens. 
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In summary, these results revealed a  broad and  variable  T cel response against  diferent 
morphotypes and celular fractions  of A. fumigatus,  but identified the  mycelial  membrane 
proteins as a  major target  of the A. fumigatus-specific  T cel response in  healthy  human 
donors. 
 
ARTE  alows  direct characterization  of  human  CD4+  T cels reacting  against single 
A. fumigatus proteins 
Until  now,  only few single  proteins  of A. fumigatus  have  been analyzed and  directly 
compared in their capacity to elicit  CD4+  T cel responses in  humans (29,  33,  34). In 
particular the direct qualitative and quantitative characterization of the responding T cels is 
missing, which avoids an experimental bias due to prolonged in vitro culture. However, the 
quality  of the  T cel response  generated in vivo  may  provide important insight into the 
immunogenic properties of specific antigenic proteins. 
Therefore,  we  performed  multi-parameter analysis  of the  T cels specific for a  panel  of  15 
selected A. fumigatus  proteins  with  diferent  biological functions and celular localization. 
Either recombinant  proteins  or synthesized  15mer  peptide  pools covering the complete 
protein sequence  were  used for stimulation.  The analyzed  proteins included cel  wal,  GPI-
anchored, secreted, as  wel as cytosolic  proteins and  were chosen  based  on their  high 
abundance  within the conidial,  mycelial  or secreted  proteome and/or their  previous 
description as  being immunogenic,  based  on  T cel  or serum reactivity (Table  1).  A 
concentration of 20 µg/ml of recombinant proteins for the stimulation of 1×107 PBMCs was 
determined based on titration of the single proteins on expanded total mycelia-reactive T cel 
lines (Supplemental Fig. S2). The C. albicans protein MP65 had previously been described as 
a major antigen target of human T cel responses (35, 36) and served as a positive control. 
Against the  majority  of the analyzed single A. fumigatus  proteins  no reactive  CD4+ T cels 
above  background could  be  detected  by standard flow-cytometry  without  pre-enrichment 
(data not shown). To enable the direct ex vivo detection of reactive CD4+ T cels against the 
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single A. fumigatus proteins, we performed ARTE from 1×107 stimulated PBMCs. Although 
the frequencies upon single protein stimulation were significantly lower as upon stimulation 
with A. fumigatus or C. albicans crude lysates, specific T cels against single proteins could 
be clearly detected compared to the non-stimulated control (Fig. 4A). The specificity of the ex 
vivo  detected single  protein-reactive  CD154+ T cels  was confirmed  by expansion and re-
stimulation of specific T cel lines (Supplemental Fig. S3). 
Interestingly, the  T cel responses against the  diferent  proteins  were  quite  variable  with 
frequencies ranging from 1.2×10-6 to 3.1×10-4 (Fig. 4B) and showed strong intra- and inter-
donor  variability (Fig.  4A,  B).  As expected, this indicates an  overal  diverse repertoire  of 
A. fumigatus-reactive  CD4+  T cels,  probably  due to  diferent exposure and/or  HLA-
restriction.  The subcelular location  of the  proteins  did  not result in a clear-cut 
phenotypic/functional characteristic of the resulting T cel response, although a trend towards 
a strong reactivity against membrane-associated proteins was observed. 
 
Integration of phenotypic and functional markers of specific T cels alows classification 
of antigenic proteins 
Since  our  method alows  multi-parameter characterization  of  very rare single A. fumigatus 
protein-specific  T cels,  we integrated cytokine  production, as  wel as  phenotypic  T cel 
markers, into  our further analyses (Fig.  5).  The combination  of frequencies,  naive/memory 
distribution and efector cytokine production alowed classification of the fungal proteins into 
three  groups: "Immunogenic"  proteins are characterized  by  high  overal  T cel frequencies, 
mainly memory type cels and high IFN-γ and/or IL-17 production. In contrast, "exhausting" 
proteins  were classified  due to their low to intermediate  overal frequencies, and lack  of 
efector cytokine  production, although the  majority  of cels  had a clear  memory  phenotype. 
These  properties are indicative for  deletion and/or anergy  of specific  T cels.  These two 
groups with obvious immune reactivity in vivo contrast with the third group, which we termed 
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"non-target" proteins, since they induce high overal T cel frequencies, but strikingly a large 
proportion  of the cels is stil in the  naive state and also lacks efector cytokine  production. 
This finding indicates that  no immune reactivity is induced in vivo. Interestingly, the 
reactivity against the mycelial crude lysate as shown in figure 5 is also characterized by a high 
frequency  of  naive  T cels and rather low efector cel frequencies,  when compared to the 
immunogenic  protein  group, suggesting that a large fraction  of the fungal  proteins actualy 
belongs to the exhausting or non-target group. 
 
T cel responses to single A. fumigatus proteins account only for a smal fraction of the 
total response against A. fumigatus crude lysate in healthy donors 
To confirm our hypothesis regarding antigen classification and to estimate to which extent the 
identified immunogenic proteins contribute to the total response in vivo, we generated specific 
T cel lines from  pre-sorted  CD4+CD45RO+  memory  T cels after stimulation  with crude 
mycelia lysate. The cel lines were then re-tested for their specificity by antigen stimulation 
with the crude lysate or the single A. fumigatus proteins, as wel as a pool thereof (Fig. 6). In 
line with our hypothesis, the main reactivity within the memory cel line was indeed directed 
against the immunogenic  proteins,  whereas exhausting  or  non-target  proteins  had  only 
minimal contribution, except for the  FG-GAP repeat  protein,  which also  generated low 
reactivity in some donors. However, for most proteins, including the immunogenic fraction, 
less than  1-2%  of the expanded  CD4+  T cel lines responded  upon re-stimulation  with the 
single proteins. In addition, a high inter-donor variability of antigenic targets was observed. 
However, for some  donors, reactivity against certain single  proteins exceeded the  1-2% 
margin.  This  was especialy true for the  known antigen  Aspf22,  which  generated strong 
responses in the majority of donor cel lines (mean reactivity 3.6%; range 0-18%). 
Taken together,  we showed that the  human  CD4+  T cel response against A. fumigatus is 
highly heterogeneous and directed against a large number of diferent proteins and epitopes, 
questioning the existence  of  one  or few immune dominant  proteins.  However, the  direct 
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multi-parameter analysis  of reactive  T cels against the single A. fumigatus  proteins alows 
predicting the immunogenic  potential  of a  particular  protein in vivo  via integration  of 
frequency, phenotype and function of specific T cels. 
 
A. fumigatus-specific Tcon and Treg recognize the same antigens 
We recently demonstrated that A. fumigatus surprisingly generates a strong Treg response in 
vivo, which even exceeds conventional memory T cels (Tmem) (18). We therefore analyzed 
whether the same  or  diferent antigens are recognized  by A. fumigatus-specific  Tmem and 
Treg. To this end, the single proteins were pooled according to our previous classification into 
an immunogenic  group, containing  proteins  with the  highest reactivity (Scw4,  Crf1,  Crf2, 
Pst1 and  Shm2) as wel as a  non-target (Gel1,  CatB) and exhausting (Aspf2,  Aspf3,  CpcB, 
Fg-Gap)  group and  used for stimulation in comparison to the  mycelial crude lysate  or the 
mycelial membrane fraction. CD137 which is expressed by Treg after 6 hours of stimulation 
was  used together  with  CD154 enrichment to  diferentiate  between  Treg (CD137+CD154-) 
and  Tcon (CD137-CD154+) (18,  37).  As shown in figure  7A and  B the  Treg response 
mirored the response  of the  Tcon, in that a  high reactivity  of specific  CD137+  Treg  was 
found in response to the A. fumigatus crude lysate, as wel as the membrane fraction and the 
immunogenic  protein  pool.  Again, the  majority  of reactive  CD154+  Tcon against the 
immunogenic and exhausting protein pools displayed a memory phenotype, whereas a larger 
proportion against the non-target pool was stil in the naive state (Fig. 7C). This resulted in an 
equaly  high  Treg to  Tmem ratio for al fractions (Fig.  7D), indicating that A. fumigatus-
specific  Treg and  Tmem are  directed against the same target antigens and that the 
A. fumigatus-specific T cel response is balanced by specific Treg cels. 
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Discussion 
Here,  we show that  ARTE can  be  used for the  direct  quantification and  multi-parameter 
characterization  of rare  human  CD4+  T cels specific for  various antigens  of the important 
human-pathogenic fungus A. fumigatus. The sensitivity and flexibility of the method enabled 
the analysis of T cels specific for various developmental stages, subcelular compartments as 
wel as a large set of selected single recombinant proteins. Importantly, the multi-parameter 
characterization  of  T cels reactive against single A. fumigatus  proteins alowed the 
classification  of  proteins into immunogenic, exhausting  or  non-target subgroups. 
Furthermore,  our results revealed that the  CD4+  T cel response is  directed against a  broad 
panel of proteins present in metabolicaly active fungal morphotypes and that specific Tcon 
and Treg cels are elicited in vivo against the very same antigens. 
The  presence  of A. fumigatus-specific  CD4+  T cels in  human  blood  has  been  described in 
several studies,  using in vitro stimulation assays  with  whole conidia and  hyphae, crude 
lysates, single proteins or epitopes (13, 14, 28, 29, 33, 34, 38, 39). However, it has not been 
defined  yet,  which  developmental stage (resting, swolen,  germinating conidia  or  mycelia) 
and which subcelular protein fraction prime A. fumigatus-specific T cels in healthy human 
donors. Here, we demonstrate that the activated developmental stages of the fungus (swolen, 
germinating conidia and  hyphae) contain the largest reservoir  of  potential  T cel epitopes. 
Furthermore, T cel antigens in the metabolic active A. fumigatus morphotypes were largely 
overlapping,  which is in line  with recent results  on the  proteomic signature  of A. fumigatus 
during early  development.  These studies showed that the  majority  of  mycelial  proteins are 
also present in al early, metabolicaly active morphotypes and only the abundance varies (21, 
40, 41). 
The further subcelular  dissection  of the A. fumigatus  mycelia antigens showed that the 
membrane-bound proteins elicited the strongest T cel reactivity as compared to the cytosolic 
fraction. This result was coroborated by the analysis of T-cel reactivity against several single 
A. fumigatus  proteins.  Here,  we  observed a  uniformly  high frequency  of reactive  memory-
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type  T cels against al analyzed  GPI-anchored  proteins, except  of  Gel1,  whereas the 
"exhausting" and "non-target" groups mainly consist of cytosolic or secreted proteins. 
Indeed, the  possibility to analyze the rare  T cels reacting against single  proteins  highlights 
the potential of the ARTE technology, since it alows classifying proteins according to their in 
vivo antigenic potential. So far A. fumigatus CD4+ target proteins have mainly been identified 
indirectly  via the  presence  of isotype-switched antibodies (25,  32,  42-46).  Alternatively, 
functional T cel assays such as proliferation or cytokine production have been used in a few 
studies (29,  33,  34,  38,  39,  47,  48),  which  do  not alow  quantitative enumeration and 
phenotypic characterization  of the reactive  T cels. In fact, for the  majority  of  proteins 
analyzed, the frequencies  of reactive  T cels  were  <10-4,  which  would  not  be  detectable  by 
standard  methods.  By the  paralel assessment  of  T cel frequency,  phenotype and function, 
three groups of A. fumigatus proteins could be defined: (i) immunogenic proteins, elicited a 
strong memory response and pro-inflammatory cytokine production in the majority of donors 
analyzed. (i) In stark contrast, other non in vivo target proteins elicited a strong in vitro T cel 
reaction, but the specific T cels were mainly in a naive state, suggesting that the antigen is 
not presented in vivo. (ii) Finaly, a large fraction of the analyzed proteins belonged to a third 
group, which we termed exhausting, since the overal frequencies, as wel as efector cytokine 
production  was relatively low, although the  majority  of reactive cels  had a clear  memory 
phenotype.  This indicates that confrontation  with the antigen takes  place in vivo  but rather 
induces anergy or deletion of the reactive T cels. Thus, the enumeration and multi-parameter 
characterization of T cels specific for single A. fumigatus proteins identifies protein-specific 
reactivity paterns and thus represents an important complementation to the data obtained with 
mixed antigen preparations. 
From the identified immunogenic  proteins,  Crf1,  Sod3 and  Aspf22  have  previously  been 
described to elicit CD4+ T cel responses in humans (29, 33, 34, 38). However, our analysis 
also identified new immunogenic proteins, including Scw4, Crf2 (25), Pst1, Shm2, GliT and 
TpiA that have not been described as human T cel targets before. The gliotoxin oxidase GliT 
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has recently  been identified  via an immunoproteome screening approach and  has  been 
suggested to represent a  novel antigen for serologic  diagnosis  of aspergilosis (45). 
Interestingly also two  other "immunogenic"  proteins, the enolase  Aspf22 and  Shm2  were 
detected in immunoblots  using sera from  patients  with alergic  bronchopulmonary 
aspergilosis (49). In addition, Shm2 belongs to the most abundant proteins identified in the 
mycelial proteome (22). 
It is important to  note that the same characteristics also apply to  other  proteins that  were 
tested in  our study, e.g.  CpcB,  Aspf2 and  Aspf3 (Table  1),  which al  belong to the 
"exhausting" group. Furthermore, CatB classified by our analysis as a "non-target" protein has 
previously been described to induce strong T cel proliferation in vitro but vaccination with 
CatB  did  not  protect  mice from invasive aspergilosis (33).  Thus it is  obvious, that  other 
factors than  protein localization, abundance  or antibody reactivity are critical  parameters to 
determine the true in vivo  T cel stimulatory capacity and  highlights the  potential  of  our 
approach to systematicaly predict immunogenic and potential protective target proteins. 
In addition to the phenotypic characteristics, ARTE also alows to determine the functionaly 
important  production  of efector cytokines, such as IFN-γ  or IL-17.  Although IL-17 is 
frequently claimed as an important cytokine for anti-fungal immune responses, the 
importance for  protection against fungal infections versus immunopathology is curently 
under debate (50-54). In this study we observed a predominant IFN-γ production and only low 
IL-17,  which is in line  with  previous reports (13,  28,  29,  34) suggesting that A. fumigatus 
elicits  predominantly  Th1 responses in vivo.  Th2 cytokines (IL-4, IL-5, IL-13)  were  only 
marginal  produced against the  defined  pools  of single  proteins (data  not shown) and  have 
previously been shown to be typicaly below 5% of al reactive CD154+ cels against the total 
soluble lysate (13).  However,  when single  proteins  were analyzed strong IFN-γ and IL-17 
cytokine  production  was  only  observed against  proteins classified as "immunogenic".  Also 
against the immunogenic proteins, IFN-γ was the dominating cytokine confirming also on the 
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level of single proteins that the in vivo response against A. fumigatus is rather biased towards 
a Th1 patern. Moreover, some proteins (e.g. Scw4, Pst1, GliT, Aspf22) elicited in addition to 
IFN-γ the co-production  of relatively  high amounts  of IL-17.  The  knowledge about the 
specific cytokine induction potential of certain proteins may help to improve vaccine design 
in the future.  However, the functional importance  of the  various  T cel cytokines  has to  be 
determined beforehand. Interestingly, by pooling proteins according to our classification, we 
found that  not  only conventional  memory  T cels,  but also regulatory  T cels  were strongly 
activated  by the immunogenic  proteins, indicating that  Tcon and  Treg recognize the same 
antigens. In fact the number of Treg exactly paraleled the number of memory Tcon resulting 
in a stable  Treg/Tmem ratio for al antigens.  This finding indicates that  Treg are  not 
selectively generated against a subgroup of proteins but their expansion seems to be coupled 
to the expansion  of conventional  T cels,  which  may  be  mediated  via  growth factor supply, 
such as IL-2 (55). Thus, the T cel response against al A. fumigatus proteins is controled by 
Treg and therefore the depletion of Treg might be a promising strategy for releasing ful T cel 
responses, e.g. for immunotherapeutic approaches. 
Finaly,  despite the fact that  our analysis could  define a set  of immunogenic A. fumigatus 
proteins, the overal T cel response was directed against a multitude of diferent proteins. In 
addition, the  T cel frequencies against single antigens  were  very low and there  was 
significant  donor-to-donor  variation.  This indicates that the A. fumigatus-specific  T cel 
response is largely  heterogeneous and also  determined  by  host-specific  or environmental 
factors, such as MHC restriction or variability in timing and dosage of antigen exposure. In 
line with this, a recent study identified 7 and 30 diferent T cel epitopes within the Crf1 and 
CatB  protein, respectively,  which are  presented  by  diferent  HLA-class I  molecules (34). 
Thus, the existence  of a single  or even a few immune  dominant antigens is rather  unlikely 
emphasizing even more the importance of technologies alowing the fast ex vivo classification 
of single proteins or even peptides in individual donors, as demonstrated here. 
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Figure legends 
 
Figure  1. Memory  CD4+  T cels from  healthy  human  donors show specific reactivity 
against lysates from  diferent A. fumigatus  growth  phases.  Folowing stimulation  of 
PBMCs  with the indicated crude lysates  of  diferent  morphotypes,  CD154+ expression  on 
CD4+ T cels was analyzed  directly ex vivo. (A)  Cels  were  gated  on lymphocytes and 
aggregates (scater area versus  height),  dead cels and  non-T cel lineages (CD14+,  CD20+, 
dump) were excluded. Representative dot plot examples from one donor with frequencies of 
CD154+ cels among CD4+ lymphocytes and (B) summary of several donors with horizontal 
lines indicating mean values. (C-E) CD154+ cels were magneticaly pre-enriched and stained 
for cytokine expression and phenotypic markers. (C) Number of CD154+ cels obtained from 
1×107 stimulated  PBMCs. (D)  Percentages  of cytokine-expressing cels among  CD154+ T 
cels and (E)  percentages  of  CD45RO+  memory cels among  CD154+  T cels are shown. 
Significance was determined using paired Student´s t-test. RC = resting conidia; SC = swolen 
conidia; GC = germinating conidia. 
 
Figure  2.  Resting conidia contain less  T cel  antigens than  other A. fumigatus 
morphotypes. Folowing stimulation with the diferent crude growth phase lysates, CD154+ 
cels  were  magneticaly isolated and expanded for  2  weeks.  Upon re-stimulation  with and 
without antigens as indicated, reactive CD4+ T cels were determined by CD154 and TNF-α 
expression. (A) Representative dot plot examples from one donor with percentage of reactive 
cels gated on CD4+ lymphocytes and (B) statistical analysis of several donors with horizontal 
lines indicating  mean  values. (C)  The fungal lysate reactive  T cel lines  were re-stimulated 
with the specific lysate  used for initial stimulation and analyzed for intracelular cytokine 
expression.  Percentages  of cytokine  producing cels among  CD154+ cels are  depicted. 
Significance was determined using paired Student´s t-test. RC = resting conidia; SC = swolen 
conidia; GC = germinating conidia. 
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Figure  3.  A  high  proportion  of stimulatory  T cel  antigens  are located in the fungal 
membrane. (A-C)  PBMCs  were stimulated  with the indicated lysates and analyzed ex vivo 
for CD154+ expression among CD4+ lymphocytes. (A) Frequencies of reactive CD154+ cels 
among CD4+ and (B) enriched CD154+ cel numbers folowing magnetic isolation from 1×107 
PBMCs. (C) Percentages of CD45RO+ memory cels among CD154+ T cels are shown. (D, 
E)  Specific  T cel lines  were expanded from isolated  CD154+  T cels and analyzed for 
reactivity by antigen re-stimulation. (D) Representative dot plot examples from one donor and 
(E) summary for several  donors.  Horizontal lines indicate  mean  values.  Significance  was 
determined using paired Student´s t-test. 
 
Figure  4. Ex vivo enumeration  of  CD4+  T cels reactive  against single A. fumigatus 
proteins. 1×107 PBMCs were stimulated with A. fumigatus crude mycelia lysate, C. albicans 
lysate and  MP65 as control antigens,  or single A. fumigatus  proteins as indicated.  CD154+ 
cels were enriched and stained intracelularly for cytokine expression. (A) Representative dot 
plot examples from one donor. For an optimal detection of rare CD154+ events, aggregates, 
dead cels and  non-target cels (CD8+,  CD14+,  CD20+)  were excluded  by  using a  dump 
channel.  The  numbers  of  CD154+ cels  obtained after enrichment are indicated. (B) 
Enumeration  of reactive  CD4+  T cels in several  donors.  The total  number  of  CD154+ cels 
obtained after enrichment  was  normalized to the total  number  of  CD4+ cels applied to the 
column. Background enriched from the non-stimulated control was subtracted. pp = peptide 
pool; r = recombinant 
 
Figure  5.  Combined characterization  of frequency,  phenotype  and function enables 
classification  of  antigenic  proteins.  Enriched  CD154+ cels  were ex vivo analyzed for 
frequency, expression of CD45RO and pro-inflammatory cytokine production and classified 
into “immunogenic”, “non-target” and “exhausting”  proteins, as indicated.  Frequency  was 
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determined as in  Fig.  4,  percentages  of  CD45RO+  memory cels among  CD154+ cels and 
percentages of cytokine-expressing cels among CD154+ T cels are shown. pp = peptide pool; 
r = recombinant 
 
Figure 6. Contribution of single A. fumigatus protein-reactive CD4+ T cels to the total 
A. fumigatus lysate response. 1×107  CD45RA-depleted  PBMCs from  healthy  donors  were 
stimulated with crude mycelia lysate. CD154+ cels were enriched and expanded for 2 weeks. 
Expanded cel lines  were re-stimulated  with crude  mycelia lysate  or indicated  proteins in 
presence of autologous APCs and the reactive CD4+ T cels were determined by CD154 and 
TNF-α expression. Summary of reactive CD4+ T cels from several donors with mean values 
is shown (n = 16). Background from non-stimulated sample was subtracted. 
 
Figure  7.  Stimulation  of A. fumigatus specific  Treg  with  pools  of immunogenic,  non-
target  and exhausting  proteins.  2×107 PBMCs  were stimulated  with A. fumigatus crude 
mycelia lysate,  membrane lysate  or the indicated  pools  of single  proteins.  CD154+ and 
CD137+ cels  were  magneticaly enriched and stained for  Foxp3 expression. (A) 
Representative  dot  plot examples from  one  donor.  Cels are  gated  on  CD4+CD154- 
lymphocytes and  Foxp3 expression  on  CD137+ cels is  depicted.  The  numbers  of 
CD137+Foxp3+  Treg cels  obtained after enrichment are indicated. (B)  Enumeration  of 
reactive  CD154+  Tcon and  CD137+  Treg in several  donors (n = 6).  The total  number  of 
CD154+ and CD137+ cels obtained after enrichment was normalized to the total number of 
CD4+ cels applied to the column. Background enriched from the non-stimulated control was 
subtracted. (C)  Percentages  of  CD45RO+  memory cels among  CD154+ cels (Tmem). (D) 
Ratio of CD137+ Treg to CD154+CD45RO+ Tmem. 
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Figure 3 
 
A C
E
B
D
Mycelia crude-reactive
Myceliamembrane-reactive CD
15
4
TNF-α
1.90%
0.74%
CMV
50.1%
17.5%
Mycelia crude
15.4%
3.36%
Cytosol
43.1%
17.4%
Membrane
9.01%
 Cel wal
35.1%1.81%
0.78%
w/o antigen
Frequencies Cel numbers
Mycelia crude-reactive Mycelia membrane-reactive
 
 
	   36 
Figure 4 
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Figure 5 
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Figure S1 
 
 
 
 
Figure  S1.  GPI-anchored  proteins  and the  non-GPI  membrane fraction  have similar 
stimulatory capacities. (A) Frequencies of CD154+ cels among CD4+ lymphocytes folowing 
ex vivo stimulation  with the indicated lysates. (B)  CD154+ cels  were enriched from  1×107 
PBMCs and analyzed for surface expression of CD45RO. Percentage of CD45RO+ memory cels 
among  CD154+ cels are  depicted. (C,  D)  Specific  T cel lines  were expanded from enriched 
crude  mycelia lysate stimulated  CD154+  T cels, and analyzed for reactivity  by antigen re-
stimulation. (C) Representative dot plot examples from one donor and (D) statistical analysis. 
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Figure S2 
 
 
 
Figure  S2.  Titration  of recombinant  proteins  on expanded  mycelia-reactive  T cel lines. 
Isolated crude  mycelia lysate-reactive  CD154+  T cels  were expanded for  2  weeks and re-
stimulated with or without mycelia lysate, or diferent concentrations of recombinant CpcB and 
Shm2  protein.  Percentages  of reactive cels  gated  on  CD4+ lymphocytes are shown, as 
determined by CD154 and TNF-α expression. 
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Figure S3 
 
 
 
Figure S3. Specificity of single protein-reactive CD154+ T cels. PBMCs were stimulated with 
the indicated  proteins.  CD154+ cels  were isolated, subsequently expanded for  3  weeks and 
tested for specificity  via antigen re-stimulation.  Percentage  of reactive cels among  CD4+ 
lymphocytes are shown for several donors, as determined by CD154 and TNF-α expression. 
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Table 1. Overview of single A. fumigatus proteins used in this study 
Protein Locus-tag Function Localization Length Preparation Identified in 
conidial 
proteome 
Identified in 
mycelial 
proteome 
Identified in 
secretome 
Identified in 
patients sera 
immunoblots 
Scw4 AFUA_6G12380 Cel wal glucanase Cel wal 369 aa Recombinant n.d. n.d. n.d. n.d. 
Crf2 AFUA_1G16190 Cel wal glucanase GPI-anchored 333 aa Recombinant n.d. x (25) n.d. n.d. 
Gel1 AFUA_2G01170 1,3-β-glucanosyltransferase GPI-anchored 452 aa Peptide pool x (41) x (41) x x (32) 
Crf1/Aspf9 AFUA_1G16190 Cel wal glucanase GPI-anchored, secreted 395 aa Peptide pool - x (25) x (56) x (32) 
Pst1 AFUA_6G10290 GPI-anchored cel wal protein GPI-anchored 405aa (aa 18-216 expressed) Recombinant n.d. n.d. n.d. n.d. 
Sod3/Aspf6 AFUA_1G14550 Manganese superoxide dismutase Cytosol 210 aa Peptide pool - x (57) - x (57) 
Shm2  AFUA_3G09320 Serine hydroxylmethyltransferase Cytosol 471 aa Peptide pool x (41) x (21, 41) - x (58) 
Aspf2 AFUA_4G09580 alergen, expressed in zinc-limiting conditions Cytosol, Secreted 310 aa Recombinant n.d. x (59) x x (49, 60, 61) 
CpcB AFUA_4G13170 RACK1 orthologue Cytosol, Secreted 316 aa Recombinant x (21, 40) x (22) x (56) x (45) 
TpiA AFUA_5G13450 Triosephosphate isomerase Cytosol, Secreted 256 aa Recombinant x (40) x (22) x (56) x (62) 
Aspf3 AFUA_6G02280 Peroxiredoxin family reductase Cytosol, Secreted 168 aa Peptide pool x (41) x (21) - x (62) 
GliT AFUA_6G09740 Gliotoxin oxidase Cytosol, Secreted 334 aa Recombinant n.d. x (63) x (63) x (45) 
Aspf22/EnoA AFUA_6G06770 Enolase Cytosol, Secreted 438 aa Recombinant x (21, 40) x (22) x (56) x (58) 
CatB AFUA_3G02270 Catalase B Cytosol, Secreted 728 aa Peptide pool x (21) x (22) x (56) x (49) 
FG-GAP AFUA_1G04130 FG-GAP repeat protein Secreted 307 aa (aa 26-307 expressed) Recombinant n.d. - x (56) x (49) 
aa amino acid; n.d. not determined 
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4 Discussion 
 
Fungal  pathogens significantly contribute to  morbidity and  mortality in  humans.  However, 
their impact on human health and diseases has been underestimated for long time (Brown et 
al.,  2012).  Accordingly,  much less is  known about the  T cel response against fungal 
pathogens in comparison for example to viruses, which much earlier have been recognized to 
cause fatal infections in immunocompromised  patients and subsequently  protective immune 
responses  have extensively  been studied.  As adoptive transfer  of  virus-specific  T cels  has 
been  demonstrated to confer  protective immunity and to control established  viral infections 
(Brestrich et al.,  2009; Feuchtinger et al.,  2006; Mackinnon et al.,  2008; Moosmann et al., 
2010), similar approaches could  be  beneficial to fight the  devastating fungal infections in 
immune-suppressed patients (Beck et al., 2006; Gaundar et al., 2012; Peruccio et al., 2005; 
Tramsen et al.,  2009; Tramsen et al.,  2013).  Also, the  development  of anti-fungal  vaccines 
might be an option to eficiently protect immunocompromised patients from fungal infections 
(Spelberg,  2011; Stevens et al.,  2011).  However,  basic  knowledge about fungus-specific 
T cels is missing that would be essential to define protective anti-fungal T cel responses and 
to consider infusion of fungus-specific T cels as a treatment option. 
Besides  being a  major cause  of infection-related  mortality in immune-suppressed  patients, 
environmental airborne fungi are increasingly associated  with alergic  hypersensitivity 
diseases.  Especialy  patients  with severe asthma commonly show sensitization to fungal 
antigens (Agarwal,  2011; Agarwal and  Gupta,  2011). In addition, susceptible  patients  with 
asthma and cystic fibrosis frequently sufer from ABPA. It is likely, that the T cel response 
difers  under these  divers  pathologic situations, as invasive fungal infections result from an 
insuficient immune response against the fungal pathogens, whereas alergic disorders are the 
consequence  of an aberant immune response  due to sensitization to fungal antigens.  To 
define a role for T cels in anti-fungal immunity under these diferent pathologic conditions, it 
demands comprehensive information about anti-fungal T cell responses in humans. 
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4.1 Direct, high-resolution analysis of the total anti-fungal human CD4+ T cel 
response 
 
Most  of the curent  data about fungus-specific  T cels result from experiments  with animal 
models. However, a variety of diferent models for invasive, disseminated, alergic, mucosal 
and superficial fungal disease have been described with several variables regarding the strain 
of mouse or other animal species used, the dose and morphotype of the fungal antigens, the 
route of infection, or usage and kind of immune-suppression and therapy (Capila et al., 2007; 
Kamei,  2001).  These  methodological  diferences among the  diferent  models  make a  direct 
comparison of results from individual studies dificult (Sheppard et al., 2006). In addition, as 
for other diseases, it is delicate to draw direct conclusions from results of animal studies on 
humans, even if the animal model mimics the human disease as best as possible. For example, 
models  with sterile  housed animals  do  not consider the efect  of  preexisting immunological 
memory acquired during exposure to the multitude of diferent antigens in an individuals life. 
Thus, analyses of antigen-specific T cels in humans need to be obtained. The comparison of 
anti-fungal  T cel immunity in  healthy  donors, as  wel as the relevant  patient  groups is 
essential to  define corelates  of  disease  progression and  protection against fungus-mediated 
diseases. In  detail,  knowledge about the frequencies, antigen-specificity,  phenotype and 
function of fungus-specific T cels is only fragmentary or lacking al together.  
 
A. fumigatus and C. albicans are two of the major opportunistic fungal pathogens in humans, 
but so far  only few studies  have analyzed A. fumigatus and C. albicans specific  T cels in 
human  peripheral  blood (Acosta-Rodriguez et al.,  2007b; Beck et al.,  2006; Bozza et al., 
2009; Chai et al., 2010; Chaudhary et al., 2010; Hebart et al., 2002; Jolink et al., 2013; Liu et 
al., 2009; Stuehler et al., 2011; Zhou et al., 2008; Zielinski et al., 2012). In addition, many of 
these studies  measured the fungus-specific  T cel response  by indirect  methods, such as 
secretion of cytokines into the supernatant or proliferation of the activated T cels. A problem 
of such approaches is that  one cannot  draw conclusions  on the  number  of antigen-specific 
cels at the time point of stimulation, since diferences in the amount of cytokine production 
or  proliferation  between the individual cels are  not considered.  Furthermore,  when 
stimulating  bulk cel  populations, such as  whole  PBMC, also  other cels  may secrete the 
measured cytokine, and  proliferation  due to  bystander activation cannot  be excluded.  Other 
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studies  measured  human fungus-specific  T cels  by the  detection  of single cytokines  using 
ELIspot assay  or flow-cytometry.  However, this restricts the analysis to  only  one  or few 
cytokines whereas specific T cels producing diferent or no cytokines are being missed. Also, 
ELIspot assays  do  not  provide additional information about the individual antigen-specific 
T cels, like the expression of phenotypic markers or co-secretion of several cytokines, as it 
applies for flow-cytometric  measurements.  Thus, the curent  data about the frequency and 
functions of fungus-specific T cels in humans are only incomplete and/or largely imprecise. 
Although  MHC-multimers  would enable a  direct  quantification and characterization  of 
fungus-specific T cel responses, they are curently not applicable to fungal antigens, since no 
immune-dominant  proteins  or epitopes are  known. In addition, also the  MHC-multimer 
technology would again only give a very restricted view on those T cels with specificity for 
the pre-selected epitopes, which most likely does not reflect the entire T cel response against 
such complex organisms like fungal pathogens. 
To  gain a  more comprehensive  picture about fungus-specific  T cel responses in  humans, a 
flow-cytometric assay  based  on the expression  of  CD154  was  developed (antigen-reactive 
T cel enrichment, ARTE) that enabled the detection of the total pool of specific CD4+ T cels, 
independent  of  MHC-alele  variation,  defined antigenic epitopes  or restriction to certain 
phenotypic or functional subsets (Bacher et al., 2013; manuscript 2). CD154 has previously 
been shown to be a highly specific marker that is up-regulated on al antigen-specific CD4+ 
T cels folowing short in vitro stimulation (Chatopadhyay et al., 2005; Frentsch et al., 2005; 
Kirchhof et al., 2007). The specificity of CD154 induction folowing stimulation with crude 
fungal lysates  was confirmed in this study, since the induction  of  CD154  by fungal lysates 
was HLA-DR dependent and required processing by APCs. In addition, fungus-specific T cel 
lines  or single cel clones  with  high reactivity could  be  generated folowing expansion  of 
enriched  CD154+ T cels (Bacher et al.,  2013;  manuscript  2;  Bacher et al.;  manuscript  6, 
submited).  The  magnetic  pre-enrichment  of the rare  CD154+ T cels enabled to rapidly 
analyze suficient numbers of target cels to discriminate even smal subpopulations that were 
previously  undetectable, e.g.  naive  or rare cytokine-producing cels. Indeed, the analysis  of 
the total  pool  of fungus-specific  T cels revealed, that restriction  of the analysis to  only the 
dominant lineage  defining cytokines (e.g. IFN-γ, IL-4, IL-17) largely  underestimates the 
actual frequencies of fungus-reactive CD4+ T cels, since the production of efector cytokines 
among al CD154+ T cels was only low (Bacher et al., manuscript 6, submited; Bacher et al., 
2013; manuscript 2). 
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Only recently it has been identified that the combination of CD154 expression with another 
activation marker, CD137, enables the discrimination between antigen-specific human Tcon 
and  Treg (Schoenbrunn et al.,  2012).  The applicability  of this  marker combination to also 
identify  pathogen-specific  Treg and  Tcon  was  demonstrated, since A. fumigatus- and 
C. albicans-specific CD137+CD154- Th cels displayed halmarks of Treg, such as expression 
of characteristic markers (CD25high, CD127-, Foxp3+, Helios+), demethylated TSDR, in vitro 
suppressive function and absence of efector cytokine expression. In contrast, CD154+CD137- 
Th cels  matched  with the  properties  of conventional  CD4+ T cels (Bacher et al.,  2013; 
manuscript  3).  By combining  both  markers  with the  pre-enrichment strategy, the flow-
cytometric assay  developed in this study alows for the first time the  direct ex vivo 
identification and characterization  of the  unrestricted  CD4+ Tcon and  Treg  pool specific for 
any antigen of interest on a single cel level, with the same sensitivity as it was demonstrated 
for multimer-based enrichment methods (∼ 1 cel within 105-106, depending on the number of 
input cels) (Bacher et al.,  2013;  manuscript  3; Bacher and  Schefold,  2013;  manuscript  1; 
Bacher et al., 2013; manuscript 2) 
The high sensitivity of the antigen-reactive enrichment assay and the possibility to analyze the 
entire fungus-specific CD4+ T cel compartment revealed profound diferences in the human 
CD4+ T cel response against A. fumigatus and C. albicans, with regard to frequency of the 
specific T cels, efector functions, phenotype, as wel as the contribution of specific Treg to 
the anti-fungal immune response. In line  with the constitutive exposure to fungal antigens, 
low frequencies of fungus-reactive T cels could be detected in al healthy donors (Bacher et 
al., 2013; manuscript 3; Bacher et al., manuscript 6, submited; Bacher et al., manuscript 5, in 
preparation).  However, C. albicans induces a clear  memory  CD4+  T cel response  with a 
considerable proportion of Th17 cels, which is accompanied by a paralel expansion of Treg. 
In contrast, the  overal  T cel response against A. fumigatus seems to  be  more tolerogenic, 
since a large proportion of the A. fumigatus-specific CD4+ T cels is stil in a naive state, and 
exposure to A. fumigatus preferentialy expands Treg (Bacher et al., 2013; manuscript 3). In 
addition, a significant proportion of the A. fumigatus-reactive memory response was induced 
by cross-reactivity to C. albicans antigens, leading to the selective induction of Th17 cels in 
the A. fumigatus immune response (Bacher et al.,  manuscript  4, in  preparation).  These 
fundamental  diferences in the  T cel response against A. fumigatus and C. albicans  were 
surprising, since the human immune system is continuously exposed to both fungi. However, 
C.  albicans is a  dimorphic  yeast and commensal  mainly residing  on the  mucosal surface of 
the gastrointestinal tract. Interaction with the immune system mainly occurs upon C. albicans 
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penetration of the usualy protective mucous layer (Cheng et al., 2012; Naglik et al., 2011). In 
contrast, A. fumigatus is an environmental fungal  organism that is  primary acquired to the 
lung by inhaling airborne spores. Thus, A. fumigatus and C. albicans largely difer in several 
parameters that  might  be criticaly for the  outcome  of a  protective immune response, 
including the expression  of  diferent  pathogen-associated  molecular  paterns (PAMPs), the 
timing, dosage and kind of antigen exposure, as wel as the site of interaction with the human 
immune system. 
 
4.2 Expanded fungus-specific Treg in human peripheral blood 
 
Al  humans are constitutively exposed to several environmental antigens, such as alergens, 
food, commensal bacteria and fungi. Fungi represent a chalenge for the immune system, as 
immune ignorance  of fungal antigens  wil lead to  uncontroled fungal  growth and invasive 
fungal diseases, as best ilustrated by the devastating fungal infections in immune-suppressed 
patients.  On the  other  hand  overeacting  or chronic immune reactions against these  daily 
encountered antigens  may result in colateral tissue  damage and alergic  disorders.  Thus, 
immunity to fungi  demands appropriate  protective immune responses  but also eficient 
control  mechanisms to  prevent tissue  damage  due to  overeacting  or chronic immune 
reactions. In addition, the anatomical site  where the immune system is confronted  with the 
fungal antigen can  vary  widely, since airborne fungal spores are inhaled into the lung, 
whereas  other fungi live as commensals in the  human  gastrointestinal tract  or  on the skin. 
How the immune system copes with this daily chalenge against the diferent fungal antigens 
is so far only poorly understood. 
Treg are wel recognized in their capacity to control immune responses against self-antigens 
(Sakaguchi et al.,  2010), and  have also  been implicated to  maintain immune  homeostasis 
against foreign antigens at mucosal sites (Belkaid and Rouse, 2005; Bilate and Lafaile, 2012; 
Curoto  de  Lafaile et al.,  2008; Curoto  de  Lafaile and  Lafaile,  2009; Josefowicz et al., 
2012).  However, the antigen-specificity  of the  Treg repertoire remained largely  undefined. 
Especialy in humans the direct detection of pathogen-specific Treg failed so far, due to the 
lack  of appropriate  methods for their identification. It is  of  particular interest that  both, 
A. fumigatus and C.  albicans, elicit a strong expansion  of specific  Treg in adult  healthy 
donors, compared to cord  blood (Bacher et al.,  2013;  manuscript  3).  Also colonization  of 
mice  with commensal  bacterial species, in  particular Clostridium species and Bacteroides 
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fragilis,  has  been  demonstrated to  promote  Treg accumulation in the intestinal  mucosa 
(Atarashi et al., 2011; Round and Mazmanian, 2010). This clearly suggests the involvement 
of  Treg in  mediating  homeostasis to  gastrointestinal commensals and at least some  of these 
colonic  Treg  have  been  demonstrated to express  TCRs specific for colonizing  bacteria 
(Lathrop et al., 2011). In addition, in several studies using mouse models of chronic infection 
with parasites, bacteria and viruses, an increased frequency of Treg at inflammatory sites has 
been reported (Belkaid and  Tarbel,  2009; Shafiani et al.,  2013), suggesting that  Treg co-
expand together with Tcon during an immune response and thus are part of the physiological 
T cel response against foreign antigens.  However in the  majority  of these studies the 
specificity of the recruited Treg has not been demonstrated, leaving open the possibility that 
Treg accumulation during infection occurs due to bystander activation. 
The expansion of C. albicans-specific Treg in humans occured along with a strong efector 
T cel response (Bacher et al.,  2013;  manuscript  3). In fact, the analysis  of the total 
C. albicans-specific  CD4+ T cel repertoire revealed that the  naive  T cel  pool  was largely 
depleted from C. albicans-reactive  T cels compared to cord  blood, whereas C. albicans-
specific  memory cels  were strongly expanded and clearly exceeded the  number  of specific 
Treg.  This supports the  hypothesis that the  occasional interaction  of C.  albicans  with the 
immune system  obviously leads to a rather strong immune response that is controled  by a 
paralel expansion  of  Treg to avoid  detrimental consequences to the  host.  Nevertheless, the 
frequency of C. albicans-specific Tcon and Treg in human gut tissues remains to be explored. 
In contrast to C. albicans, A. fumigatus elicited only a minimal expanded memory response in 
healthy donors, whereas a large proportion of the specific Tcon repertoire was stil in a naive 
state. However, A. fumigatus-specific Treg were equal or in some donors even exceeded the 
number  of specific  naive and  memory  Tcon in  healthy  donors.  Furthermore, A. fumigatus 
Treg strongly suppressed the Tcon response in in vitro assays (Bacher et al., 2013; manuscript 
3).  Therefore it seems that the continuous inhalation  of airborne A. fumigatus antigens 
preferentialy generates a Treg response, which might play an important role in the mediation 
of airway tolerance. In line  with this idea, a recent study  highlighted that lung resident 
macrophages  of  mice  have a  unique capacity to  promote  Treg responses against airborne 
antigens (Soroosh et al., 2013). Furthermore, tetramer enrichment approaches have identified 
human  Treg specific for epitopes  of  birch  or alder alergens in  humans (Palomares et al., 
2011; Wambre et al., 2012). In summary, these data point out that the lung might be a site for 
the preferential generation and/or induction of Treg responses that provide airway tolerance to 
inhaled antigens. Also  our  own  preliminary  data further indicate that the  CD4+ T cel 
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responses of healthy donors against several alergen lysates (e.g. birch polen, ryegrass polen, 
house  dust  mite)  display the same  patern as A. fumigatus-specific  T cels  with a strong 
expansion  of alergen-specific  Treg,  while leaving the  majority  of specific  Tcon in a  naive 
state (Bacher and Schefold, unpublished data). 
 
Two  main types  of  Treg  have  been identified, that  both contribute to the  maintenance  of 
immune tolerance: tTreg that develop in the thymus, as wel as pTreg that develop outside the 
thymus under a variety of conditions, including infections, chronic inflammation and antigen 
presentation in absence of inflammation (sub-immunogenic conditions) (Bilate and Lafaile, 
2012).  The identified fungus-specific  Treg  displayed  halmarks  of tTreg, e.g. expression  of 
Helios,  demethylated  TSDR, lack  of efector cytokine expression and  highly suppressive 
capacity in in vitro assays (Bacher et al., 2013; manuscript 3). Although the curent paradigm 
is that the  TCR repertoire  of tTreg is  biased towards the recognition  of self-antigens 
(Andersson et al., 2007), the tTreg repertoire has been demonstrated to be similar complex as 
the Tcon repertoire (Fazileau et al., 2007; Kasow et al., 2004; Pacholczyk et al., 2006). Using 
tetramer enrichment approaches, tTreg specific for foreign epitopes have been detected in the 
naive repertoire of mice (Moon et al., 2011). A recent study in mice further demonstrated that 
tTreg contribute to tolerance to commensal  bacteria (Cebula et al.,  2013).  These results are 
consistent with the idea, that tTreg can also recognize foreign antigens. Nevertheless, due to 
the lack of distinctive markers, it remains unclear whether the fungus-specific Treg arise from 
the tTreg or pTreg compartment, or whether both populations contribute to the mediation of 
tolerance against constantly encountered fungal antigens. Also in a recently described mouse 
model  of colitis it  has  been  demonstrated, that  both tTreg and  pTreg  were required for 
protection from  disease,  probably  by expanding the  diversity  of recognized  T cel targets 
(Haribhai et al., 2011). 
The  presence  of  high frequencies  of fungus-specific  Treg in  peripheral  blood  of  healthy 
human  donors  has several important clinical implications.  Especialy  patients  with  CF,  who 
are characterized  by an impaired  mucociliary clearance, frequently sufer from Aspergilus 
driven alergies,  which can result in severe  ABPA.  However, the susceptibility  of some  of 
these  patients to  develop alergy towards Aspergilus antigens,  whereas  others  do  not, are 
curently  not  wel  understood. Indeed, a strongly altered cytokine  profile  of A. fumigatus-
specific  memory  T cels towards a  Th2  phenotype  was  observed in  half  of the analyzed  CF 
patients in this study (Bacher et al., 2013; manuscript 3). Strikingly, those patients with a Th2 
biased  phenotype,  displayed a strongly reduced  Treg/Tmem ratio, compared to  non-Th2 
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patients.  This suggests, that the  balance  between  Treg and  Tmem  might  be a  decisive 
parameter in the development of alergy. In this regard it wil be important to see, whether the 
reduced  Treg/Tmem ratio  might  have a  predictive  value for alergy  development against 
A. fumigatus antigens. The observed Treg/Tmem ratio did not result from reduced numbers of 
A. fumigatus specific  Treg,  but an increased  number  of specific  Th2-type  memory cels, 
compared to  non-Th2  CF  patients.  Thus strategies, to enhance the  number  of specific  Treg, 
might  be a treatment  option for  CF and also  otherwise alergic  patients.  However, as  CF 
patients  do  not in  general sufer from alergy against  other  harmless antigens (i.e.  polens, 
house  dust  mite, etc.),  but selectively  develop alergies against Aspergilus, an  overal  Treg 
defect in these patients seems unlikely. These data rather suggest, that the altered Treg/Tmem 
ratio is the result of an increased fungal load in the patients, maybe due to reduced phagocyte 
function (Donnely and Barnes, 2012), which alows conventional T cels to escape from Treg 
mediated control. However, also the functional capacities of the specific Treg in CF patients 
stil remain to be explored. 
In contrast to their assumably  protective function in  healthy  donors, the  generation  of a 
fungus-specific  Treg response in immunocompromised fungus infected  patients  might 
interfere with the development of a protective anti-fungal immune response. Although a clear 
increase of fungus-specific CD4+ Tcon frequencies was observed in fungus infected patients, 
the absolute numbers of reactive cels did not exceed the range of healthy donors, due to low 
overal counts of CD4+ T cels in these patients (Bacher et al., manuscript 5, in preparation). 
As the presence of fungus-specific Treg in these strongly immune-suppressed patients has not 
been demonstrated so far, it wil be important to determine whether fungus-specific Treg are 
involved in  dampening the fungus-specific immune response. It  has  been shown  previously 
that A. fumigatus spores  may evade innate immune recognition  by an immunological inert 
rodlet layer (Aimanianda et al.,  2009; Bruns et al.,  2010), as  wel as  by  binding  of 
complement regulators (Behnsen et al.,  2008). In this regard, the  preferential activation  of 
Treg cels  by A. fumigatus antigens could represent a further evading strategy,  which  might 
lead to enhanced survival and  persistence  of the fungus. It is  particular  of interest that the 
A. fumigatus proteins that have been identified in this study to elicit a strong memory Tcon 
response in healthy donors are also the main drivers of specific Treg expansion (Bacher et al., 
manuscript 6, submited). This, counter-regulation of the A. fumigatus T cel response might 
represent a barier for vaccine success and depletion of Treg could be a promising strategy to 
elicit ful anti-fungal T cel responses for immunotherapeutic approaches. 
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4.3 Influence of T cel cross-reactivity on anti-fungal immune responses 
 
Upon antigen recognition, antigen-specific  naive  T cels  undergo clonal expansion and 
diferentiate into efector and memory cels, which provide protection upon re-exposure to the 
pathogen (Jenkins et al.,  2001).  Hence, the antigen-specific  memory repertoire  of an 
individual represents a colection of expanded T cel clones, selected within the multitude of 
diferent immune responses  during the individuals´ life (Geiger et al.,  2009).  Although the 
T cel receptor repertoire is  highly  divers, it contains cross-reactive specificities, since the 
degeneracy  of the  T cel receptor alows recognition  of similar  peptides  by a single  TCR 
(Welsh and  Selin,  2002).  Thus, the  memory  T cel repertoire created in response to  one 
antigen can influence the immune response to another  unrelated antigen  by  T cel cross-
recognition of similar or identical peptides (Selin et al., 2006; Welsh et al., 2010; Welsh and 
Selin, 2002). 
T cel cross-reactivity  of  CD8+  T cels seems to  be a relatively common event  between 
diferent viruses in murine model systems, as wel as in humans (Acierno et al., 2003; Brehm 
et al.,  2002; Clute et al.,  2005; Kim et al.,  2005; Nilges et al.,  2003; Urbani et al.,  2005; 
Wedemeyer et al.,  2001; Welsh et al.,  2010).  Furthermore cross-reactive  T cels  have  been 
described  between  viral and  bacterial (Hohn et al.,  2003), alogeneic (Brehm et al.,  2003; 
Burows et al.,  1994; D'Orsogna et al.,  2010) and even self-antigens (McCoy et al.,  2006; 
Sospedra et al.,  2005; Wucherpfennig and  Strominger,  1995).  Recent  data  have also 
suggested the existence of cross-reactive immunity between fungi. Fungal cel wal structures 
have  been shown to confer  protective immunity in  mouse  models, since  vaccination  with 
heat-kiled Saccharomyces  protected  mice against lethal chalenge  with  diferent fungi, for 
instance Aspergilus,  Candida  or Coccidioides species (Capila et al.,  2009; Stevens et al., 
2011).  However,  whether this cross-protection is  mediated  by cross-reactive  T cels  or 
antibodies or whether it reflects a less specific mechanism, i.e. activation of innate immune 
cels during infection, has not been explored. In other recent studies, the generation of a CD4+ 
TCR transgenic  mouse  with specificity against a shared epitope  of four related  dimorphic 
fungi (Wüthrich et al., 2011), as wel as the identification of a cross-reactive T cel epitope of 
A. fumigatus and C.  albicans (Stuehler et al.,  2011)  have  been reported.  Thus, it seems 
obvious, that also  distantly related fungal species containing thousands  of  diferent  proteins 
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might share  highly conserved  protein sequences,  which can trigger cross-reactive  T cel 
responses between fungal pathogens. 
Interestingly, the curent study revealed that the T cel cross-reactivity between only distantly 
related fungi, i.e.  Mucorales and Aspergilus spp. is  only low,  whereas  T cels reactive to 
Scedosporia spp. and Fusaria spp. contained a significant fraction  of cels cross-reactive to 
Aspergilus spp. In addition, a strong  T cel cross-reactivity  between  diferent Aspergilus 
species was identified (Bacher et al., manuscript 5, in preparation). These data suggest, that 
the level  of  T cel cross-reactivity reflects at least to a certain extent the actual  overlap  of 
homologous  or similar antigenic epitopes and thus the  developmental relationship  between 
fungal species.  However,  one  of the  most  pronounced  T cel cross-reactivity  was identified 
between the  only  distantly related fungal  pathogens A. fumigatus and C. albicans. 
Intriguingly, in this case, the  observed  T cel cross-reactivity  did  not simply reflect the 
overlap  between the A. fumigatus and C. albicans specific  T cel repertoire,  but rather 
represents the selective expansion of cross-reactive cels, since the naive A. fumigatus-specific 
T cel pool was largely depleted from cross-reacting T cels. Furthermore, the cross-reactive 
cels  displayed  phenotypical and functional characteristics  of C.  albicans-reactive  T cels 
(Bacher et al.,  manuscript  4, in  preparation).  Hence, the selective expansion and the  high 
prevalence  of the cross-reactive cels  might  be  due to the constant encounter and thus 
permanent triggering  via C. albicans antigens. It  wil  be important to further  determine the 
protein specificity of the cross-reactive versus A. fumigatus-only reactive memory T cels to 
gain insights, whether diferent proteins of A. fumigatus are targeted in the lung and to define 
a role of cross-reactivity under physiological and pathological conditions.  
 
C. albicans is a commensal  on the  human skin and a common  part  of the intestinal 
microbiota. The gut microbiota is known to have a major impact the immune homeostasis of 
the  host (Backhed et al.,  2005; Macpherson and  Haris,  2004).  For example, in  germ-free 
mice, the adaptive immune system is largely underdeveloped (Round and Mazmanian, 2009). 
Inappropriate inflammatory responses to intestinal microorganisms are hypothesized to play a 
major role in the development and progression of inflammatory bowel diseases in geneticaly 
susceptible hosts (Abraham and Cho, 2009). In this regard it is especialy of interest, that the 
antigen-specific  T cel response against the  gut commensal C. albicans  was indeed strongly 
increased in  patients  with  CD and also  displayed alterations in the  production  of  pro-
inflammatory cytokines, i.e.  higher levels  of IFN-γ, IL-17 and IL-22 (Bacher et al., 
manuscript 4, in preparation). Also against other prominent gut commensals, like E. coli, an 
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increased CD4+ T cel response can be detected in CD patients, however in this case IFN-γ 
production is strongly reduced (Bacher and Schefold, unpublished data; Ergin et al., 2011). 
These  data indicate that a subpopulation  of  patients  with  CD  has indeed elevated  T cel 
reactivity against  gut  microbiota,  which is  probably  due to increased  permeability  of the 
intestinal barier.  However,  despite the  general increase in anti-microbiota  T cel responses, 
stil a pathogen-specific modulation of the adaptive immune response takes place. Thus it wil 
be important, to find corelates  of the antigen-specific  T cel responses in  CD  patients  with 
the course of disease, to beter define the role of microbiota-specific T cel responses in IBD. 
However, the intestinal microbiota is not only known to afect local immune homeostasis, but 
also immuno-pathology at gut-distal sites. In particular, the induction of Th17 cels has been 
demonstrated to depend on the presence of certain microbiota (Atarashi et al., 2008; Ivanov et 
al., 2009; Ivanov et al., 2008; Wu et al., 2010). Inappropriate Th17 responses have also been 
linked to a  number  of  gut-distal  diseases, including autoimmunity and severe lung 
inflammation (Akdis et al., 2012; Beteli et al., 2007; Cosmi et al., 2011). It is not yet clear, 
whether the Th17 cels that arise in presence of the commensal microbiota are also specific 
for commensal-derived antigens, or might also recognize other antigens at distal sites. As the 
intestinal  microbiota is  highly  divers it represents an extraordinary large amount  of foreign 
antigens.  Thus,  one  possible  mechanism  of  how intestinal  microorganisms  might influence 
non  gut-associated  pathology could  be  T cel cross-reactivity  between  gastrointestinal and 
gut-distal antigens. Estimations suggest that the intestinal microbiota encodes indeed 100-fold 
more  genes than the  human  genome (Ley et al.,  2006).  Thus, T cross-reactivity  driven  by 
commensal microbiota might be a common event in shaping antigen-specific T cel responses 
against gut-distal antigens. 
In the curent study it  was shown that C. albicans  driven  T cel cross-reactivity  has a 
profound influence  on the  T cel response against several inhaled fungal  pathogens. 
Remarkably,  up to  one third  of the A. fumigatus-specific  memory  T cels in  healthy  donors 
were indeed cross-reactive to C. albicans.  Considering further, that a large  proportion  of 
A. fumigatus-specific conventional T cels are stil in a naive state and preferentialy specific 
regulatory  memory  T cels  were identified in response to A. fumigatus (Bacher et al.,  2013; 
manuscript 3), these data further suggest that in healthy human donors no major conventional 
T cel  memory formation against inhaled A. fumigatus antigens takes  place.  Also in the 
analysis  of  T cel reactivity against several single A. fumigatus  proteins, an  overal  higher 
proportion of Th17 cels was identified for many immunogenic proteins, compared to the total 
T cel response against the A. fumigatus crude extract (Bacher et al., manuscript 6, submited). 
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This suggests, that the  T cel response against these  proteins  might  be induced  via cross-
reactivity to C. albicans. In fact, for the IL-17 inducing  proteins  Scw4 and 
Aspf 22, orthologous proteins exist in C. albicans (Nisini et al., 2001; Sundstrom and Aliaga, 
1994). 
 
Another important finding  of this study  was that the efect  of cross-reactivity  was  not  only 
observed on a quantitative level, but intriguingly also leads to a qualitative modulation of the 
T cel response against airborne fungi  by selective induction  of an IL-17/IL-22  producing 
T cel population. Although both, IFN-γ producing Th1 cels and IL-17 producing Th17 cels 
have been implicated to play a role in anti-fungal immune responses, the role of Th17 cels is 
stil controversialy  discussed.  Patients  with  STAT3  mutation,  who lack  Th17 cels, sufer 
from recurent candidiasis (McDonald,  2012),  but  not  other fungal infections, emphasizing 
the importance  of  Th17 responses for anti-Candida immune  defense,  but  questioning their 
role in  other anti-fungal immune responses.  However, in several  mouse  models,  protective 
roles  of  Th17 cels against  diferent fungal  pathogens  have  been  described, for instance 
Cryptococcus neoformans, Pneumocystis carini, Blastomyces dermatitidis (Kleinschek et al., 
2006; Rudner et al., 2007; Wüthrich et al., 2013). Contrarily, other studies suggest that Th17 
cels exacerbate inflammation and induce severe tissue  pathology in  mouse  models  of 
pulmonary aspergilosis (Romani et al., 2008; Zelante et al., 2009; Zelante et al., 2007). The 
deviating  protective versus  pathological role  of  Th17 cels in anti-fungal immunity in these 
studies  might simply reflect experimental  diferences  of the infection  models. In addition, 
especialy Th17 cels have been demonstrated to strongly vary between mice and humans in 
terms of precursors and diferentiation requirements (Annunziato et al., 2009; Annunziato et 
al., 2010; Annunziato and Romagnani, 2009). This makes conclusions from the role of Th17 
cels in animal models on the human anti-fungal T cel response dificult. Nevertheless, also 
in humans inappropriate Th17 responses are associated with a variety of severe lung diseases, 
including severe asthma,  COPD and airway  hypersensitivity (Alcorn et al.,  2010; Cosmi et 
al., 2011; Halwani et al., 2013). In particular, Th17 cels have been suggested to play a role in 
severe asthma  with fungal sensitization and cystic fibrosis (Chan et al.,  2013; Tan et al., 
2011). Thus, the induction of Th17 cels into the immune response against airborne fungi by 
cross-reactivity to C. albicans  might even  have  pathological consequences in  predisposed 
patients. In this scenario, the C. albicans induced cross-reactive Th17 cels might be further 
expanded through increased load  of airborne fungal antigens in the  patients´ lung and thus 
contribute to the disease development and/ or chronification. It wil be important to determine 
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the prevalence of airborne fungus-reactive Th17 cels in these particular patient groups and to 
find potential corelates with the course and status of the diseases.    
 
 
4.4 Fungus-specific CD4+ T cel response during invasive fungal infections 
 
Invasive fungal infections (IFI) are the  most  devastating  diseases caused  by environmental 
fungi and result in significant  mortality  of the infected  patients.  The rapid and reliable 
diagnosis of IFI has been shown to be crucial for a successful treatment outcome (Chamilos et 
al.,  2008; Cornely et al.,  2011),  but so far  only few  diagnostic and  prognostic tools are 
available in the clinical seting. The curent diagnosis of IFI is dificult, because the clinical 
manifestations are not generaly specific for fungal infections, and the available non-invasive 
diagnostic tools lack sensitivity and specificity (De Pauw et al., 2008; Ostrosky-Zeichner et 
al.,  2005).  Proven IFI can  only  be  diagnosed  by the  histological examination  of a sample 
taken from the infected site (De  Pauw et al.,  2008).  This requires  highly invasive  methods 
such as  biopsies  or surgical resection,  which are rarely feasible for  most  of the criticaly il 
patients and thus represent  only the last therapeutic  option after  unsuccessful anti-fungal 
treatment.  Therefore, the early  diagnosis  of IFI and  precise  definition  of the fungal species 
directly from peripheral blood samples could dramaticaly improve timely and targeted anti-
fungal treatment and thus the outcome of invasive fungal infections. 
Measurement of antigen-specific T cels has been suggested to be a promising strategy for the 
diagnosis  of  other infectious  diseases, e.g. tuberculosis  or lyme  boreliosis (Forsberg et al., 
1995; Harari et al., 2011; Lalvani et al., 2001; Meyer et al., 2000). Using CD154+ expression 
as a read-out, low frequencies of reactive CD4+ T cels against various opportunistic fungal 
pathogens were detected in al healthy donors (Bacher et al., manuscript 6, submited; Bacher 
et al., manuscript 5, in preparation). However, the frequency ranges in healthy donors were 
quite conserved at a low level, indicating that despite chronic exposure to fungal pathogens, 
the  T cel reactivity in  healthy individuals is rather low. In contrast, strongly increased 
frequencies  of fungus-reactive  CD4+  T cels  were  detected in  patients  with invasive fungal 
infections (Bacher et al., manuscript 5, in preparation). Importantly, the increased frequencies 
were  only  present  during acute fungal infection, and rapidly  declined folowing removal  of 
the fungus  by surgery.  This  underlines that the  quantification  of fungus-specific  T cels 
represents a promising strategy for the diagnosis of IFI. The measurement of fungus-specific 
CD4+ T cels was possible despite massive disease-associated alterations in the composition 
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of the patients PBMCs, demonstrating the robustness and sensitivity of the assay and the high 
potential to advance IFI diagnosis. 
However, in  15%  of the analyzed  patients  no  T cel frequencies could  be  detected  because 
they  had insuficient  numbers  of  T cels,  APCs,  or  had a too  high  background  of  CD154 
expression.  These limitations are  most likely associated  with the  previous treatment and 
probably transient.  Furthermore, in  most  of these cases just a single  measurement could  be 
performed.  Therefore, repeated  measurements and adjusted sample  volumes  might further 
reduce the  number  of  drop  out.  Nevertheless, the induction  of  CD154 expression requires 
processing of the fungal lysates by functional APCs and the background expression of CD154 
has to  be suficiently low to  detect an increase  of fungus-reactive  T cels.  Such limitations 
could  be  overcome  by  measuring antigen-specific  T cels  with  peptide-MHC class I 
multimers that directly bind to the T cel receptor, independent of the activation status of the 
T cels. However, as already stated above, the usage of multimers requires prior knowledge of 
exactly  defined antigenic epitopes and  needs to  be  matched  with the individual  MHC 
haplotypes  of the  patients.  Since  no immuno-dominant fungal antigens are  known so far, 
multimer-detection is not applicable to analyze fungus-specific T cels. Indeed, the analysis of 
T cel target  proteins from A. fumigatus revealed a  broad and  heterogeneous reactivity to a 
variety  of  different  proteins in  healthy  donors,  questioning the existence  of  one  or few 
immuno-dominant fungal antigens (Bacher et al.,  manuscript  6, submited). In addition, the 
prevalent  protein-specificity  of the specific  T cels  may  difer  between individual  patients. 
Therefore the  possibility to  use complete lysates from  diferent fungal species,  which are 
naturaly  processed  by the  APCs, enables to cover the  broad repertoire  of fungal antigens, 
independent of host-specific factors (e.g. MHC restriction and/ or TCR repertoire specificity). 
Besides the reliable detection of IFI, it is essential to know which fungal pathogen causes the 
invasive  disease, since  diferent fungal  pathogens require adjusted anti-fungal treatment 
(Cornely et al.,  2009; Kuse et al.,  2007; van  Burik et al.,  2006; Vehreschild et al.,  2013). 
However, even if the fungus  has  been isolated from  biopsies  or lung resection, the 
microscopic  discrimination  of similar filamentous fungi is  quite chalenging (Ostrosky-
Zeichner, 2012). The measurement of fungus-specific CD4+ T cels alowed a clear distinction 
between the most frequent invasive filamentous fungal genera Aspergilus spp. and Mucorales 
(Bacher et al.,  manuscript  5, in  preparation).  This  was confirmed  by the re-stimulation  of 
expanded fungus-reactive T cel lines, which showed only low T cel cross-reactivity between 
Aspergilus and  Mucorales species.  However,  within  diferent Aspergilus species, a strong 
T cel cross-reactivity was observed, indicating that discrimination on a species level might be 
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dificult  or requires comparative testing against  various A. fumigatus species. In addition, 
cross-reactivity was observed within Scedosporia spp. and Fusarium spp. specific T cel lines. 
This demonstrates, that depending on the fungal pathogen, cross-reactive T cels may account 
for  diferent  proportions  of the total fungal species-reactive  T cel  pool and that 
discrimination  of some fungal  pathogens requires  more  detailed analysis.  This  has to  be 
considered regarding the  diagnosis  of IFI,  based  on specific  T cel frequency alterations in 
high-risk patients. 
By comparing the results of the CD154+ T cel assay with the curent clinical diagnosis, the 
test  yielded a  high sensitivity and specificity in the analyzed  patients cohort  of  91.7% and 
92.3%, respectively.  For comparison,  other  non-invasive  blood and  BAL  based standard 
diagnostic assays reported sensitivities and specificities for ELISA measurement of cel wal 
β-1,3-D-glucan of 50% and 99% (Lamoth et al., 2012), for galactomannan of 78% and 81% 
(Leeflang et al.,  2008) and for  PCR  methods  of  75% and  87% (Mengoli et al.,  2009). In 
addition, galactomannan, the test with the highest sensitivity, is restricted to the detection of 
aspergilosis (De  Pauw et al.,  2008).  Thus the results  obtained  with the  T cel assay in the 
analyzed  patients cohort clearly exceeded the results  of curently available  blood tests for 
invasive fungal infections. Furthermore, the comparison of the T cel assay with the clinical 
diagnosis  was  performed  by considering  patients  with  proven and  probable IFI as  having 
confirmed IFI, whereas those patients with possible and no IFI were handled as having no IFI. 
Thus, the values for sensitivity and specificity of the T cel assay may even be higher, since 
the reference diagnosis is ambiguous in cases of probable and possible IFI. Indeed, regarding 
only  healthy  donors and  proven IFI, the test  yielded a sensitivity and sensitivity  of each 
100%, since no donor in the healthy control group (n = 100) had increased T cel frequencies 
and al six cases  of  proven IFI  were identified  by increased  T cel signals.  Of course, these 
results have to be evaluated in statisticaly adequate patient cohorts. 
 
The presence of high frequencies of fungus-specific CD4+ T cels in IFI patients also raises an 
important immunological  question.  For instance,  despite the strong expansion  of fungus-
specific CD4+ T cels, the fungal infection is not efectively cleared by the patients´ imune 
system.  Besides their  presence in  peripheral  blood, increased frequencies  of fungus-specific 
CD4+  T cels could also  be  detected in lung resections from infected  patients (Bacher and 
Schefold, unpublished data), indicating that the specific T cels are indeed present at the site 
of infection.  However, irespective  of increased frequencies  of fungus-reactive  T cels, the 
absolute numbers of CD4+ T cels in peripheral blood were strongly reduced in most patients. 
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Therefore,  despite  markedly increased frequencies in IFI  patients, the absolute  numbers  of 
fungus-specific T cels did not exceed the range of healthy donors for most patients or time 
points (Bacher et al., manuscript 5, in preparation). Thus one can hypothesize, that expansion 
or persistence of fungus-specific T cels in this strongly immune-suppressed patients cohort is 
only insuficient.  This  would also  be in line  with the fact that the fungus-specific  T cels 
revealed  only limited cytokine  producing capacity, indicating  only restricted efector 
functions of fungus-reactive T cels during fungal infections (Bacher et al., manuscript 5, in 
preparation). 
In summary, these results  may in  part explain  why invasive  mold infections are  not 
efectively cleared, despite the activation of a fungus-specific CD4+ T cel response and give 
a further rational for adoptive T cel transfer approaches to reconstitute and/or assist the anti-
fungal  CD4+  T cel response in IFI  patients.  The  multi-parameter characterization  of single 
A. fumigatus protein-specific T cel responses provided no evidence for the existence of one 
or a few immuno-dominant antigens but revealed a quite heterogeneous T cel response to a 
variety  of  diferent antigens in  healthy  donors.  Nevertheless, it enabled the classification  of 
various  proteins into "immunogenic", "tolerogenic"  or "exhausting"  groups (Bacher et al., 
manuscript  6, submited).  Thus, the  pre-selection  of certain antigens according to the 
phenotypic and functional characteristics of the reactive T cels might help to define immuno-
stimulatory and  protective targets for  vaccination strategies  or adoptive  T cel therapy 
approaches and could even be applied to define a selected set of target antigens for individual 
patients. Since in healthy donors the A. fumigatus-specific T cel response is strongly counter-
regulated  by specific  Treg cels (Bacher et al.,  2013;  manuscript  3), it  wil  be important to 
determine a  potential role for  Treg as additional risk factor for  preventing anti-fungal 
immunity in immunocompromised patients. However, also other parameters such as presence 
and function  of innate immune cels to execute  T cel signals  might  be causative for the 
failure to resolve the fungal infections in IFI patients and remain to be explored.  
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5 Summary 
 
Invasive fungal infections are a  major cause  of infection related  mortality in 
immunocompromised  patients.  Furthermore, inappropriate immune responses to fungal 
pathogens are associated with disease exacerbations in particular in patients with alergies or 
compromised lung functions, such as asthma or cystic fibrosis. Antigen-specific CD4+ T cels 
have  been suggested to  play a  major role in anti-fungal immune responses.  However, the 
exact quantification and detailed characterization of fungus-specific CD4+ T cels in humans 
has  been  hampered so far  by the lack  of appropriate  methods for their identification.  To 
overcome this technology gap, a flow-cytometric method was developed that alows for the 
first time the direct ex vivo detection and comprehensive characterization of the entire fungus-
reactive  CD4+  T cel compartment from  human  peripheral  blood, i.e. conventional  memory 
and naive CD4+ T cels (Tcon), as wel as regulatory T cels (Treg). Based on the magnetic 
pre-enrichment of fungal antigen stimulated CD154+ Tcon and CD137+ Treg, fungus-reactive 
CD4+ T cels can be analyzed from large starting cel numbers, which alows the colection of 
suficient numbers of target cels for subsequent phenotypic and functional analyses with high 
statistical  precision.  This technology  was  used to  perform a  detailed characterization  of the 
CD4+ T cel response against two  of the  major fungal  pathogens in  humans, the constantly 
inhaled airborne fungus Aspergilus fumigatus and the  gut- and skin-residing commensal 
Candida albicans. 
The analysis  of A. fumigatus and C.  albicans-reactive  CD4+  T cels revealed  profound 
diferences in the  T cel response against  both fungi, suggesting  diferent  pathogen-related 
and/or tissue compartment-specific immune  mechanisms. Interestingly,  both, specific  Tcon 
and Treg, could readily be detected in the blood of al healthy adult donors, reflecting most 
likely the frequently encounter  with  both fungal  pathogens.  However, whereas A. fumigatus 
generates  predominantly a  memory  Treg response and a large  part  of the specific  Tcon 
repertoire  was stil in a  naive state, a clear  dominating  memory  Tcon response could  be 
detected against C. albicans with only minor contribution of Treg. This tolerance patern of 
the A. fumigatus-specific T cel response was abrogated in patients with severe A. fumigatus 
alergies, suggesting that counter-regulation of anti-A. fumigatus immune responses by Treg 
might be an important mechanism for prevention of alergic disorders. 
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The further functional characterization of fungus-specific Tcon revealed a strong expansion of 
C. albicans-specific Th17 cels, whereas against A. fumigatus, as wel as other airborne fungi, 
Th17 cels  were  only rare,  questioning the curent  paradigm that  Th17 cels are in  general 
mandatory in anti-fungal immune  defense. Importantly, in al analyzed  donors, the 
A. fumigatus-reactive  memory  T cel repertoire always contained a significant population of 
cels with cross-reactivity to C. albicans antigens and only these cross-reactive cels displayed 
phenotypical characteristics  of  Th17 cels and  were able to  produce IL-17 and IL-22.  This 
finding might reflect a general mechanism, how the intestinal microbiota can influence local 
as wel as systemic immune homeostasis and pathology by specific expansion of particular Th 
cel subsets with reactivity to gastrointestinal and gut-distal antigens. 
Importantly, the possibility to characterize in detail the anti-fungal T cel response in healthy 
donors ofered the opportunity to find disease-associated changes in relevant patient groups. 
The analysis of a cohort of immunocompromised hematologic patients revealed that patients 
with invasive fungal infections  displayed strongly increased frequencies  of fungus-reactive 
T cels, compared to healthy controls or patients at risk, but without fungal infections. These 
data strongly suggest that the  measurement  of antigen-specific  T cel responses in  high-risk 
patients  might  be a  potential  parameter for the  diagnosis  of invasive fungal infections from 
peripheral blood samples. Despite increased frequencies within the CD4+ T cel compartment, 
the absolute  numbers  of fungus-reactive  T cels  were  not augmented and efector functions 
were  only limited.  Hence, adoptive transfer approaches  of fungus-specific  T cels  might 
confer protective immunity by reconstituting the anti-fungal CD4+ T cel response in high-risk 
patients, but are mainly hampered by the lacking knowledge about protective T cel targets. 
Indeed, the analysis  of  various A. fumigatus  development stages, subcelular fractions and 
single A. fumigatus proteins indicated that the T cel response is highly divers, questioning the 
existence  of  one  or few immuno-dominant target antigens.  However, the in  depth 
characterization of T cels specific for single A. fumigatus proteins revealed quantitative and 
qualitative  diferences  which alowed to classify the  various  proteins into "immunogenic" 
"exhausting"  or irelevant "non-target"  groups.  Thus this approach  may  provide a  general 
screening  procedure to identify appropriate  T cel targets for adoptive  T cel therapy  or 
vaccine development enabling pre-emptive or therapeutic intervention against the devastating 
fungal infections in immunocompromised patients. 
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6 Zusammenfassung 
 
Invasive Pilzinfektionen stelen eine Hauptursache für die Mortalität bei immunsupprimierten 
Patienten dar. Weiterhin sind unangemessene Immunreaktionen gegen Pilze mit Krankheits-
Verschlechterung in  Patienten  mit  Alergie  oder  beeinträchtigter  Lungenfunktion, z.B.  bei 
Asthma oder Mukoviszidose, assoziert. Verschiedene Daten deuten darauf hin, dass Antigen-
spezifische  CD4+  T  Zelen eine  wesentliche  Role in  der Immunantwort  gegen  pathogene 
Pilze spielen.  Alerdings  konnte eine exakte  Quantifizierung  und  detailierte 
Charakterisierung  von  Pilz-spezifischen  CD4+  T  Zelen im  Menschen  bislang  nicht 
durchgeführt werden, da keine geeigneten Methoden für deren Identifizierung zur Verfügung 
standen.  Um  diese  Technologie-Lücke zu schließen,  wurde eine  durchflusszytometrische 
Methode entwickelt,  die es erstmals ermöglicht,  das  gesamte  Pilz-spezifische  CD4+ T Zel 
Repertoire, d.h. konventionele Gedächtnis- und Naive T Zelen (Tcon), sowie regulatorische 
T  Zelen (Treg),  direkt ex vivo im  menschlichen  peripheren  Blut zu  detektieren  und 
umfassend zu charakterisieren.  Basierend auf  der  magnetischen  Voranreicherung  von 
Antigen-stimulierten CD154+ Tcon und CD137+ Treg, können Pilz-spezifische CD4+ T Zelen 
aus großen Start-Zelzahlen analysiert werden. Dies ermöglicht es, ausreichende Mengen an 
Zielzelen zu  detektieren,  um anschließende  phänotypische  und funktionele  Analysen  mit 
hoher statistischer  Präzision  durchzuführen.  Diese  Technologie  wurde angewandt,  um  die 
menschliche  CD4+  T  Zel  Antwort  gegen zwei  bedeutende  human-pathogene  Pilze,  den 
dauerhaft inhalierten  Schimmelpilz Aspergilus fumigatus, sowie  den  Darm-  und  Haut-
besiedelnden Hefepilz Candida albicans, detailiert zu charakterisieren. 
Die Analyse von A. fumigatus- und C. albicans-reaktiven CD4+ T Zelen zeigte umfassende 
Unterschiede in  der  T  Zel  Antwort  gegen  beide  Pilze auf.  Dies lässt auf  verschiedene 
Pathogen-bezogene  und/  oder  Gewebekompartiment-spezifische Immunmechanismen 
schließen. Interessanterweise  konnten sowohl spezifische  Tcon als auch  Treg  gegen  beide 
Pilze im  Blut  von erwachsenen  Menschen  nachgewiesen  werden,  was  höchstwahrscheinlich 
den regelmäßigen  Kontakt  des Immunsystems  mit  beiden  Pilzen reflektiert.  Während 
A. fumigatus jedoch  überwiegend eine  Gedächtnis  Treg  Antwort  generiert  und ein  Großteil 
der spezifischen Tcon Antwort noch einen naiven Phänotyp aufweist, ist die T Zel Antwort 
gegen C.  albicans eindeutig  durch  konventionele  Gedächtnis  T  Zelen  dominiert,  mit  nur 
geringer Beteiligung von Treg. Dieses Toleranz-Muster der A. fumigatus-spezifischen T Zel 
Antwort ist in  Patienten  mit schwerer Aspergilus  Alergie aufgehoben,  was  vermuten lässt, 
dass die Regulation der A. fumigatus-spezifischen T Zel Antwort durch Treg einen wichtigen 
Mechanismus darstelt, um alergische Immunreaktionen zu unterdrücken. 
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Die  weitere  Charakterisierung  der  Pilz-spezifischen  Tcon zeigte eine starke  Expansion  von 
C. albicans-spezifischen  Th17  Zelen,  während sowohl  gegen A. fumigatus, als auch andere 
luftübertragene  Pilze,  Th17  Zelen  unterepräsentiert  waren.  Dies stelt  das  derzeitige 
Paradigma in  Frage,  dass  Th17  Zelen in anti-Pilz Immunantworten  generel zwingend 
erforderlich sind.  Weiterhin  konnte  gezeigt  werden,  dass  das A. fumigatus-spezifische 
Gedächtnis  T  Zel  Repertoire eine signifikante  Population  von  Zelen enthält,  welche 
kreuzreaktiv  mit C. albicans  Antigenen sind  und  dass  nur  diese  kreuzreaktiven  Zelen 
phänotypische Marker von Th17 Zelen exprimieren und in der Lage sind, die Th17 Zytokine 
IL-17 und IL-22 zu sekretieren. Diese gezielte Induktion einer T Zel Sub-Population durch 
Kreuzreaktivität zwischen  gastro-intestinalen  und  peripheren  Antigenen  könnte einen 
generelen  Mechanismus  darstelen,  wie  die intestinale  Mikrobiota sowohl lokale, als auch 
systemische Immunhomöostase und Pathologie beeinflussen kann. 
Die  Möglichkeit  die anti-Pilz  T  Zel  Antwort in  gesunden  Spendern  detailiert zu 
charakterisieren stelt eine Grundvoraussetzung dar, um krankheitsassozierte Änderungen in 
relevanten  Patientengruppen zu erkennen.  Die  Analyse  von immunsupprimierten 
hämatologischen  Patienten zeigte,  dass im  Blut  von  pilzinfizierten  Patienten stark erhöhte 
Frequenzen an Pilz-reaktiven T Zelen detektiert werden können, im Gegensatz zu gesunden 
Menschen oder Risikopatienten ohne Pilzinfektion. Daher scheint die Messung von Antigen-
spezifischen  T Zel  Antworten in  Risikopatienten ein  vielversprechender  Parameter für  die 
Diagnose  von invasiven  Pilzinfektionen zu sein.  Trotz erhöhter  Frequenzen innerhalb  des 
CD4+  T  Zel  Kompartiments,  war  die absolute  Zahl an  Pilz-spezifischen  CD4+  T  Zelen 
jedoch  nicht erhöht  und  die  T  Zel  Efektor  Funktionen  nur limitiert.  Daher  wären adoptive 
Transferverfahren von Pilz-spezifischen T Zelen denkbar, um die anti-Pilz T Zel Antwort in 
Risikopatienten  wieder  herzustelen.  Ein solcher  Ansatz  wird  hauptsächlich  dadurch 
behindert, dass keine protektiven T Zel Zielantigene von Pilzen bekannt sind. 
Die  Analyse  von  Antigenen  verschiedener  Morphotypen, zelulärer  Proteinfraktionen  und 
Einzelproteine zeigte in der Tat, dass die T Zel Antwort gegen A. fumigatus sehr divers ist, 
was die Existenz von einem oder wenigen immun-dominanten Zielantigenen in Frage stelt. 
Die  detailierte  Charakterisierung  der  T  Zel  Antwort  gegen einzelne A. fumigatus  Proteine 
zeigte jedoch  quantitative  und  qualitative  Unterschiede auf,  die eine  Klassifizierung  der 
Proteine in „immunogene“, „ausbrennende“  oder irelevante „Nicht-Ziel“  Antigene 
ermöglichte. Dieser Ansatz könnte eine generele Screening Methode darstelen, um geeignete 
T  Zel  Antigene für adoptive  T  Zel  Therapien  oder  Vakzinierung zu identifizieren  und so 
präventive  oder therapeutische  Möglichkeiten  gegen  die  verheerenden  Pilzinfektionen in 
immunsupprimierten Patienten zu entwickeln. 
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